{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25259914",
                "http://www.ncbi.nlm.nih.gov/pubmed/26373274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760773",
                "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                "http://www.ncbi.nlm.nih.gov/pubmed/28969871",
                "http://www.ncbi.nlm.nih.gov/pubmed/26581522",
                "http://www.ncbi.nlm.nih.gov/pubmed/11439347",
                "http://www.ncbi.nlm.nih.gov/pubmed/19029249",
                "http://www.ncbi.nlm.nih.gov/pubmed/24836024",
                "http://www.ncbi.nlm.nih.gov/pubmed/22989712"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22989712",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Approximately 10% of all cancers, but a higher proportion of sarcomas, use the recombination-based alternative lengthening of telomeres (ALT) to maintain telomeres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11439347",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11439347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 353,
                    "text": "However there is at least one alternative mechanism of telomere lengthening (ALT) which is characterized by heterogeneous and elongated telomeres in the absence of telomerase activity (TA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760773",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Alternative lengthening of telomeres (ALT) is a telomerase-independent telomere maintenance mechanism that occurs in a subset of cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Alternative lengthening of telomeres (ALT) is an enigmatic process that allows certain cancers to maintain telomeres in the absence of telomerase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25259914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Telomere clustering is required for the homologous recombination events that maintain chromosome ends in cells relying on alternative lengthening of telomeres (ALT)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Some human cancers maintain telomeres using alternative lengthening of telomeres (ALT), a process thought to be due to recombination."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26373274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "In this issue of Cancer Cell, Ramamoorthy and Smith report that cancer cells that maintain their chromosome ends through alternative lengthening of telomeres (ALT) display persistent sister telomere cohesion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26581522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Alternative lengthening of telomeres (ALT) involves homology-directed telomere synthesis."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                "http://www.ncbi.nlm.nih.gov/pubmed/25024372",
                "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                "http://www.ncbi.nlm.nih.gov/pubmed/26329882",
                "http://www.ncbi.nlm.nih.gov/pubmed/25170079",
                "http://www.ncbi.nlm.nih.gov/pubmed/22753116",
                "http://www.ncbi.nlm.nih.gov/pubmed/26554817",
                "http://www.ncbi.nlm.nih.gov/pubmed/18585098",
                "http://www.ncbi.nlm.nih.gov/pubmed/28795382",
                "http://www.ncbi.nlm.nih.gov/pubmed/28336912"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28795382",
                    "endSection": "abstract",
                    "offsetInBeginSection": 827,
                    "offsetInEndSection": 970,
                    "text": "Fibroblast growth factor 21 (FGF21) and adiponectin represent the two major hormones secreted from the liver and adipose tissues, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 221,
                    "offsetInEndSection": 336,
                    "text": "FGF21 is secreted from liver upon fasting and acts on adipose tissue to promote lipolysis and responses to fasting."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25170079",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 336,
                    "text": "Fibroblast growth factor 21 (FGF21), a hormone that is predominantly secreted by the liver, exerts a broad range of effects upon the metabolism of carbohydrates and lipids."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 124,
                    "offsetInEndSection": 220,
                    "text": "FGF19 is secreted from intestine upon feeding and acts on liver to suppress bile acid synthesis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 19,
                    "text": "Klotho and \u03b2Klotho."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 337,
                    "offsetInEndSection": 442,
                    "text": "FGF23 is secreted from bone and acts on kidney to inhibit phosphate reabsorption and vitamin D synthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336912",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "We have previously shown that Fibroblast growth factor 21 (Fgf21) is expressed in the thymus as well as in the liver."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336912",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Fgf21 regulates T-cell development in the neonatal and juvenile thymus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26329882",
                    "endSection": "abstract",
                    "offsetInBeginSection": 229,
                    "offsetInEndSection": 328,
                    "text": "The small intestine of neonatal (but not adult) mice highly expresses \u03b2-Klotho in the luminal area."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 737,
                    "offsetInEndSection": 938,
                    "text": "Accordingly, FGF19, but not FGF21, activates FGF signaling in hepatocytes that primarily express FGFR4 and reduces transcription of CYP7A1 that encodes the rate-limiting enzyme for bile acid synthesis."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388932",
                "http://www.ncbi.nlm.nih.gov/pubmed/22004789",
                "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                "http://www.ncbi.nlm.nih.gov/pubmed/17439941",
                "http://www.ncbi.nlm.nih.gov/pubmed/25701678",
                "http://www.ncbi.nlm.nih.gov/pubmed/25531226",
                "http://www.ncbi.nlm.nih.gov/pubmed/25504797"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "While neddylation is known to activate cullin (CUL)-RING ubiquitin ligases (CRLs), its role in regulating T cell signaling is poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 197,
                    "offsetInEndSection": 327,
                    "text": "Here, we show that NEDD8 is covalently conjugated to histone 2A (H2A), and that neddylation of H2A antagonizes its ubiquitylation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 655,
                    "text": "Interestingly, RNF168 is itself a substrate for NEDD8, and neddylation of RNF168 is necessary for its E3 ubiquitin activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22004789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 538,
                    "text": "NEDD8 (neural-precursor-cell-expressed developmentally down-regulated 8) is the UBL most closely related to ubiquitin, and its best-studied role is the activation of CRLs (cullin-RING ubiquitin ligases) by its conjugation to a conserved C-terminal lysine residue on cullin proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 656,
                    "offsetInEndSection": 774,
                    "text": "Inhibition of RNF168 neddylation impairs the interaction between RNF168 and its E2 enzyme Ubc13 (also known as UBE2N)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 168,
                    "offsetInEndSection": 306,
                    "text": "In particular, conjugation of NEDD8 (neddylation) serves to regulate protein ubiquitination through modifications to E3 ubiquitin ligases."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "RNF168-mediated H2A neddylation antagonizes ubiquitylation of H2A and regulates DNA damage repair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 265,
                    "text": "Unlike RING-type neddylation ligases, HECT-type neddylation ligase remains less defined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17439941",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 984,
                    "text": "Mutant Cul1 that is unable to recruit adaptor and substrate recognition subunits exhibits markedly reduced neddylation, and inhibiting binding of adaptor and substrate recognition subunits to wild type Cul1 reduces Nedd8 modification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 204,
                    "text": "Neddylation is a posttranslational modification that plays important roles in regulating protein structure and function by covalently conjugating NEDD8, an ubiquitin-like small molecule, to the substrate."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                "http://www.ncbi.nlm.nih.gov/pubmed/18054789",
                "http://www.ncbi.nlm.nih.gov/pubmed/19322196",
                "http://www.ncbi.nlm.nih.gov/pubmed/24310611",
                "http://www.ncbi.nlm.nih.gov/pubmed/22139015",
                "http://www.ncbi.nlm.nih.gov/pubmed/18342610",
                "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                "http://www.ncbi.nlm.nih.gov/pubmed/11377793",
                "http://www.ncbi.nlm.nih.gov/pubmed/27760120",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388737"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27760120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 239,
                    "offsetInEndSection": 411,
                    "text": "How DNA damage induces assembly and execution of a DNA replication complex (break-induced replisome) at telomeres or elsewhere in the mammalian genome is poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24310611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 324,
                    "text": "DNA replication stress is prevalent in cancer, but BIR has not been characterized in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22139015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 617,
                    "text": "A functional replisome is restored by the reloading of GINS and polymerase \u025b onto DNA in a fashion that is dependent on RAD51 and MRE11 but independent of replication origin assembly and firing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 599,
                    "text": "The targeting preference for the terminus of replication and DNA double-strand breaks is dependent on the Tn7-encoded protein TnsE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19322196",
                    "endSection": "abstract",
                    "offsetInBeginSection": 469,
                    "offsetInEndSection": 677,
                    "text": "Here, we show that the replication checkpoint suppresses the formation of Rad52 foci in an Mrc1-dependent manner and prevents homologous recombination (HR) at chromosome breaks induced by the HO endonuclease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Double-strand breaks in DNA can be repaired by homologous recombination including break-induced replication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19322196",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 304,
                    "text": "Tolerance to replication stress also depends on the Mec1 kinase, which activates the DNA replication checkpoint in an Mrc1-dependent manner in response to fork arrest."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18342610",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 653,
                    "text": "Cleavage is dependent on DNA replication, but the observation of two ends at the break argues that cleavage does not occur at the replication fork."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                    "endSection": "abstract",
                    "offsetInBeginSection": 109,
                    "offsetInEndSection": 258,
                    "text": "In this reaction, the end of a broken DNA invades an intact chromosome and primes DNA replication resulting in the synthesis of an intact chromosome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24310611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Break-induced replication repair of damaged forks induces genomic duplications in human cells."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                "http://www.ncbi.nlm.nih.gov/pubmed/11390511",
                "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                "http://www.ncbi.nlm.nih.gov/pubmed/20305780",
                "http://www.ncbi.nlm.nih.gov/pubmed/22189956",
                "http://www.ncbi.nlm.nih.gov/pubmed/20888336",
                "http://www.ncbi.nlm.nih.gov/pubmed/18220905",
                "http://www.ncbi.nlm.nih.gov/pubmed/16569374",
                "http://www.ncbi.nlm.nih.gov/pubmed/15743780"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1459,
                    "offsetInEndSection": 1723,
                    "text": "CONCLUSIONS\nOur results indicate that TLR2 agonists indirectly inhibit fibrocyte differentiation and that, for some TLR2 agonists, this inhibition involves other cell types in the PBMC population secreting an unknown factor that inhibits fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11390511",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1061,
                    "offsetInEndSection": 1291,
                    "text": "We show that secondary lymphoid chemokine, a ligand of the CCR7 chemokine receptor, acts as a potent stimulus for fibrocyte chemotaxis in vitro and for the homing of injected fibrocytes to sites of cutaneous tissue injury in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                    "endSection": "abstract",
                    "offsetInBeginSection": 125,
                    "offsetInEndSection": 322,
                    "text": "Since Toll-like receptors (TLRs) are present on monocytes, and pathogens that can infect a wound have and/or release TLR agonists, we examined whether TLR agonists affect fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 793,
                    "offsetInEndSection": 951,
                    "text": "The activated fibrocyte build the collagen of the granulation tissue and then remodel and ensure wound contraction by becoming fibroclasts and myofibroblasts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 838,
                    "text": "Monoclonal antibodies that bind to Fc gammaRI (CD64) or Fc gammaRII (CD32) also inhibit fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 481,
                    "text": "The microscopic, electron microscopic and immunohistochemical observation of biopsy specimens taken at an early stage, at close and regular intervals (every 4 hours), from open skin wounds created in the pig and the monkey, together with quantitative analysis of the various cell types in the granulation tissue, supports the conception that the activated fibrocyte (fibroblast) originates from the fibrocyte of the wound edges and thus completes some earlier experimental studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1041,
                    "offsetInEndSection": 1219,
                    "text": "This factor is not interferon (IFN)-\u03b1, IFN-\u03b3, interleukin (IL)-12, aggregated immunoglobulin G (IgG) or serum amyloid P (SAP), factors known to inhibit fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 438,
                    "offsetInEndSection": 586,
                    "text": "As SAP binds to Fc receptors for immunoglobulin G (IgG; Fc gammaRs), Fc gammaR activation may be an inhibitory signal for fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1280,
                    "offsetInEndSection": 1449,
                    "text": "These results suggest that culturing murine spleen cells in serum-free medium is a rapid and efficient system to study factors that can affect fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 412,
                    "offsetInEndSection": 566,
                    "text": "An alternative source of fibrocytes is the splenic reservoir of monocytes, where one can obtain significantly more cells compared to the peripheral blood."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26687445",
                "http://www.ncbi.nlm.nih.gov/pubmed/25385579",
                "http://www.ncbi.nlm.nih.gov/pubmed/24055342",
                "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                "http://www.ncbi.nlm.nih.gov/pubmed/28376483",
                "http://www.ncbi.nlm.nih.gov/pubmed/26536864",
                "http://www.ncbi.nlm.nih.gov/pubmed/27693036",
                "http://www.ncbi.nlm.nih.gov/pubmed/25846769",
                "http://www.ncbi.nlm.nih.gov/pubmed/25972893"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25972893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Long non-coding RNAs (lncRNAs) are transcripts without protein-coding potential but having a pivotal role in numerous biological functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                    "endSection": "abstract",
                    "offsetInBeginSection": 603,
                    "offsetInEndSection": 912,
                    "text": "We show that LOI results in defects in muscle differentiation and hypertrophy and identify primary downstream targets: Igf2 overexpression results in over-activation of MAPK signaling while loss of H19 lncRNA prevents normal down regulation of p53 activity and therefore results in reduced AKT/mTOR signaling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27693036",
                    "endSection": "abstract",
                    "offsetInBeginSection": 973,
                    "offsetInEndSection": 1093,
                    "text": "These findings indicated that H19 might regulate the tumor growth and metastasis via miR-140 dependent iASPP regulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26687445",
                    "endSection": "abstract",
                    "offsetInBeginSection": 754,
                    "offsetInEndSection": 1042,
                    "text": "Our results uncover an unanticipated regulatory circuit involving broad epigenetic alterations by a single abundantly expressed lncRNA that may underlie gene methylation dynamics of development and diseases and suggest that this mode of regulation may extend to other cellular components."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1076,
                    "offsetInEndSection": 1260,
                    "text": "This study thus identifies new biochemical roles for the H19 lncRNA and underscores that LOI phenotypes are multigenic so that complex interactions will contribute to disease outcomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26536864",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1337,
                    "offsetInEndSection": 1558,
                    "text": "According to a holistic approach, the versatile, seemingly contradictory functions of H19 are essential to, and differentially harnessed by, the tumor cell depending on its context within the process of tumor progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                    "endSection": "abstract",
                    "offsetInBeginSection": 959,
                    "offsetInEndSection": 1150,
                    "text": "This work thus adds to the body of literature describing the multiple roles in oncogenesis, cellular growth, glucose metabolism, and now regulation of steroidogenesis, of this complex lncRNA."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Loss of imprinting mutations define both distinct and overlapping roles for misexpression of IGF2 and of H19 lncRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 595,
                    "text": "Here we demonstrate that StAR is a novel target of the microRNA let-7, which itself is regulated by the long noncoding RNA (lncRNA) H19."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24055342",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 332,
                    "text": "However, how H19 acts to regulate gene function has remained enigmatic, despite the recent implication of its encoded miR-675 in limiting placental growth."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27456981",
                "http://www.ncbi.nlm.nih.gov/pubmed/25851859",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987820",
                "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                "http://www.ncbi.nlm.nih.gov/pubmed/25390401",
                "http://www.ncbi.nlm.nih.gov/pubmed/22703855",
                "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                "http://www.ncbi.nlm.nih.gov/pubmed/28154831",
                "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                "http://www.ncbi.nlm.nih.gov/pubmed/12090544"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 467,
                    "text": "SUMMARY\nDinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1661,
                    "text": "CONCLUSION\nDinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28154831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 511,
                    "text": "GD2 is the first ganglioside proven to be an effective target antigen for cancer immunotherapy with the regulatory approval of dinutuximab, a chimeric anti-GD2 therapeutic antibody."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1290,
                    "offsetInEndSection": 1592,
                    "text": "Dinutuximab administered in combination with GM-CSF, IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and limited therapeutic options."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987820",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "Filgrastim-sndz (Zarxio) to help prevent infections related to chemotherapy, dinutuximab (Unituxin) for high-risk pediatric neuroblastoma, and panobinostat (Farydak) for multiple myeloma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25851859",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "The FDA approved the use of dinutuximab, in combination with three other agents, for high-risk neuroblastoma, offering patients the first major new treatment in more than a decade."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27456981",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma [Formula: see text]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Dinutuximab is a monoclonal antibody targeted at disialoganglioside (GD2), a tumor-associated antigen widely expressed in human neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 149,
                    "offsetInEndSection": 308,
                    "text": "The incorporation of dinutuximab into standard treatment regimens for patients with high-risk neuroblastoma has changed the landscape of neuroblastoma therapy."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27550178",
                "http://www.ncbi.nlm.nih.gov/pubmed/26079792",
                "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/24475069",
                "http://www.ncbi.nlm.nih.gov/pubmed/21431156",
                "http://www.ncbi.nlm.nih.gov/pubmed/26518661",
                "http://www.ncbi.nlm.nih.gov/pubmed/8601195"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 432,
                    "offsetInEndSection": 544,
                    "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24475069",
                    "endSection": "abstract",
                    "offsetInBeginSection": 817,
                    "offsetInEndSection": 1103,
                    "text": "Empirical studies on synthetic samples and applications using several ChIP data sets including 16 TF (transcription factor) ChIP-seq data sets and five TF ChIP-exo data sets have demonstrated that our proposed method is capable of finding these motifs with high efficiency and accuracy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26518661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 631,
                    "text": "We show that Leo1-Paf1 [a subcomplex of the RNA polymerase II-associated factor 1 complex (Paf1C)] is required to prevent the spreading of heterochromatin into euchromatin by mapping the heterochromatin mark H3K9me2 using high-resolution genomewide ChIP (ChIP-exo)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1138,
                    "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 475,
                    "offsetInEndSection": 664,
                    "text": "When applied to our GR and the few available public ChIP-exo data sets, we find that ChIP-exo footprints are protein- and recognition sequence-specific signatures of genomic TF association."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 869,
                    "text": "A significant improvement of the ChIP-seq technique results from the addition of an exonuclease treatment during the immunoprecipitation step (ChIP-exo) that lowers background noise and more importantly increases the identification of binding sites to a level near to single-base resolution by effectively footprinting DNA-bound proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 297,
                    "text": "To identify sequences responsible for recruitment of this transcription factor (TF) to individual loci, we turned to the high-resolution ChIP-exo approach."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24475069",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "ChIP-seq, which combines chromatin immunoprecipitation (ChIP) with next-generation parallel sequencing, allows for the genome-wide identification of protein-DNA interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27550178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "Recently, a number of advances have been implemented into the core ChIP-seq (chromatin immunoprecipitation coupled with next-generation sequencing) methodology to streamline the process, reduce costs or improve data resolution."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                "http://www.ncbi.nlm.nih.gov/pubmed/19715670",
                "http://www.ncbi.nlm.nih.gov/pubmed/22677107",
                "http://www.ncbi.nlm.nih.gov/pubmed/18179904",
                "http://www.ncbi.nlm.nih.gov/pubmed/2308845",
                "http://www.ncbi.nlm.nih.gov/pubmed/20591530",
                "http://www.ncbi.nlm.nih.gov/pubmed/15313545",
                "http://www.ncbi.nlm.nih.gov/pubmed/3032452",
                "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                "http://www.ncbi.nlm.nih.gov/pubmed/26530673"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26530673",
                    "endSection": "abstract",
                    "offsetInBeginSection": 262,
                    "offsetInEndSection": 571,
                    "text": "This approach is indispensable if information about wide range of deletion types in a sample is critical, such as in studies concerning distribution of deletion breakpoints (as opposed to approaches where fraction of a single deletion or a limited set of deletions is used as a proxy for total deletion load)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3032452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 453,
                    "text": "Members of the Alu family of repetitive sequences are frequently found at the breakpoints and we describe a novel deletion due to homologous recombination between such repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19715670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 299,
                    "offsetInEndSection": 500,
                    "text": "In this study, we investigated the deletion breakpoints of the parkin mutations in 22 families with AR-JP and examined the possible association between these deletion events and meiotic recombinations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19715670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 108,
                    "offsetInEndSection": 298,
                    "text": "On initial screening of Japanese patients with AR-JP, we had found that approximately half of the parkin mutations are deletions occurring between exons 2 and 5, forming a deletion hot spot."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 162,
                    "text": "Large deletions are found in approximately 5% of patients with severe haemophilia A, but only a few deletion breakpoints have been characterised precisely so far."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 512,
                    "text": "Seven of the deletions, five of which were unique to a particular animal, did not have direct repeats at the deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22677107",
                    "endSection": "abstract",
                    "offsetInBeginSection": 77,
                    "offsetInEndSection": 186,
                    "text": "The Pakistani deletion is 506kb in length, and the second largest \u03b5\u03b3\u03b4\u03b2 thalassemia deletion reported to date."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2308845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 928,
                    "text": "Computer analysis showed a correlation between the location of the deletion breakpoints and sequences in human mtDNA similar to the target sequence for Drosophila topoisomerase II."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 244,
                    "text": "The large majority of mitochondrial DNA (mtDNA) deletions analyzed from mitochondrial myopathies and aging humans have been found to be flanked by direct repeats, a finding which has led to the slip-replication hypothesis of deletion formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22677107",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 76,
                    "text": "We describe a novel deletion causing \u03b5\u03b3\u03b4\u03b2 thalassemia in a Pakistani family."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27308606",
                "http://www.ncbi.nlm.nih.gov/pubmed/29344130",
                "http://www.ncbi.nlm.nih.gov/pubmed/22258142",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                "http://www.ncbi.nlm.nih.gov/pubmed/27246710",
                "http://www.ncbi.nlm.nih.gov/pubmed/24039610",
                "http://www.ncbi.nlm.nih.gov/pubmed/22319583",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429839"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 965,
                    "text": "Although, the precise contribution of RNA molecules by themselves and RNA-regulated processes on cancer development is currently unknown, recent data suggest their important role in carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 545,
                    "text": "Studies on the recently discovered of EBV-encoded microRNAs (ebv-miRNAs) showed that these small molecules function as post-transcriptional gene regulators and may play a role in the carcinogenesis process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 756,
                    "text": "Emerging evidence shows that circRNAs play important roles in several diseases, particularly in cancer where they act through regulating protein expression of the pivotal genes that are critical for carcinogenesis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Circular RNA participates in the carcinogenesis and the malignant behavior of cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 338,
                    "text": "Reports have shown that EBV produces several viral oncoproteins, yet their pathological roles in carcinogenesis are not fully elucidated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 39,
                    "offsetInEndSection": 208,
                    "text": "According to the currently accepted model of carcinogenesis, several consequential mutations in oncogenes or tumor suppressor genes are necessary for cancer development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 753,
                    "offsetInEndSection": 838,
                    "text": "The importance of several miR-BARTs in carcinogenesis has recently been demonstrated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 515,
                    "text": "Recent studies have mainly been devoted to the function of the circular RNA sponge for miR-7 (ciRS-7) and sex-determining region Y (SRY) by targeting microRNA-7 (miR-7) and microRNA-138 (miR-138), respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 691,
                    "offsetInEndSection": 897,
                    "text": "Furthermore, circRNA, together with its gene silencing ability, also shows its potential in RNA interference (RNAi) therapy by binding to target RNAs, which provides a novel perspective in cancer treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22258142",
                    "endSection": "abstract",
                    "offsetInBeginSection": 175,
                    "offsetInEndSection": 293,
                    "text": "Yiya is a 1.9 kb long intergenic ncRNA gene mapped to chromosome 1q41, a well-established cancer susceptibility locus."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12573800",
                "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                "http://www.ncbi.nlm.nih.gov/pubmed/17555553",
                "http://www.ncbi.nlm.nih.gov/pubmed/23604405",
                "http://www.ncbi.nlm.nih.gov/pubmed/28017472",
                "http://www.ncbi.nlm.nih.gov/pubmed/7076336",
                "http://www.ncbi.nlm.nih.gov/pubmed/23954170",
                "http://www.ncbi.nlm.nih.gov/pubmed/21972134",
                "http://www.ncbi.nlm.nih.gov/pubmed/7375016"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 430,
                    "text": "Nardilysin enhances the alpha-secretase activity of the disintegrin and metalloproteases (ADAMs) 10 and 17, thereby possibly contributing to reduced generation of amyloidogenic fragments from the amyloid precursor protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 818,
                    "offsetInEndSection": 936,
                    "text": "Mitochondrial MDH increased nardilysin activity about 50%, while nardilysin stabilized mMDH towards heat inactivation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17555553",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23954170",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Nardilysin prevents amyloid plaque formation by enhancing \u03b1-secretase activity in an Alzheimer's disease mouse model."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28017472",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Loss of Nardilysin, a Mitochondrial Co-chaperone for \u03b1-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and Neurodegeneration."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21972134",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Tubulin potentiates the interaction of the metalloendopeptidase nardilysin with the neuronal scaffold protein p42IP4/centaurin-\u03b11 (ADAP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21972134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 300,
                    "text": "We found colocalization of the neuronal protein p42(IP4) (centaurin-\u03b11; ArfGAP with dual pleckstrin homology domain [ADAP1]), the metalloendopeptidase nardilysin (NRD; involved in axonal maturation and myelination) and tubulin in the cytosol and at the plasma membrane of SH-SY5Y neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 431,
                    "offsetInEndSection": 602,
                    "text": "A prerequisite for the alpha-secretase-stimulating effect of nardilysin on the activity of ADAMs in vivo is cellular co-expression of nardilysin with ADAM10 and/or ADAM17."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 221,
                    "text": "Gel filtration chromatography showed that nardilysin activity in a rat testis or rat brain extract exhibited an apparent molecular weight of approximately 300 kDa compared to approximately 187 kDa for the purified enzyme."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "The peptidase nardilysin is involved in degradation of neuropeptides and limited intracellular proteolysis."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                "http://www.ncbi.nlm.nih.gov/pubmed/8295886",
                "http://www.ncbi.nlm.nih.gov/pubmed/762406",
                "http://www.ncbi.nlm.nih.gov/pubmed/20849365",
                "http://www.ncbi.nlm.nih.gov/pubmed/17301213",
                "http://www.ncbi.nlm.nih.gov/pubmed/16572060",
                "http://www.ncbi.nlm.nih.gov/pubmed/17915461",
                "http://www.ncbi.nlm.nih.gov/pubmed/9636858",
                "http://www.ncbi.nlm.nih.gov/pubmed/28164990",
                "http://www.ncbi.nlm.nih.gov/pubmed/18346520"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Mycobacterium tuberculosis is very rarely found in erythema induratum of Bazin; recently, we found an unusual case with positive acid-fast bacilli and polymerase chain reaction for detecting M.\u00a0tuberculosis in both skin lesions of the extremities and the site of Mantoux test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17915461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 257,
                    "offsetInEndSection": 659,
                    "text": "The informative value of the study rapid method for the diagnosis of tuberculosis was generally 1.8 times less than that of the Mantoux tuberculin test with 2 TE of PPD-L (only intensive and hyperergic tuberculin tests were kept in mind): 6.1 times less in patients with small forms; 1.4 times less in the examinees with disseminated processes; 1.5 times greater than in chronic pulmonary tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18346520",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "This study compared the effectiveness of the QuantiFERON-TB Gold (QFT) assay with the Mantoux tuberculin skin test to detect Mycobacterium tuberculosis infection in 29 children during a school outbreak of tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8295886",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 344,
                    "text": "It is demonstrated that tuberculin electrophoresis in chemoprophylaxix for M.tuberculosis infection in adolescents with a marked of hyperergic reaction to the Mantoux test (2TU) contributes to enhancement of nonspecific immunological reactivity, to a decline in immunospecific reactions, and reduction in the response to the Mantoux test (2TU)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17915461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 256,
                    "text": "The diagnostic informative value of the Serochek MBT test (Zephyr Biomedicals, India) in detecting serum Mycobacterium tuberculosis antibodies was compared with that of the Mantoux tuberculin test with 2 TE of PPD-L in patients with pulmonary tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9636858",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1100,
                    "offsetInEndSection": 1262,
                    "text": "We conclude that the application of antigens by the Mantoux method is more efficient than MULTITEST CMI for detecting DTH skin responses in HIV-infected patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Mycobacterium tuberculosis found at both skin lesions and Mantoux testing site in a patient with erythema induratum of Bazin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9636858",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 574,
                    "text": "DTH responses were assessed with use of two antigenic panels administered simultaneously: tuberculin purified protein derivative (PPD) plus three control antigens (Candida albicans, mumps antigen, and tetanus toxoid) administered by the Mantoux method and by a multiple-puncture device delivering seven antigens percutaneously (MULTITEST CMI; Institut M\u00e9rieux, Lyon, France)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9636858",
                    "endSection": "abstract",
                    "offsetInBeginSection": 575,
                    "offsetInEndSection": 888,
                    "text": "Eighty-three patients (23%) were anergic, 216 (60%) reacted to both panels, 55 (15%) did not react to MULTITEST CMI but did react to the antigens administered by Mantoux method, and only five (1%) reacted to MULTITEST CMI without reacting to antigens administered by the Mantoux method (P < .001, McNemar's test)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20849365",
                    "endSection": "abstract",
                    "offsetInBeginSection": 804,
                    "offsetInEndSection": 1031,
                    "text": "We therefore recommend proper clinical assessment and other investigations for the diagnosis of TB in children in settings with a high prevalence of HIV infection and malnutrition, as Mantoux reaction results may be unreliable."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                "http://www.ncbi.nlm.nih.gov/pubmed/27172589",
                "http://www.ncbi.nlm.nih.gov/pubmed/21060220",
                "http://www.ncbi.nlm.nih.gov/pubmed/25104323",
                "http://www.ncbi.nlm.nih.gov/pubmed/25920860",
                "http://www.ncbi.nlm.nih.gov/pubmed/25449904",
                "http://www.ncbi.nlm.nih.gov/pubmed/27475263",
                "http://www.ncbi.nlm.nih.gov/pubmed/26936552",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/27217465"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1166,
                    "offsetInEndSection": 1278,
                    "text": "An identical set of plasma samples were analyzed utilizing the Bio-Plex Pro\u2122 human cytokine 27-plex immunoassay."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27217465",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 54,
                    "text": "Biomarker Panel for Chronic Graft-Versus-Host Disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25449904",
                    "endSection": "abstract",
                    "offsetInBeginSection": 621,
                    "offsetInEndSection": 933,
                    "text": "METHODS\nAn eight-month parallel diagnostic study was conducted to measure potential economic benefits of testing hospitalised patients with the Luminex xTAG Gastrointestinal Pathogen Panel (GPP) compared with conventional laboratory testing (based on a combination of culture, microscopy and enzyme immunoassay)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 169,
                    "text": "Serological diagnostics of hepatitis B in clinical laboratories is mainly based on detection of HBs antigen (HBsAg) in human serum or plasma using commercial ELISA kits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25449904",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "A cost benefit analysis of the Luminex xTAG Gastrointestinal Pathogen Panel for detection of infectious gastroenteritis in hospitalised patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "Performance of ELISA HBsAg Test Kits with Use of the Different Types of Panels Containing HBsAg."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25449904",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1248,
                    "offsetInEndSection": 1438,
                    "text": "CONCLUSION\nSyndromic testing of patients against a broad panel of organisms using a multiplex molecular panel can both improve detection rates and allow better laboratory workflow practices."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27217465",
                    "endSection": "abstract",
                    "offsetInBeginSection": 479,
                    "offsetInEndSection": 667,
                    "text": "Of 105 proteins showing at least a 1.25-fold difference in expression, 22 were selected on the basis of involvement in relevant pathways and enzyme-linked immunosorbent assay availability."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8222382",
                "http://www.ncbi.nlm.nih.gov/pubmed/1688257",
                "http://www.ncbi.nlm.nih.gov/pubmed/19558342",
                "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                "http://www.ncbi.nlm.nih.gov/pubmed/27920715",
                "http://www.ncbi.nlm.nih.gov/pubmed/24121849",
                "http://www.ncbi.nlm.nih.gov/pubmed/10695494",
                "http://www.ncbi.nlm.nih.gov/pubmed/19389587",
                "http://www.ncbi.nlm.nih.gov/pubmed/27428494",
                "http://www.ncbi.nlm.nih.gov/pubmed/23804334"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24121849",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 187,
                    "text": "Alteplase is a licensed thrombolytic treatment for ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 564,
                    "offsetInEndSection": 715,
                    "text": "Ticlopidine (500 mg/day), a new antiplatelet agent, is more effective than aspirin in preventing stroke and death in patients with TIA or minor stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 369,
                    "text": "Antithrombotic treatment with an antiplatelet agent or anticoagulant assumes a prior clinical classification into categories of transient ischaemic attack (TIA) or minor stroke, acute partial stable stroke, stroke-in-progression, and completed stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24121849",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "Thrombolytic dosing in acute ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1688257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 211,
                    "text": "Thrombolytic therapy is likely to be effective in some patients with stroke, but further improvements may require combination treatment with neuroprotective agents that can be given rapidly with relative safety."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 862,
                    "offsetInEndSection": 937,
                    "text": "Aspirin has not been directly shown to be effective after completed stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23804334",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 50,
                    "text": "Is sonothrombolysis an effective stroke treatment?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 716,
                    "offsetInEndSection": 861,
                    "text": "Ticlopidine (500 mg/day) is effective in preventing recurrent stroke, myocardial infarction, or vascular death in patients with completed stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1688257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 539,
                    "offsetInEndSection": 657,
                    "text": "Combined glutamate antagonist and thrombolytic therapy may provide increased efficacy and safety for stroke treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8222382",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Antiplatelet therapy in the treatment of cerebrovascular disease."
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12668060",
                "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                "http://www.ncbi.nlm.nih.gov/pubmed/17923143",
                "http://www.ncbi.nlm.nih.gov/pubmed/17234143",
                "http://www.ncbi.nlm.nih.gov/pubmed/21344187",
                "http://www.ncbi.nlm.nih.gov/pubmed/14575721",
                "http://www.ncbi.nlm.nih.gov/pubmed/18418417",
                "http://www.ncbi.nlm.nih.gov/pubmed/18278824",
                "http://www.ncbi.nlm.nih.gov/pubmed/24664764",
                "http://www.ncbi.nlm.nih.gov/pubmed/15454965"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Adeno-associated viral (AAV) vector-mediated gene replacement for the treatment of muscular dystrophy represents a promising therapeutic strategy in modern medicine."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15454965",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 834,
                    "text": "Here, we review immunity against AAV vector and transgene in the context of gene delivery specific to muscles for treating muscular dystrophies and non-muscle diseases in large animal models and human trials, factors that influence the intensity of the immune responses, and immune modulatory strategies to prevent unwanted immune responses and induce tolerance to the vector and therapeutic gene for a successful gene therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18278824",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 592,
                    "text": "Adeno-associated viruses (AAVs) represent an attractive alternative to adenoviral vector systems as they enable stable and long-term expression and can target a variety of different ocular cell types depending on the capsid serotype; recently clinical trails for congenital blindness was initiated with a vector-based AAV serotype 2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21344187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 228,
                    "offsetInEndSection": 410,
                    "text": "The paper firstly introduced the AAV vectors and the techniques of eye delivery, then summarized some tested genes that were used in past treatment to retinal degeneration disorders."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21344187",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Adeno-associated virus (AAV) based gene therapy for eye diseases."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14575721",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 57,
                    "text": "Adeno-associated viral vectors for retinal gene transfer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18418417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 701,
                    "offsetInEndSection": 850,
                    "text": "Here, we review different approaches for treating inherited retinal degenerations and more common acquired retinal disorders using AAV-based vectors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14575721",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Vectors derived from adeno-associated viruses (AAV) represent a promising tool for retinal gene transfer in pre-clinical and clinical settings."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18418417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 323,
                    "text": "The most widely used vectors for ocular gene delivery are based on adeno-associated virus (AAV), because they elicit minimal immune responses and mediate long-term transgene expression in a variety of retinal cell types."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20873404",
                "http://www.ncbi.nlm.nih.gov/pubmed/28635796",
                "http://www.ncbi.nlm.nih.gov/pubmed/14702207",
                "http://www.ncbi.nlm.nih.gov/pubmed/22679745",
                "http://www.ncbi.nlm.nih.gov/pubmed/15005642",
                "http://www.ncbi.nlm.nih.gov/pubmed/24961534",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                "http://www.ncbi.nlm.nih.gov/pubmed/19122569",
                "http://www.ncbi.nlm.nih.gov/pubmed/16651823",
                "http://www.ncbi.nlm.nih.gov/pubmed/29450391"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 621,
                    "offsetInEndSection": 776,
                    "text": "Citicoline has been studied worldwide in both ischemic and hemorrhagic clinical stroke with excellent safety and possibly efficacy found in several trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 777,
                    "offsetInEndSection": 1015,
                    "text": "A meta-analysis of four randomized US clinical citicoline trials concluded that treatment with oral citicoline within the first 24 h after a moderate to severe stroke is safe and increases the probability of complete recovery at 3 months."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Efficacy of citicoline as an acute stroke treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1016,
                    "offsetInEndSection": 1129,
                    "text": "Citicoline clinical efficacy trials are now continuing outside of the US in both ischemic and hemorrhagic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22679745",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Choline-positive neuroprotectors citicoline and choline alfoscerate decreased blood concentration of protein S100 in clinical trial on 52 patients in the first days after acute ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20873404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 322,
                    "text": "Citicoline is a unique drug with neuroprotective properties that demonstrated the positive results in patients with stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19122569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 696,
                    "text": "Although individual human stroke trials have been inconclusive, meta-analysis of 10 trials enrolling 2279 patients suggests patients receiving citicoline had substantially reduced frequencies of death and disability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15005642",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 362,
                    "text": "Citicoline has also been investigated as a therapy in stroke patients, although the results of trials to date are inconclusive."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20873404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 198,
                    "text": "Data on the mechanism of action of the neuroprotector citicoline, its effectiveness in the experimental models of cerebral ischemia and in patients with ischemic and hemorrhagic stroke are reviewed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28635796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 760,
                    "offsetInEndSection": 1252,
                    "text": "According to the results of clinical trials of the dosage regimen, citicoline administered in the dose of 1000 mg/day for 8 weeks accelerates the regression of hemiplegia; the intravenous injection in the dose of 750 mg/day for 10 days, starting with the first 48 hours of stroke onset symptoms, promotes the recovery of motor and cognitive functions; the intravenous injection in the dose of 1 g within 14 days improves the recovery of consciousness, general condition and functional status."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9119402",
                "http://www.ncbi.nlm.nih.gov/pubmed/10022501",
                "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                "http://www.ncbi.nlm.nih.gov/pubmed/7689553",
                "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                "http://www.ncbi.nlm.nih.gov/pubmed/28559441",
                "http://www.ncbi.nlm.nih.gov/pubmed/8567751",
                "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                "http://www.ncbi.nlm.nih.gov/pubmed/12686136"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 413,
                    "text": "The LOXL3\u00a0protein contains four scavenger receptor cysteine-rich\u00a0(SRCR) domains in the N-terminus in addition to the C-terminal characteristic domains of the lysyl oxidase\u00a0(LOX) family, such as a copper-binding domain, a cytokine receptor\u2011like domain and residues for the lysyl-tyrosyl quinone cofactor."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 45,
                    "text": "Lysyl oxidase-like protein from bovine aorta."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                    "endSection": "abstract",
                    "offsetInBeginSection": 980,
                    "offsetInEndSection": 1239,
                    "text": "We have isolated a 56-kDa protein identified by amino acid sequencing as the bovine lysyl oxidase-like precursor, which is cleaved at the Arg-Arg-Arg sequence at positions 89-91 by a furin-like activity, as revealed after deblocking of the N-terminal residue."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12686136",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "Lysyl oxidase (LOX) and four lysyl oxidase-like proteins, LOXL, LOXL2, LOXL3 and LOXL4, each contain a copper binding site, conserved lysyl and tyrosyl residues that may contribute to quinone co-factor formation, and a cytokine receptor-like domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 987,
                    "text": "It appears therefore that the genes encoding lysyl oxidase and a lysyl oxidase-like protein share a common evolutionary origin and may also be functionally related."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "We have isolated a number of recombinant clones from a human skin fibroblast cDNA library that contain extensive sequence homology to several coding domains within the human lysyl oxidase mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                    "endSection": "abstract",
                    "offsetInBeginSection": 81,
                    "offsetInEndSection": 295,
                    "text": "Their deduced amino acid sequences are characterized by a strong similarity in the C-terminal region, corresponding to the lysyl oxidase family catalytic domain, and by marked differences in the N-terminal regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8567751",
                    "endSection": "abstract",
                    "offsetInBeginSection": 500,
                    "offsetInEndSection": 730,
                    "text": "Both cell lines secreted apparently identical, 29 kDa forms of mature lysyl oxidase each of which catalyzed the deamination of human recombinant tropoelastin and alkylamines, consistent with the known specificity of lysyl oxidase."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                "http://www.ncbi.nlm.nih.gov/pubmed/26249737",
                "http://www.ncbi.nlm.nih.gov/pubmed/22872134",
                "http://www.ncbi.nlm.nih.gov/pubmed/18805046",
                "http://www.ncbi.nlm.nih.gov/pubmed/19047680",
                "http://www.ncbi.nlm.nih.gov/pubmed/24597762",
                "http://www.ncbi.nlm.nih.gov/pubmed/29195860",
                "http://www.ncbi.nlm.nih.gov/pubmed/16397142",
                "http://www.ncbi.nlm.nih.gov/pubmed/28846098"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28846098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 887,
                    "offsetInEndSection": 1020,
                    "text": "Here we report that GDNF-family receptor \u03b1-like (GFRAL), an orphan member of the GFR-\u03b1 family, is a high-affinity receptor for GDF15."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Growth differentiation factor-15 (GDF15), a member of the transforming growth factor-\u03b2 superfamily, is associated with human cancer progress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16397142",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "Here we identified growth-differentiation factor 15 (GDF15) (also known as MIC-1), a secreted member of the transforming growth factor (TGF)-beta superfamily, as a novel antihypertrophic regulatory factor in the heart."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28846098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 279,
                    "text": "Growth/differentiation factor 15 (GDF15), also known as MIC-1, is a distant member of the transforming growth factor-\u03b2 (TGF-\u03b2) superfamily and has been implicated in various biological functions, including cancer cachexia, renal and heart failure, atherosclerosis and metabolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19047680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "Growth differentiation factor 15 (GDF15) is a divergent member of the transforming growth factor-beta superfamily and has been identified in different contexts as a hypoxia-inducible gene product and as a molecule involved in hepcidin regulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28846098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1613,
                    "offsetInEndSection": 1724,
                    "text": "Together, our data demonstrate that GFRAL is a receptor for GDF15 that mediates the metabolic effects of GDF15."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 269,
                    "text": "Growth differentiation factor 15 (GDF15), a transforming growth factor (TGF)-beta superfamily member, has been cloned from a placenta cDNA library as a gene product that has promoted activation of pro-matrix metalloproteinase (MMP)2 mediated by membrane type (MT)1-MMP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26249737",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Growth differentiation factor-15 (GDF15), a member of the TGF-\u03b2 superfamily, affects tumor biology of certain cancers, but remains poorly understood in bladder cancer cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18805046",
                    "endSection": "abstract",
                    "offsetInBeginSection": 747,
                    "offsetInEndSection": 955,
                    "text": "Based on these observations, we conclude that GDF15 is a positive gene of OSCC development and progression and GDF15 can be used as an additional marker for histopathologic evaluation of OSCC differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26249737",
                    "endSection": "abstract",
                    "offsetInBeginSection": 758,
                    "offsetInEndSection": 982,
                    "text": "The expressions of mammary serine protease inhibitor (MASPIN) and N-myc downstream-regulated family genes (NDRG1, NDRG2, and NDRG3) were upregulated by GDF15 overexpressions and rhGDF15 treatments in bladder carcinoma cells."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24853856",
                "http://www.ncbi.nlm.nih.gov/pubmed/20068404",
                "http://www.ncbi.nlm.nih.gov/pubmed/20215986",
                "http://www.ncbi.nlm.nih.gov/pubmed/27603326",
                "http://www.ncbi.nlm.nih.gov/pubmed/17631027",
                "http://www.ncbi.nlm.nih.gov/pubmed/23717903",
                "http://www.ncbi.nlm.nih.gov/pubmed/25190612",
                "http://www.ncbi.nlm.nih.gov/pubmed/28894914",
                "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                "http://www.ncbi.nlm.nih.gov/pubmed/27639907"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23717903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 550,
                    "text": "This review describes some dysimmune neuromuscular disorders and their recent management: syndrome of peripheral nerve hyperexcitability (treatment of cramps, immunosuppressors); Guillain-Barr\u00e9 syndrome (new mechanisms and consensus treatment); chronic inflammatory demyelinating polyradiculoneuropathy (new indication for the use of pulse dexamethasone, new scores of activity); importance of subcutaneous immunoglobulin in multifocal motor neuropathy and of infusions of rituximab in myasthenia gravis; new entities in myositis and their treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20068404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "Ofatumumab is an anti-CD20 IgG1kappa human monoclonal antibody that is being considered by the US Food and Drug Administration and the European Medicines Agency for marketing approval as a treatment for chronic lymphocytic leukemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27639907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "INTRODUCTION\nRituximab is a chimeric anti-CD20\u00a0monoclonal antibody generally well tolerated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24853856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 318,
                    "text": "This is the case of a 79-year-old man with chronic lymphocytic leukemia who presented with Guillain-Barr\u00e9 syndrome with features overlapping with the Miller Fisher syndrome and Bickerstaff brainstem encephalitis and positive antiganglioside GQ1b antibody about 6 months after treatment with bendamustine and rituximab."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27603326",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 31,
                    "text": "Rituximab: Uses in Dermatology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                    "endSection": "abstract",
                    "offsetInBeginSection": 452,
                    "offsetInEndSection": 685,
                    "text": "Here we describe a pediatric patient with steroid-dependent chronic ITP who presented with arthralgia and fever ten days after the second infusion of rituximab (on day 10), and presented with malaise and maculopapular rash on day 21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1056,
                    "text": "To our knowledge, among pediatric patients who received rituximab for chronic ITP, this is the sixth documented case of serum sickness and the only one who manifested an elevated level of HACA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25190612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 686,
                    "offsetInEndSection": 868,
                    "text": "We summarize data from preclinical studies and recent clinical trials including the Phase III trial in chronic lymphocytic leukemia (CLL), which led to FDA approval in November 2013."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27603326",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 709,
                    "text": "Currently, rituximab is only FDA-approved for treatment of follicular and diffuse large B-cell non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis (formerly Wegener's granulomatosis) and microscopic polyangiitis."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23493417",
                "http://www.ncbi.nlm.nih.gov/pubmed/27548226",
                "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                "http://www.ncbi.nlm.nih.gov/pubmed/16054100",
                "http://www.ncbi.nlm.nih.gov/pubmed/29053959",
                "http://www.ncbi.nlm.nih.gov/pubmed/22907750",
                "http://www.ncbi.nlm.nih.gov/pubmed/25621662",
                "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                "http://www.ncbi.nlm.nih.gov/pubmed/28166452",
                "http://www.ncbi.nlm.nih.gov/pubmed/24754597"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28166452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 284,
                    "text": "Recent evidence has shown that DNA replication stress is a major driver of genomic instability and tumorigenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Oncogene-induced replication stress is recognized as the primary cause of accumulation of DNA damage and genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 754,
                    "text": "Loss of WRN affects cell cycle progression and results in enhanced accumulation of double-strand breaks and instability at common fragile sites in cells experiencing oncogene-induced replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1218,
                    "text": "Overall, our findings give insights into the mechanisms protecting replication forks in cells experiencing oncogene-induced replication stress, and identify factors that, when mutated or dysfunctional, may enhance genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27548226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 947,
                    "text": "Although replication stress has been proven to induce genomic instability and tumorigenesis, recent studies have counterintuitively shown that enhancing replicative stress through further loosening of the remaining checkpoints in cancer cells to induce their catastrophic failure of proliferation may provide an alternative therapeutic approach."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 766,
                    "offsetInEndSection": 930,
                    "text": "Furthermore, overexpression of TBP alone causes the hallmarks of oncogene-induced replication stress, including replication fork slowing, DNA damage and senescence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25621662",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 709,
                    "text": "A model to explain the presence of the three hallmarks listed above, as well as the patterns of genomic instability observed in human cancers, proposes that the genes driving cell proliferation induce DNA replication stress, which, in turn, generates genomic instability and selects for escape from apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29053959",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 794,
                    "text": "In addition to SMARCAL1, other SNF2-family fork remodelers, including ZRANB3 and HLTF, cause nascent DNA degradation and genomic instability in BRCA1/2-deficient cells upon replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1219,
                    "offsetInEndSection": 1535,
                    "text": "In addition, because concomitant depletion of WRN and MUS81 causes synthetic sickness in cells growing under oncogene-induced replication stress, our results support the possibility of targeting cancer cells with an impaired replication fork recovery pathway by a specific inactivation of the other parallel pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23493417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 812,
                    "offsetInEndSection": 968,
                    "text": "We also highlight the checkpoint function as an anti-cancer barrier preventing cells malignant transformation following oncogene-induced replication stress."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1684050",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584894",
                "http://www.ncbi.nlm.nih.gov/pubmed/8789849",
                "http://www.ncbi.nlm.nih.gov/pubmed/17170912",
                "http://www.ncbi.nlm.nih.gov/pubmed/7517371",
                "http://www.ncbi.nlm.nih.gov/pubmed/23595645",
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/17210911",
                "http://www.ncbi.nlm.nih.gov/pubmed/19043689",
                "http://www.ncbi.nlm.nih.gov/pubmed/1550546"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 943,
                    "text": "We assessed this method by comparing the aDNA results from one petrous bone processed using our novel method to its pair, which was processed using established protocols for sampling disarticulated petrous bones."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 495,
                    "text": "The osseous labyrinth inside the petrous bone has been shown to yield higher amounts of endogenous DNA than any other skeletal element; however, accessing this labyrinth in cases of a complete or reconstructed skull involves causing major structural damage to the cranial vault or base."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684050",
                    "endSection": "abstract",
                    "offsetInBeginSection": 104,
                    "offsetInEndSection": 320,
                    "text": "Significant amounts of genetic information can be recovered from ancient bone: mitochondrial DNA sequences of 800 base pairs have been amplified from a 750-year-old human femur by using the polymerase chain reaction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17170912",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 471,
                    "text": "The objective of this article is to present a personal classification of petrous bone cholesteatomas, a survey of recent surgical attitudes, and our present surgical strategy based on our experience with 54 operations between 1978 and 1990."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17170912",
                    "endSection": "abstract",
                    "offsetInBeginSection": 833,
                    "offsetInEndSection": 987,
                    "text": "Five cases with petrous bone cholesteatomas in different locations are described in detail to present the signs and symptoms together with the management."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Ancient DNA (aDNA) research involves invasive and destructive sampling procedures that are often incompatible with anthropological, anatomical, and bioarcheological analyses requiring intact skeletal remains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8789849",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Morphometric variables on the human petrous portion of the temporal bone can provide identification of sex in fragmented skeletal remains."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7517371",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 40,
                    "text": "The biochemistry of ancient DNA in bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 944,
                    "offsetInEndSection": 1160,
                    "text": "We show a decrease in endogenous DNA and molecular copy numbers when the drilling method is used; however, we also show that this method produces more endogenous DNA and higher copy numbers than any postcranial bone."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21041408",
                "http://www.ncbi.nlm.nih.gov/pubmed/11572975",
                "http://www.ncbi.nlm.nih.gov/pubmed/25961948",
                "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                "http://www.ncbi.nlm.nih.gov/pubmed/28520720",
                "http://www.ncbi.nlm.nih.gov/pubmed/9659912",
                "http://www.ncbi.nlm.nih.gov/pubmed/11886074",
                "http://www.ncbi.nlm.nih.gov/pubmed/21445000",
                "http://www.ncbi.nlm.nih.gov/pubmed/1868837",
                "http://www.ncbi.nlm.nih.gov/pubmed/11278282"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21445000",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 514,
                    "text": "We have previously shown that in vitro-transcribed, protein-free U6 and U2 snRNAs can catalyze a two-step splicing reaction in trans on two short RNA oligonucleotides that is identical to the splicing reactions performed by many self-splicing group II introns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 640,
                    "offsetInEndSection": 822,
                    "text": "The splicing of these ultra-short introns was repressed by a splicing inhibitor, spliceostatin A, suggesting that SF3b (a U2 snRNP component) is involved in their splicing processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28520720",
                    "endSection": "abstract",
                    "offsetInBeginSection": 827,
                    "offsetInEndSection": 958,
                    "text": "Short intron splicing efficiency is increased by secondary structure, and we detect both canonical and non-canonical short introns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1868837",
                    "endSection": "abstract",
                    "offsetInBeginSection": 292,
                    "offsetInEndSection": 383,
                    "text": "Instead, AU-rich sequences, a characteristic feature of dicot plant introns, are essential."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11886074",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "We describe in this review, the salient splicing features of group I introns of bacteriophage T4 and propose, a hypothetical model to fit in the self-splicing of nrdB intron of T4 phage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11572975",
                    "endSection": "abstract",
                    "offsetInBeginSection": 723,
                    "offsetInEndSection": 1540,
                    "text": "We conclude: (i) that short introns in Drosophila melanogaster and Caenorhabditis elegans contain essentially all of the information for their recognition by the splicing machinery, and computer programs that simulate splicing specificity can predict the exact boundaries of approximately 95% of short introns in both organisms; (ii) that in yeast, the 5'ss, branch signal, and 3'ss can accurately identify intron locations but do not precisely determine the location of 3' cleavage in every intron; and (iii) that the 5'ss, branch signal, and 3'ss are not sufficient to accurately identify short introns in plant and human transcripts, but that specific subsets of candidate intronic enhancer motifs can be identified in both human and Arabidopsis that contribute dramatically to the accuracy of splicing simulators."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 479,
                    "text": "By screening an annotated human transcriptome database (H-InvDB), we identified three model ultra-short introns: the 56-nt intron in the HNRNPH1 (hnRNP H1) gene, the 49-nt intron in the NDOR1 (NADPH dependent diflavin oxidoreductase 1) gene, and the 43-nt intron in the ESRP2 (epithelial splicing regulatory protein 2) gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1125,
                    "offsetInEndSection": 1369,
                    "text": "Remarkably, shared G-rich intronic sequences in the 49- and 43-nt introns were required for their splicing, suggesting that these ultra-short introns may recruit a novel auxiliary splicing mechanism linked to G-rich intronic splicing enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9659912",
                    "endSection": "abstract",
                    "offsetInBeginSection": 545,
                    "offsetInEndSection": 731,
                    "text": "Rather, the four classes of introns described here can be sorted into two mechanistic classes (U2- or U12-dependent) by inspection of the complete set of conserved splice site sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25961948",
                    "endSection": "abstract",
                    "offsetInBeginSection": 608,
                    "offsetInEndSection": 819,
                    "text": "We then provide experimental and bioinformatic evidence for the splicing of 15 introns, of which 12 introns were remarkably G-rich and 9 introns contained completely inefficient splice sites and/or branch sites."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10996130",
                "http://www.ncbi.nlm.nih.gov/pubmed/19813219",
                "http://www.ncbi.nlm.nih.gov/pubmed/11820729",
                "http://www.ncbi.nlm.nih.gov/pubmed/2866930",
                "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                "http://www.ncbi.nlm.nih.gov/pubmed/2875077",
                "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                "http://www.ncbi.nlm.nih.gov/pubmed/19962663",
                "http://www.ncbi.nlm.nih.gov/pubmed/19283672",
                "http://www.ncbi.nlm.nih.gov/pubmed/3797"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10996130",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 513,
                    "text": "Particular emphasis is placed upon the properties and inhibition of lysyl oxidase, the enzyme which initiates the covalent crosslinking of extracellular collagen molecules converting these to insoluble fibers, and upon the properties and inhibition of prolyl hydroxylase, the intracellular enzyme which hyroxylates proline residues within collagen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11820729",
                    "endSection": "abstract",
                    "offsetInBeginSection": 851,
                    "offsetInEndSection": 1146,
                    "text": "On the other hand, coenzyme A did not stimulate the activity nor the gene expression of two other processing enzymes: lysyl hydroxylase, which provides the sites for glycosylation and crosslinking between collagen peptides, and lysyl oxidase, a fundamental enzyme in intermolecular crosslinking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "The deposition of insoluble functional collagen occurs following extracellular proteolytic processing of procollagens by procollagen N- and C-proteinases, fibril formation, and lysyl oxidase dependent cross-linking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2866930",
                    "endSection": "abstract",
                    "offsetInBeginSection": 568,
                    "offsetInEndSection": 683,
                    "text": "The results suggest that lysyl oxidase initiates crosslink formation at an early stage in collagen fibrillogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                    "endSection": "abstract",
                    "offsetInBeginSection": 430,
                    "offsetInEndSection": 704,
                    "text": "Studies determine whether inhibition of procollagen C-proteinase activity with a specific BMP-1 inhibitor results in perturbations in lysyl oxidase activation, and in collagen processing, deposition, and cross-linking in phenotypically normal cultured murine MC3T3-E1 cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "A procollagen C-proteinase inhibitor diminishes collagen and lysyl oxidase processing but not collagen cross-linking in osteoblastic cultures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Lysyl oxidase catalyzes the formation of crosslinking aldehydes in collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3797",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 256,
                    "text": "Activity of lysyl oxidase, an enzyme responsible for production of aldehydic precursors for lysine-derived collagen crosslinks, was measured in tibial metaphyses from chicks receiving different dietary levels of vitamin D and Ca for 2 weeks after hatching."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19813219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Lysyl oxidase (LOX) is a copper-dependent enzyme that initiates covalent crosslinking of elastin precursors by oxidizing peptidyl lysine to aminoadipic semi-aldehydes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2866930",
                    "endSection": "abstract",
                    "offsetInBeginSection": 227,
                    "offsetInEndSection": 482,
                    "text": "The apparent binding affinity of lysyl oxidase for native fibrils is quite similar to that for fibrils prepared from pepsin- or chymotrypsin-digested type I collagen, demonstrating that the enzyme binds to the triple-helical portion of collagen molecules."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23992719",
                "http://www.ncbi.nlm.nih.gov/pubmed/2980021",
                "http://www.ncbi.nlm.nih.gov/pubmed/9827946",
                "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                "http://www.ncbi.nlm.nih.gov/pubmed/3881094",
                "http://www.ncbi.nlm.nih.gov/pubmed/7933737",
                "http://www.ncbi.nlm.nih.gov/pubmed/18167574",
                "http://www.ncbi.nlm.nih.gov/pubmed/1235315",
                "http://www.ncbi.nlm.nih.gov/pubmed/378143",
                "http://www.ncbi.nlm.nih.gov/pubmed/15480006"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/378143",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "A new method is described for stabilizing dehiscence or instability of median sternotomy incisions using stainless steel retention sutures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18167574",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Steel wire sternum fixation in patients who underwent median sternotomy for cardiac surgery, is a routine procedure in our clinical practice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 348,
                    "text": "We describe the case of a 51-year-old woman with severe nickel allergy who underwent aortic valve replacement with a nickel-free ON-X prosthesis and sternal closure by Fiberwire # 2 suture without complications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Nickel allergy can raise clinical problems in patients undergoing cardiac surgery who require sternal closure with stainless steel wire."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23992719",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 384,
                    "text": "We describe an easy and safe way for sternal stenting using conventional sternal steel wires."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15480006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 96,
                    "offsetInEndSection": 267,
                    "text": "The standard method of closure uses stainless steel wiring of the sternal halves; however, in complicated sternal closures, sternal cut-through and wire failure can occur."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15480006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 826,
                    "offsetInEndSection": 1025,
                    "text": "The use of plate and wire fixation represents an alternate method to conventional techniques to achieve sternal closure, stability, and uncomplicated wound healing in these difficult-to-manage cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3881094",
                    "endSection": "abstract",
                    "offsetInBeginSection": 132,
                    "offsetInEndSection": 345,
                    "text": "This article presents a simple, easy-to-perform method of sternal closure utilizing reinforcement of the sternal halves with a material that is less likely to cut through the sternum and that is readily available."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2980021",
                    "endSection": "abstract",
                    "offsetInBeginSection": 273,
                    "offsetInEndSection": 408,
                    "text": "These wires occasionally break or pull through bone, resulting in instability of either a portion of the sternum or the entire sternum."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23992719",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Twisted wire stent technique for delayed sternal closure after congenital heart operations."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16464717",
                "http://www.ncbi.nlm.nih.gov/pubmed/26774474",
                "http://www.ncbi.nlm.nih.gov/pubmed/22334133",
                "http://www.ncbi.nlm.nih.gov/pubmed/26934309",
                "http://www.ncbi.nlm.nih.gov/pubmed/27662867",
                "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                "http://www.ncbi.nlm.nih.gov/pubmed/28533025",
                "http://www.ncbi.nlm.nih.gov/pubmed/25561718",
                "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                "http://www.ncbi.nlm.nih.gov/pubmed/27068475"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 322,
                    "text": "Here, by using genome-wide binding profiling, we show extensive occupancy of transcription factors of myogenesis (MyoD and Myogenin) at extragenic enhancer regions coinciding with RNA synthesis (i.e., eRNA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 210,
                    "offsetInEndSection": 300,
                    "text": "However, it remains unclear how tightly coupled eRNA production is with enhancer activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 509,
                    "text": "In particular, multiple regions were transcribed to eRNA within the regulatory region of MYOD1, including previously characterized distal regulatory regions (DRR) and core enhancer (CE)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28533025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 329,
                    "offsetInEndSection": 415,
                    "text": "Additionally, eRNA has also served as a marker for global identification of enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 943,
                    "text": "We have uncovered a P-TEFb activation mechanism and reveal altered eRNA expression that is related to abnormal AR function and may potentially be a therapeutic target in CRPC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                    "endSection": "abstract",
                    "offsetInBeginSection": 342,
                    "offsetInEndSection": 517,
                    "text": "PSA eRNA binds to CYCLIN T1, activates P-TEFb, and promotes cis and trans target gene transcription by increasing serine-2 phosphorylation of RNA polymerase II (Pol II-Ser2p)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28533025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 328,
                    "text": "The correlation between eRNA production and enhancer activity has stimulated studies on the potential role of eRNAs in transcriptional regulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26774474",
                    "endSection": "abstract",
                    "offsetInBeginSection": 934,
                    "offsetInEndSection": 1074,
                    "text": "Collectively, these findings illustrate the complex epigenetic circuitry imposed by PGC-1\u03b1 at the eRNA level to fine-tune energy metabolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27662867",
                    "endSection": "abstract",
                    "offsetInBeginSection": 508,
                    "offsetInEndSection": 743,
                    "text": "The procedure can be multiplexed to simultaneously visualize both eRNA and protein-coding transcript at the site of transcriptional elongation, thereby permitting analysis of dynamics between the two transcript species in single cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                    "endSection": "abstract",
                    "offsetInBeginSection": 518,
                    "offsetInEndSection": 615,
                    "text": "We define an HIV-1 TAR RNA-like (TAR-L) motif in PSA eRNA that is required for CYCLIN T1 binding."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                "http://www.ncbi.nlm.nih.gov/pubmed/28715909",
                "http://www.ncbi.nlm.nih.gov/pubmed/22326347",
                "http://www.ncbi.nlm.nih.gov/pubmed/11248028",
                "http://www.ncbi.nlm.nih.gov/pubmed/8358435",
                "http://www.ncbi.nlm.nih.gov/pubmed/22909319",
                "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                "http://www.ncbi.nlm.nih.gov/pubmed/23591814"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 716,
                    "text": "Our results not only define GTPBP2 as a ribosome rescue factor but also unmask the disease potential of mutations in nuclear-encoded tRNA genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22326347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 908,
                    "offsetInEndSection": 1186,
                    "text": "Our results showed accumulations of peptidyl-tRNA associated with ribosomes in mutants for release factors (RF1, RF2, and RF3), ribosome recycling factor (RRF), Pth, and transfer-messenger RNA (tmRNA), implying that each of these factors cooperate in rescuing stalled ribosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 766,
                    "text": "Rrn3 is the first RNA polymerase I-specific transcription factor shown to be functionally conserved between yeast and mammals, suggesting that at least one mechanism that regulates ribosomal RNA synthesis is conserved among eukaryotes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22909319",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "During the initiation stage of eukaryotic mRNA translation, the eIF4G (eukaryotic initiation factor 4G) proteins act as an aggregation point for recruiting the small ribosomal subunit to an mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23591814",
                    "endSection": "abstract",
                    "offsetInBeginSection": 285,
                    "offsetInEndSection": 373,
                    "text": "PIP2 makes a complex with Pol I and the Pol I transcription factor UBF in the nucleolus."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "RNA polymerase I transcription factor Rrn3 is functionally conserved between yeast and human."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22909319",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1274,
                    "offsetInEndSection": 1429,
                    "text": "As the novel eIF4GII sequence diverges from eIF4GI, these data suggest that the eIF4GII N-terminus plays an alternative role in initiation factor assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 530,
                    "text": "Point mutation of an amino acid that is conserved between the yeast and human proteins compromises the function of each factor, confirming that the observed sequence similarity is functionally significant."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "We have cloned a human cDNA that is related to the RNA polymerase I transcription factor Rrn3 of Saccharomyces cerevisiae."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 13,
                    "text": "RNA function."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19446725",
                "http://www.ncbi.nlm.nih.gov/pubmed/24639348",
                "http://www.ncbi.nlm.nih.gov/pubmed/21749416",
                "http://www.ncbi.nlm.nih.gov/pubmed/23136963",
                "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                "http://www.ncbi.nlm.nih.gov/pubmed/18723831",
                "http://www.ncbi.nlm.nih.gov/pubmed/18707017",
                "http://www.ncbi.nlm.nih.gov/pubmed/15899984",
                "http://www.ncbi.nlm.nih.gov/pubmed/23009808",
                "http://www.ncbi.nlm.nih.gov/pubmed/15075362"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15899984",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 440,
                    "text": "Platelet-derived chemokines, such as regulated on activation, normal T expressed and secreted (RANTES; CC chemokine ligand 5), platelet factor 4 [PF4; CXC chemokine ligand 4 (CXCL4)], and epithelial neutrophil-activating protein 78 (ENA-78; CXCL5), or precursors, such as beta-thromboglobulin, which can be processed to neutrophil-activating protein-2 (NAP-2; CXCL7), may play an important role in monocyte recruitment during atherogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 158,
                    "offsetInEndSection": 255,
                    "text": "CXCL8 (interleukin-8) is a member of the chemokine family that acts on CXCR1 and CXCR2 receptors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 380,
                    "text": "CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL7 are also ELR+ chemokine members that bind to these receptors, especially CXCR2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23136963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 101,
                    "offsetInEndSection": 247,
                    "text": "Chemokine (C-X-C motif) ligand 7 (CXCL7) has been found associated with pro-inflammatory responses, but its role in cancer growth remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15075362",
                    "endSection": "abstract",
                    "offsetInBeginSection": 646,
                    "offsetInEndSection": 980,
                    "text": "Other CC chemokines, such as CC chemokine ligand-2 monocyte chemotactic protein-1 (MCP-1/CCL2), MCP-2 (CCL8), and MCP-3 (CCL7) as well as the CXC chemokine receptor-4 (CXCR4) agonist stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12), also dose-dependently enhanced neutrophil chemotaxis toward a suboptimal concentration of IL-8."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15075362",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1075,
                    "offsetInEndSection": 1272,
                    "text": "Alternatively, IL-8 and C5a did not synergize with an inactive precursor form of CXCL7, connective tissue-activating peptide-III/CXCL7, or the chemoattractant neutrophil-activating peptide-2/CXCL7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24639348",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Chemokines comprise a family of secreted proteins that activate G protein-coupled chemokine receptors and thereby control the migration of leukocytes during inflammation or immune surveillance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707017",
                    "endSection": "abstract",
                    "offsetInBeginSection": 687,
                    "offsetInEndSection": 930,
                    "text": "Pathway analysis showed that CXCL7 induced the expression of all chemokines binding the interleukin (IL) receptors A and B, CXCR1 and CXCR2, as well as the IL6 signal transducer (gp130) and its ligands IL6 and leukemia inhibitory factor (LIF)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18723831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 295,
                    "offsetInEndSection": 483,
                    "text": "The megakaryocyte CXCL7 gene product is proteolytically cleaved into the strong neutrophil chemoattractant, NAP-2, which has also been implicated in repair cell homing to vascular lesions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21749416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 358,
                    "offsetInEndSection": 480,
                    "text": "The chemokines and their receptors are promiscuous in that one chemokine can often bind several receptors, and vice versa."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                "http://www.ncbi.nlm.nih.gov/pubmed/12765697",
                "http://www.ncbi.nlm.nih.gov/pubmed/21135052",
                "http://www.ncbi.nlm.nih.gov/pubmed/8273075",
                "http://www.ncbi.nlm.nih.gov/pubmed/19372375",
                "http://www.ncbi.nlm.nih.gov/pubmed/28199210",
                "http://www.ncbi.nlm.nih.gov/pubmed/27618067",
                "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                "http://www.ncbi.nlm.nih.gov/pubmed/21140288"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1032,
                    "text": "Genetic variants of the TRPM2 gene confer a risk of developing Western Pacific amyotropic lateral sclerosis and parkinsonism-dementia complex and bipolar disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1710,
                    "offsetInEndSection": 1803,
                    "text": "Targeting TRPM2 systemically represents a promising therapeutic approach for ischemic stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27618067",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 40,
                    "text": "Targeting TRPM2 in ROS-Coupled Diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 351,
                    "text": "The G20210A mutation in the prothrombin gene is associated with an increased risk of a first venous thromboembolic episode; few data are available about the long-term risk for recurrent venous thromboembolism and it is not known whether or not carriers of the mutation should be recommended lifelong anticoagulant treatment after the first thrombosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1357,
                    "offsetInEndSection": 1483,
                    "text": "Notably, the pharmacological TRPM2 inhibitor, N-(p-amylcinnamoyl)anthranilic acid, was equally protective in the stroke model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 659,
                    "text": "We investigated 624 patients, referred for previous objectively documented deep venous thrombosis of the legs or pulmonary embolism, to determine the risk of recurrent thromboembolism in heterozygous carriers of the G20210A mutation in the prothrombin gene after the first episode of venous thromboembolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8273075",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 392,
                    "text": "There is an association between thromboembolism and hereditary deficiency of antithrombin III, protein C or protein S. In young patients, impaired fibrinolytic activity may represent the most common haemostatic abnormality associated with thrombosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Transient receptor potential melastatin subfamily member 2 cation channel regulates detrimental immune cell invasion in ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28199210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 791,
                    "text": "The wide expression of TRPM2 might render it as a potentially significant therapeutic target in pathological settings including cardiovascular and neurodegenerative diseases and of great relevance in drug design, feed additives and other industries."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27805221",
                "http://www.ncbi.nlm.nih.gov/pubmed/27392219",
                "http://www.ncbi.nlm.nih.gov/pubmed/27775637",
                "http://www.ncbi.nlm.nih.gov/pubmed/27119012",
                "http://www.ncbi.nlm.nih.gov/pubmed/29107512",
                "http://www.ncbi.nlm.nih.gov/pubmed/28174309",
                "http://www.ncbi.nlm.nih.gov/pubmed/28125631",
                "http://www.ncbi.nlm.nih.gov/pubmed/28122329",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                "http://www.ncbi.nlm.nih.gov/pubmed/27278486"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Zika virus (ZIKV), a mosquito-transmitted flavivirus, responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, re-emerged in the last decade causing serious human diseases including microcephaly, congenital malformations, and Guillain-Barr\u00e9 syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27775637",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Zika virus (ZIKV) is a flavivirus related to the Dengue, yellow fever and West Nile viruses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27805221",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 234,
                    "text": "Zika virus (ZIKV) is an emergent arbovirus that has attracted attention in the last year as a possible causative agent of congenital malformation; it shows a remarkably increased microcephaly risk during otherwise healthy pregnancies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28174309",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Compared with other flaviviruses, Zika virus (ZIKV) is uniquely associated with congenital diseases in pregnant women."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29107512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "Zika virus (ZIKV) has evolved from an overlooked mosquito-borne flavivirus into a global health threat due to its astonishing causal link to microcephaly and other disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2235,
                    "offsetInEndSection": 2416,
                    "text": "To elucidate the functional significance of glycosylation in ZIKV pathogenicity, recombinant ZIKVs from infectious clones with or without the glycan on the E protein were generated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Zika Virus Encoding Non-Glycosylated Envelope Protein is Attenuated and Defective in Neuroinvasion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27119012",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "There is a suspected link between Brazilian babies born with microcephaly and Zika virus (ZIKV) infection."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27805221",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Analysis of worldwide sequence mutations in Zika virus proteins E, NS1, NS3 and NS5 from a structural point of view."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 979,
                    "offsetInEndSection": 1127,
                    "text": "The recombinant ZIKV generated from the infectious clone, which contains the VNDT motif, is highly pathogenic and causes lethality in a mouse model."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9399878",
                "http://www.ncbi.nlm.nih.gov/pubmed/9847188",
                "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                "http://www.ncbi.nlm.nih.gov/pubmed/12527516",
                "http://www.ncbi.nlm.nih.gov/pubmed/29354985",
                "http://www.ncbi.nlm.nih.gov/pubmed/15153678",
                "http://www.ncbi.nlm.nih.gov/pubmed/9847138",
                "http://www.ncbi.nlm.nih.gov/pubmed/18312723",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                "http://www.ncbi.nlm.nih.gov/pubmed/11125060"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 942,
                    "offsetInEndSection": 1189,
                    "text": "CONCLUSION\nIt has been possible to establish a fetal medicine database, which monitors first-trimester screening for chromosomal abnormalities and second-trimester screening for major fetal malformations with the input from already collected data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 205,
                    "text": "EXProt is a non-redundant protein database containing a selection of entries from genome annotation projects and public databases, aimed at including only proteins with an experimentally verified function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9847138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1021,
                    "offsetInEndSection": 1276,
                    "text": "MIPS provides access through its WWW server (http://www.mips.biochem.mpg.de) to a spectrum of generic databases, including the above mentioned as well as a database of protein families (PROTFAM), the MITOP database, and the all-against-all FASTA database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18312723",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 223,
                    "text": "A luminescence database for minerals and materials has been complied from the literature, the aim being to create a resource that will aid in the analysis of luminescence spectral of ionic species in minerals and materials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12527516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 331,
                    "offsetInEndSection": 476,
                    "text": "A method for online searching through the database is elaborated in this paper by introducing the construction of the medical parasites database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9847138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 1020,
                    "text": "This report describes the systematic and up-to-date analysis of genomes (PEDANT), a comprehensive database of the yeast genome (MYGD), a database reflecting the progress in sequencing the Arabidopsis thaliana genome (MATD), the database of assembled, annotated human EST clusters (MEST), and the collection of protein sequence data within the framework of the PIR-International Protein Sequence Database (described elsewhere in this volume)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11125060",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The Gene Expression Database (GXD) is a community resource of gene expression information for the laboratory mouse."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 206,
                    "offsetInEndSection": 560,
                    "text": "In EXProt release 2.0 we have collected entries from the Pseudomonas aeruginosa community annotation project (PseudoCAP), the Escherichia coli genome and proteome database (GenProtEC) and the translated coding sequences from the Prokaryotes division of EMBL nucleotide sequence database, which are described as having an experimentally verified function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15153678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 715,
                    "offsetInEndSection": 921,
                    "text": "The number of polymorphic microsatellite loci incorporated in our database is over 1,000 in all strains, and the URL site for our database is located at http:// www.shigen.nig.ac.jp /mouse/mmdbj/mouse.html."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9399878",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The PROMISE (Prosthetic centres andmetalions in protein activesites) database aims to gather together comprehensive sequence, structural, functional and bibliographic information on proteins which possess prosthetic centres, with an emphasis on active site structure and function."
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                "http://www.ncbi.nlm.nih.gov/pubmed/16390119",
                "http://www.ncbi.nlm.nih.gov/pubmed/8070411",
                "http://www.ncbi.nlm.nih.gov/pubmed/8687178",
                "http://www.ncbi.nlm.nih.gov/pubmed/15987735",
                "http://www.ncbi.nlm.nih.gov/pubmed/25412371",
                "http://www.ncbi.nlm.nih.gov/pubmed/16492704",
                "http://www.ncbi.nlm.nih.gov/pubmed/25753366",
                "http://www.ncbi.nlm.nih.gov/pubmed/15771482"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15771482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 189,
                    "offsetInEndSection": 335,
                    "text": "The CDC reaction provides a simple and efficient catalytic method to construct beta-nitroamine via the reaction between sp3 C-H and sp3 C-H bonds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16390119",
                    "endSection": "abstract",
                    "offsetInBeginSection": 233,
                    "offsetInEndSection": 323,
                    "text": "This methodology provides a direct way to use allylic sp3 C-H bonds for forming C-C bonds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25412371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "A copper-catalyzed method for the oxidation of allylic and benzylic sp(3) C-H by aqueous tert-butyl hydroperoxide (T-Hydro) in water using a recyclable fluorous ligand has been developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8070411",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1101,
                    "offsetInEndSection": 1233,
                    "text": "It appears that neither the glutamine-rich domains A and B nor the D domain of Sp1 can be replaced by the homologous regions of Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16492704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1089,
                    "offsetInEndSection": 1217,
                    "text": "Our results support a model in which entry of Sp1, Sp3 and RNA polymerase II into the newly formed nuclei is an ordered process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "A novel metal-free synthesis of quinazolinones via dual amination of sp(3) C-H bonds was developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 479,
                    "offsetInEndSection": 596,
                    "text": "Moreover, PIAS1 strongly stimulated SUMO conjugation to Sp3, thus acting as an E3 ligase for SUMO conjugation to Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16492704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 795,
                    "offsetInEndSection": 1022,
                    "text": "In late telophase, Sp1 and Sp3 are equally segregated between daughter cells, and their subnuclear organization as distinct foci is restored in a sequential fashion with Sp3 regrouping into the newly formed nuclei prior to Sp1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 65,
                    "offsetInEndSection": 142,
                    "text": "Here we show that Sp3 is a target for SUMO modification in vivo and in vitro."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8070411",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1234,
                    "offsetInEndSection": 1304,
                    "text": "Our results suggest that Sp3 is an inhibitory member of the Sp family."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/614471",
                "http://www.ncbi.nlm.nih.gov/pubmed/21994798",
                "http://www.ncbi.nlm.nih.gov/pubmed/12479802",
                "http://www.ncbi.nlm.nih.gov/pubmed/19029936",
                "http://www.ncbi.nlm.nih.gov/pubmed/18785844",
                "http://www.ncbi.nlm.nih.gov/pubmed/25528554",
                "http://www.ncbi.nlm.nih.gov/pubmed/17643367",
                "http://www.ncbi.nlm.nih.gov/pubmed/28292442",
                "http://www.ncbi.nlm.nih.gov/pubmed/20720162",
                "http://www.ncbi.nlm.nih.gov/pubmed/21146412"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12479802",
                    "endSection": "abstract",
                    "offsetInBeginSection": 152,
                    "offsetInEndSection": 296,
                    "text": "A recent publication in the November 15 issue of Cell shows that the bacterium may accomplish such a feat by hijacking the proteasome machinery."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17643367",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Hijacking the DNA damage response to enhance viral replication: gamma-herpesvirus 68 orf36 phosphorylates histone H2AX."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28292442",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18785844",
                    "endSection": "abstract",
                    "offsetInBeginSection": 251,
                    "offsetInEndSection": 474,
                    "text": "In recent years, it has become evident that protozoan pathogens, including members of the phylum Apicomplexa, also hijack their host cell's functions to access nutrients and to escape cellular defenses and immune responses."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18785844",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Hijacking of host cellular functions by the Apicomplexa."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029936",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "The epithelial polarity program: machineries involved and their hijacking by cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12479802",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 35,
                    "text": "Hijacking the host cell proteasome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1237,
                    "offsetInEndSection": 1347,
                    "text": "Here, we review how the EPP integrates its three machineries and the strategies used by cancer to hijack them."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25528554",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Hijacking of death receptor signaling by bacterial pathogen effectors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21146412",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 35,
                    "text": "How viruses hijack cell regulation."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/63655",
                "http://www.ncbi.nlm.nih.gov/pubmed/21169831",
                "http://www.ncbi.nlm.nih.gov/pubmed/25969679",
                "http://www.ncbi.nlm.nih.gov/pubmed/456032",
                "http://www.ncbi.nlm.nih.gov/pubmed/25942668",
                "http://www.ncbi.nlm.nih.gov/pubmed/10413953",
                "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                "http://www.ncbi.nlm.nih.gov/pubmed/11717558",
                "http://www.ncbi.nlm.nih.gov/pubmed/531713",
                "http://www.ncbi.nlm.nih.gov/pubmed/27648387"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 262,
                    "text": "Iatrogenic disease (tinea incognito) is a new and more subtle form."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/63655",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Familial distribution of chronic tinea imbricata in an untreated Melanesian population was consistent with a genetic predisposition to this disease."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25969679",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Cheek and periorbital peculiar discoid lupus erythematosus: rare clinical presentation mimicking tinea faciei, cutaneous granulomatous disease or blepharitis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/531713",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "Tinea capitis formed 20% of all superficial mycotic infections, which in turn represented 12% of all skin disease diagnosed at the skin outpatient department of Al-Jamaheria hospital in Benghazi."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 691,
                    "offsetInEndSection": 893,
                    "text": "We also present a clinical description of the disease, the differential diagnosis and how currently some other emerging diseases such as syphilis in immunocompromised patients can mimic tinea imbricata."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/63655",
                    "endSection": "abstract",
                    "offsetInBeginSection": 316,
                    "offsetInEndSection": 513,
                    "text": "In married couples there was no concordance of the disease above that expected by chance and the observed segregation of tinea imbricata accorded well with that predicted by the genetic hypothesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25969679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 100,
                    "offsetInEndSection": 269,
                    "text": "Although DLE is a chronic autoimmune dermatosis, it has a variety of rare clinical presentations, including periorbital DLE, comedonic DLE and hypertrophic DLE recently."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10413953",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Tinea pedis in the most common type of dermatophytosis, but can mimic many cutaneous diseases and tend to be chronic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 350,
                    "offsetInEndSection": 690,
                    "text": "RECENT FINDINGS\nThis review covers the most interesting aspects of the infrequent disease tinea imbricata, including the historical background, the epidemiologic aspects, highlighting the genetic and racial patterns of susceptibility to the acquisition of the disease, and the immunologic aspects that help to explain its clinical behavior."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 194,
                    "text": "More recently, the disease has occurred in the immunocompromised patient."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1483697",
                "http://www.ncbi.nlm.nih.gov/pubmed/9760201",
                "http://www.ncbi.nlm.nih.gov/pubmed/17436248",
                "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                "http://www.ncbi.nlm.nih.gov/pubmed/1543902",
                "http://www.ncbi.nlm.nih.gov/pubmed/18493052",
                "http://www.ncbi.nlm.nih.gov/pubmed/12802286",
                "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                "http://www.ncbi.nlm.nih.gov/pubmed/8307326",
                "http://www.ncbi.nlm.nih.gov/pubmed/20236111"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1765,
                    "text": "A number of recombination-associated motifs were found to be over-represented at translocation breakpoints (including DNA polymerase pause sites/frameshift hotspots, immunoglobulin heavy chain class switch sites, heptamer/nonamer V(D)J recombination signal sequences, translin binding sites, and the chi element) but, with the exception of the translin-binding site and immunoglobulin heavy chain class switch sites, none of these motifs were over-represented at deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17436248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 706,
                    "offsetInEndSection": 957,
                    "text": "In one proband, the deletion breakpoints are associated with DNA fragments containing noncontiguous sequences of chromosome 10, whereas, in the other two families, the breakpoints are within paralogous LCRs, removing approximately 7.2 Mb and 32 genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 327,
                    "offsetInEndSection": 772,
                    "text": "Using the Gross Rearrangement Breakpoint Database [GRaBD; www.uwcm.ac.uk/uwcm/mg/grabd/grabd.html] (containing 397 germ-line and somatic DNA breakpoint junction sequences derived from 219 different rearrangements underlying human inherited disease and cancer), we have analyzed the sequence context of translocation and deletion breakpoints in a search for general characteristics that might have rendered these sequences prone to rearrangement."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1766,
                    "offsetInEndSection": 1918,
                    "text": "Alu sequences were found to span both breakpoints in seven cases of gross deletion that may thus be inferred to have arisen by homologous recombination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1543902",
                    "endSection": "abstract",
                    "offsetInBeginSection": 930,
                    "offsetInEndSection": 1126,
                    "text": "In addition, the distal breakpoints of two viable albino deletions, which remove part of the tyrosinase gene and extend distally, were localized in the vicinity of the lethal deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 964,
                    "offsetInEndSection": 1072,
                    "text": "Deletion breakpoints were found to be AT-rich whereas by comparison, translocation breakpoints were GC-rich."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1073,
                    "offsetInEndSection": 1280,
                    "text": "Alternating purine-pyrimidine sequences were found to be significantly over-represented in the vicinity of deletion breakpoints while polypyrimidine tracts were over-represented at translocation breakpoints."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Translocation and gross deletion breakpoints in human inherited disease and cancer I: Nucleotide composition and recombination-associated motifs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9760201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1111,
                    "text": "No deletion or duplication of chromosomal material was found near the breakpoints in patient 3 [46,XX,t(2;6)(q33.1;p12.2)]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "The albino-deletion complex of the mouse: molecular mapping of deletion breakpoints that define regions necessary for development of the embryonic and extraembryonic ectoderm."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25144332",
                "http://www.ncbi.nlm.nih.gov/pubmed/27780979",
                "http://www.ncbi.nlm.nih.gov/pubmed/24507715",
                "http://www.ncbi.nlm.nih.gov/pubmed/28825722",
                "http://www.ncbi.nlm.nih.gov/pubmed/24974018",
                "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                "http://www.ncbi.nlm.nih.gov/pubmed/27912097",
                "http://www.ncbi.nlm.nih.gov/pubmed/28652379",
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/26342908"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28652379",
                    "endSection": "abstract",
                    "offsetInBeginSection": 193,
                    "offsetInEndSection": 340,
                    "text": "This long non-coding RNA (lncRNA) localizes to nuclear speckles, where it interacts with a subset of splicing factors and modulates their activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27912097",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24507715",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 460,
                    "text": "Here we show that nuclear enriched abundant transcript 1 (NEAT1), an essential lncRNA for the formation of nuclear body paraspeckles, is induced by influenza virus and herpes simplex virus infection as well as by Toll-like receptor3-p38 pathway-triggered poly I:C stimulation, resulting in excess formation of paraspeckles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24507715",
                    "endSection": "abstract",
                    "offsetInBeginSection": 576,
                    "offsetInEndSection": 839,
                    "text": "We found that splicing factor proline/glutamine-rich (SFPQ), a NEAT1-binding paraspeckle protein, is a repressor of IL8 transcription, and that NEAT1 induction relocates SFPQ from the IL8 promoter to the paraspeckles, leading to transcriptional activation of IL8."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25144332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 662,
                    "offsetInEndSection": 936,
                    "text": "Recently Arabidopsis RRP6L1, a plant paralog of the conserved nuclear RNA surveillance protein Rrp6, was shown to mediate RdDM through retention of lncRNAs in the chromatin, thereby revealing that accumulation of functional lncRNAs requires more than simply RNA polymerases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                    "endSection": "abstract",
                    "offsetInBeginSection": 280,
                    "offsetInEndSection": 463,
                    "text": "Here, we describe one lncRNA, Firre, that interacts with the nuclear-matrix factor hnRNPU through a 156-bp repeating sequence and localizes across an ~5-Mb domain on the X chromosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27912097",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1116,
                    "text": "In summary, we describe a p53-regulated, pluripotency-specific lncRNA that safeguards the hESC state by disrupting SIRT6 activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                    "endSection": "abstract",
                    "offsetInBeginSection": 775,
                    "offsetInEndSection": 909,
                    "text": "Thus, our data suggest a model in which lncRNAs such as Firre can interface with and modulate nuclear architecture across chromosomes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                "http://www.ncbi.nlm.nih.gov/pubmed/29296732",
                "http://www.ncbi.nlm.nih.gov/pubmed/22055187",
                "http://www.ncbi.nlm.nih.gov/pubmed/26294014",
                "http://www.ncbi.nlm.nih.gov/pubmed/28846090",
                "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                "http://www.ncbi.nlm.nih.gov/pubmed/26846207",
                "http://www.ncbi.nlm.nih.gov/pubmed/28789639",
                "http://www.ncbi.nlm.nih.gov/pubmed/26656845"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Assay for Transposase Accessible Chromatin (ATAC-seq) is an open chromatin profiling assay that is adapted to interrogate chromatin accessibility from small cell numbers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26656845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 1052,
                    "text": "Despite a modest sample size, we identified 2,707 independent caQTLs (at a false discovery rate of 10%) and demonstrated how RASQUAL and ATAC-seq can provide powerful information for fine-mapping gene-regulatory variants and for linking distal regulatory elements with gene promoters."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 666,
                    "text": "The method is a fast and sensitive alternative to DNase-seq for assaying chromatin accessibility genome-wide, or to MNase-seq for assaying nucleosome positions in accessible regions of the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26656845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 767,
                    "text": "We illustrate how RASQUAL can be used to maximize association detection by generating the first map of chromatin accessibility QTLs (caQTLs) in a European population using ATAC-seq."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) is a useful method to map genome-wide chromatin accessibility and nucleosome positioning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1066,
                    "offsetInEndSection": 1347,
                    "text": "I-ATAC integrates command-line data processing tools (FASTQC, Trimmomatic, BWA, Picard, ATAC_BAM_shiftrt_gappedAlign.pl, Bedtools and Macs2) into an easy-to-use platform with user interface to automatically pre-process ATAC-seq samples with parallelized and customizable pipelines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1348,
                    "offsetInEndSection": 1565,
                    "text": "Its performance has been tested using public ATAC-seq datasets in GM12878 and CD4+T cells and a feature-based comparison is performed with some available interactive LIMS (Galaxy, SMITH, SeqBench, Wasp, NG6, openBIS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28846090",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "We present Omni-ATAC, an improved ATAC-seq protocol for chromatin accessibility profiling that works across multiple applications with substantial improvement of signal-to-background ratio and information content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 307,
                    "text": "This method probes DNA accessibility with hyperactive Tn5 transposase, which inserts sequencing adapters into accessible regions of chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "This unit describes Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq), a method for mapping chromatin accessibility genome-wide."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27604899",
                "http://www.ncbi.nlm.nih.gov/pubmed/21473016",
                "http://www.ncbi.nlm.nih.gov/pubmed/25524096",
                "http://www.ncbi.nlm.nih.gov/pubmed/24632195",
                "http://www.ncbi.nlm.nih.gov/pubmed/21625552",
                "http://www.ncbi.nlm.nih.gov/pubmed/25799440",
                "http://www.ncbi.nlm.nih.gov/pubmed/22221045",
                "http://www.ncbi.nlm.nih.gov/pubmed/24976123",
                "http://www.ncbi.nlm.nih.gov/pubmed/8138784",
                "http://www.ncbi.nlm.nih.gov/pubmed/22222791"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27604899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 141,
                    "offsetInEndSection": 368,
                    "text": "However, the highly identical TALE repeat sequences make it challenging to assemble TALEs using conventional cloning approaches, and multiple repeats in one plasmid are easily catalyzed for homologous recombination in bacteria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21625552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 815,
                    "offsetInEndSection": 968,
                    "text": "Assembly is performed in two successive one-pot cloning steps using the Golden Gate cloning method that allows seamless fusion of multiple DNA fragments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22222791",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 311,
                    "text": "The DNA-binding domain of each TALE consists of tandem 34-amino acid repeat modules that can be rearranged according to a simple cipher to target new DNA sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24976123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 412,
                    "offsetInEndSection": 577,
                    "text": "This method takes advantage of uracil-specific excision reagent (USER), an enzyme that can cleave DNA constructs and create long, unique single-strand DNA overhangs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24632195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 324,
                    "text": "TALEs, CRISPR/Cas, and sRNAs can be easily fashioned to bind any specific sequence of DNA (TALEs, CRISPR/Cas) or RNA (sRNAs) because of the simple rules governing their interactions with nucleic acids."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27604899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 930,
                    "offsetInEndSection": 1164,
                    "text": "This system makes TALEN assembly much simpler than the conventional cloning of two DNA fragments because this strategy combines digestion and ligation into one step using circular vectors and different modules to avoid gel extraction."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25524096",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "A multiplexed transcription activator-like effector system for detecting specific DNA sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25524096",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 738,
                    "text": "Here, we demonstrate a system in which a TALE protein bound to a nitrocellulose strip has been utilized to capture purified DNA, which is then detected using the binding of a second distinct TALE protein conjugated to a protein tag that is then detected by a dot blot."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24976123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1316,
                    "offsetInEndSection": 1535,
                    "text": "We thus contribute to an easier approach for effective TALENs synthesis, which may highly facilitate the wide application of TALEN technology in genome editing, especially for human cells that require precise targeting."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21625552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Generation of customized DNA binding domains targeting unique sequences in complex genomes is crucial for many biotechnological applications."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7378695",
                "http://www.ncbi.nlm.nih.gov/pubmed/2834426",
                "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                "http://www.ncbi.nlm.nih.gov/pubmed/22240774",
                "http://www.ncbi.nlm.nih.gov/pubmed/8209869",
                "http://www.ncbi.nlm.nih.gov/pubmed/10861657",
                "http://www.ncbi.nlm.nih.gov/pubmed/11705325",
                "http://www.ncbi.nlm.nih.gov/pubmed/16914397",
                "http://www.ncbi.nlm.nih.gov/pubmed/6290548",
                "http://www.ncbi.nlm.nih.gov/pubmed/434730"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Paget's disease of the breast is a disorder of the nipple-areola complex that, while rare, is often associated with an underlying carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16914397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Paget's disease is a common skeletal disorder in the elderly; however, monostotic Paget's disease of the patella is very rare and only a few cases have been reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 355,
                    "text": "A high index of suspicion is necessary to diagnose Paget disease in a patient with Darier disease, for a potentially fatal disease could easily be missed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2834426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Vulvar Paget's disease, in contrast to its mammary counterpart, has been found to be associated with an underlying apocrine sweat gland carcinoma in about only 1/4 of the cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10861657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Paget disease of the bone is a common skeletal disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7378695",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 333,
                    "text": "The frequency and extent of lumbar spondylosis is no greater in patients with Paget's disease (osteitis deformans) affecting the lumbar spine than in control groups, whether or not the disease is accompanied by deformity of vertebrae, and we have found no evidence that Paget's disease predisposes to our enhances lumbar spondylosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6290548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 238,
                    "offsetInEndSection": 399,
                    "text": "If one estimates male breast carcinoma to be approximately 1% of the rate in the female population, then Paget's disease in men is clearly a rare clinical event."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 453,
                    "offsetInEndSection": 539,
                    "text": "It is supported by the predominance of breast cancer markers found in Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10861657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 396,
                    "text": "We report the identification and clinical characterization of a large pedigree of Paget disease and demonstrate that the Paget disease gene in this pedigree is not linked to the region on 18q, thus confirming linkage heterogeneity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11705325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 247,
                    "text": "There is a genetic predisposition for Paget's disease, with one predisposition locus identified on chromosome 18q-21-22."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3015011",
                "http://www.ncbi.nlm.nih.gov/pubmed/6969580",
                "http://www.ncbi.nlm.nih.gov/pubmed/12760895",
                "http://www.ncbi.nlm.nih.gov/pubmed/9925535",
                "http://www.ncbi.nlm.nih.gov/pubmed/6752115",
                "http://www.ncbi.nlm.nih.gov/pubmed/3489648",
                "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                "http://www.ncbi.nlm.nih.gov/pubmed/3878359",
                "http://www.ncbi.nlm.nih.gov/pubmed/6454378",
                "http://www.ncbi.nlm.nih.gov/pubmed/8494361"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 37,
                    "offsetInEndSection": 167,
                    "text": "8158), M. fortuitum and M. phlei (MPI) produce a constitutive beta-lactamase that has penicillinase and cephalosporinase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9925535",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "The sequences of the promoter regions and of the structural genes for 13 penicillinase, extended-spectrum, and inhibitor-resistant TEM-type beta-lactamases have been determined, and an updated blaTEM gene nomenclature is proposed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Pseudomonas cepacia 249 produces an inducible beta-lactamase with penicillinase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3489648",
                    "endSection": "abstract",
                    "offsetInBeginSection": 597,
                    "offsetInEndSection": 941,
                    "text": "AmoR TicR CtnR strains (18%) often produced two beta-lactamases (penicillinase and cephalosporinase) and they were resistant to Amo/CA; in this group, susceptibility to Tic/CA depends on the nature and the amount of the beta-lactamase produced, except for Serratia marcescens for which antibiotic resistance is probably due to other mechanisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12760895",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 356,
                    "text": "MIC measurements and steady-state kinetic analyses indicate that Bla1 possesses penicillinase activity while Bla2 possesses penicillinase, cephalosporinase, and carbapenem-hydrolyzing activities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 36,
                    "text": "Mycobacterium smegmatis (N.C.T.C."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 168,
                    "offsetInEndSection": 170,
                    "text": "2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6969580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 229,
                    "text": "N-Formimidoyl thienamycin (MK0787) was active against beta-lactamase-producing strains and was an effective inhibitor of beta-lactamases extracted and purified from these strains except for plasmid-mediated penicillinase type IV."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11260879",
                "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                "http://www.ncbi.nlm.nih.gov/pubmed/3622005",
                "http://www.ncbi.nlm.nih.gov/pubmed/28803354",
                "http://www.ncbi.nlm.nih.gov/pubmed/7229325",
                "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                "http://www.ncbi.nlm.nih.gov/pubmed/15893082",
                "http://www.ncbi.nlm.nih.gov/pubmed/23778599",
                "http://www.ncbi.nlm.nih.gov/pubmed/7777329",
                "http://www.ncbi.nlm.nih.gov/pubmed/8778662"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 499,
                    "offsetInEndSection": 699,
                    "text": "The adults of Haemaphysalis elliptica, the most abundant tick species infesting cats and wild felids, were most numerous on a domestic cat in late winter and in mid-summer, during 2 consecutive years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7777329",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 515,
                    "text": "Rabies has been confirmed in this region among the above species as well as in a domestic cat (Felis catus) and a cow (Bos indicus) by fluorescent antibody tests (FAT) and/or histopathology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 29,
                    "offsetInEndSection": 132,
                    "text": "from the small intestine of the domestic cat (Felis catus L.) in Malaysia is described and illustrated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28803354",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 314,
                    "text": "We describe five cases of myiasis of domestic cats, Felis silvestris catus L. (Carnivora: Felidae), reported in 2016 in northern Italy and caused by three Diptera species: Sarcophaga argyrostoma (Robineau-Desvoidy) (Sarcophagidae), Calliphora vicina Robineau-Desvoidy and Lucilia sericata (Meigen) (Calliphoridae)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "title",
                    "offsetInBeginSection": 29,
                    "offsetInEndSection": 105,
                    "text": "(Nematoda: Ascaridoidea) from the domestic cat (Felis catus Linnaeus, 1758)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 287,
                    "text": "Ticks collected from domestic cats (Felis catus), cheetahs (Acinonyx jubatus),caracals (Caracal caracal), African wild cats (Felis lybica), black-footed cats (Felis nigripes), a serval (Leptailurus serval), lions(Panthera leo), and leopards (Panthera pardus) were identified and counted."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 268,
                    "offsetInEndSection": 274,
                    "text": "canis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 426,
                    "offsetInEndSection": 498,
                    "text": "The domestic cats and wild felids harboured 11 ixodid species in common."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15893082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 183,
                    "offsetInEndSection": 496,
                    "text": "The most common flea was the cat flea, Ctenocephalides felis (389 males and 1148 females), followed by the dog flea, Ctenocephalides canis (250 males and 285 females), a generalist/carnivore flea, Pulex simulans (106 males and 213 females), and a sticktight flea, Echidnophaga gallinacea (3 males and 89 females)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 425,
                    "text": "Thirteen species of ixodid ticks and one argasid tick were identified from domestic cats and 17 species of ixodid ticks from wild felids."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                "http://www.ncbi.nlm.nih.gov/pubmed/10037138",
                "http://www.ncbi.nlm.nih.gov/pubmed/12960026",
                "http://www.ncbi.nlm.nih.gov/pubmed/28533409",
                "http://www.ncbi.nlm.nih.gov/pubmed/21916612",
                "http://www.ncbi.nlm.nih.gov/pubmed/25183525",
                "http://www.ncbi.nlm.nih.gov/pubmed/18662993",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/28938092",
                "http://www.ncbi.nlm.nih.gov/pubmed/23933634"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21916612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 291,
                    "text": "The CCCTC-binding factor (CTCF), which binds insulator elements in vertebrates, also facilitates coordinated gene expression at several gene clusters, including the \u03b2-globin, Igf2/H19 (insulin like growth factor 2/H19 noncoding RNA), and major histocompatibility complex (MHC) class II loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23933634",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1176,
                    "offsetInEndSection": 1406,
                    "text": "This eviction is also correlated with the expression of an antisense non-coding RNA transcribing through the CTCF-binding region indicating that non-coding RNA transcription could be the cause and the consequence of CTCF eviction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12960026",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 827,
                    "text": "In osteosarcoma tumors, aberrant methylation of the IGF2/H19 ICR results in equally aberrant CTCF binding, yet expression of these genes does not correlate with CTCF binding."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18662993",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12960026",
                    "endSection": "abstract",
                    "offsetInBeginSection": 528,
                    "offsetInEndSection": 652,
                    "text": "In the fetal brain, CTCF binding is monoallelic and specific for the unmethylated ICR, yet IGF2/H19 expression is biallelic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10037138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 632,
                    "offsetInEndSection": 744,
                    "text": "We concluded that CTCF expression and activity is controlled at transcriptional and post-transcriptional levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                    "endSection": "abstract",
                    "offsetInBeginSection": 925,
                    "offsetInEndSection": 1092,
                    "text": "Thus, tumour subsets exist that display concurrent decreased BRCA1 expression, BRCA1 promoter methylation, cytoplasmic CTCF expression and with DNMT3b over-expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18662993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1075,
                    "offsetInEndSection": 1319,
                    "text": "These findings offer insight into general epigenetic mechanisms by which CTCF governs gene expression by orchestrating chromatin loop structures and by serving as a DNA-binding protein scaffold to recruit and bind polycomb repressive complexes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1093,
                    "offsetInEndSection": 1361,
                    "text": "We suggest that these altered CTCF and DNMT3b expression patterns represent (a) critical events responsible for the epigenetic inactivation of BRCA1 and (b) a diagnostic signature for epigenetic inactivation of other tumour suppressor genes in sporadic breast tumours."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                "http://www.ncbi.nlm.nih.gov/pubmed/16149095",
                "http://www.ncbi.nlm.nih.gov/pubmed/18435766",
                "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                "http://www.ncbi.nlm.nih.gov/pubmed/26600626",
                "http://www.ncbi.nlm.nih.gov/pubmed/15541308",
                "http://www.ncbi.nlm.nih.gov/pubmed/20722494"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nRecently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Mutations in LRRK2 (leucine-rich repeat kinase 2) (also known as PARK8 or dardarin) are responsible for the autosomal-dominant form of PD (Parkinson's disease)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Mutations in the leucine-rich repeat kinase 2 (LRRK 2), encoding dardarin protein, have been demonstrated to be linked to autosomal dominant Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26600626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 239,
                    "text": "INTRODUCTION\nMutations in the leucine-rich repeat kinase 2 gene (LRRK2 or Dardarin) are considered to be a common cause of autosomal dominant and sporadic Parkinson\u00b4s disease, but the prevalence of these mutations varies among populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18435766",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 188,
                    "text": "BACKGROUND AND PURPOSE\nMutations in LRRK2, encoding leucine-rich repeat kinase 2 (or Dardarin), cause autosomal dominant Parkinson's disease (AdPD) and are also found in sporadic PD (sPD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Mutations in the leucine-rich kinase 2 gene (LRRK 2) encoding dardarin, on chromosome 12, are a common cause of familial and sporadic Parkinson's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20722494",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 329,
                    "text": "BACKGROUND\nPathogenic mutations in leucine-rich repeat kinase 2 (LRRK2; PARK8) encoding dardarin, implicated in patients with autosomal dominant and sporadic Parkinson's disease (PD) among different ethnic groups (Ashkenazi Jews, North African Arabs, Basques) might be of some help in diagnostic screening and genetic counseling."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16149095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 763,
                    "offsetInEndSection": 950,
                    "text": "Because of the tremor observed in PD and because a number of the families are of Basque descent, we have named this protein dardarin, derived from the Basque word dardara, meaning tremor."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22200771",
                "http://www.ncbi.nlm.nih.gov/pubmed/17186470",
                "http://www.ncbi.nlm.nih.gov/pubmed/16159874",
                "http://www.ncbi.nlm.nih.gov/pubmed/28376382",
                "http://www.ncbi.nlm.nih.gov/pubmed/15384984",
                "http://www.ncbi.nlm.nih.gov/pubmed/15523650",
                "http://www.ncbi.nlm.nih.gov/pubmed/23257444",
                "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                "http://www.ncbi.nlm.nih.gov/pubmed/22689679",
                "http://www.ncbi.nlm.nih.gov/pubmed/20378560"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17186470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Diamond-Blackfan anemia (DBA) is a rare congenital red-cell aplasia characterized by anemia, bone-marrow erythroblastopenia, and congenital anomalies and is associated with heterozygous mutations in the ribosomal protein (RP) S19 gene (RPS19) in approximately 25% of probands."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15523650",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 207,
                    "text": "Mutations in the ribosomal protein (RP)S19 gene have been found in about 25% of the cases of Diamond-Blackfan anemia (DBA), a rare congenital hypoplastic anemia that includes variable physical malformations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22200771",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 343,
                    "text": "U2AF1 is frequently mutated in myeloid hematopoietic malignancies, especially in myelodysplastic syndrome (MDS), and SF3B1 is frequently mutated in both MDS and chronic lymphocytic leukemia (CLL)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22689679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 592,
                    "text": "As a proof of concept, we designed a multiplex ligation-dependent probe amplification assay targeted to screen the six genes that are most frequently mutated in Diamond-Blackfan anemia patients: RPS17, RPS19, RPS26, RPL5, RPL11, and RPL35A."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20378560",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1240,
                    "text": "Remarkably, cleft palate was seen in two patients with RPL5 mutations, and thumb anomalies were seen in six patients with an RPS19 or RPL5 mutation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23257444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 950,
                    "offsetInEndSection": 1090,
                    "text": "The hypospadias can be observed in some patients with RPS19 mutation and some dactyl anomalies are associated with RPL11 and RPL5 mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20378560",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 658,
                    "text": "DESIGN AND METHODS\nWe screened 49 Japanese patients with Diamond-Blackfan anemia (45 probands) for mutations in the six known genes associated with Diamond-Blackfan anemia: RPS19, RPS24, RPS17, RPL5, RPL11, and RPL35A."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20378560",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1021,
                    "offsetInEndSection": 1091,
                    "text": "All patients with RPS19 and RPL5 mutations had physical abnormalities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23257444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 345,
                    "text": "Twenty-one cases of DBA admitted in our hospital from Dec 2008 to Aug 2012 were screened by PCR for mutations in the nine known genes associated with DBA: RPS19, RPS24, RPS17, RPL5, RPL11, RPS7, RPL35a, RPS10 and RPS26."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20378560",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1528,
                    "offsetInEndSection": 1693,
                    "text": "Genotype-phenotype data suggest an association between anomalies and RPS19 mutations, and a negative association between small-for-date phenotype and RPL5 mutations."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21783031",
                "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                "http://www.ncbi.nlm.nih.gov/pubmed/25829014",
                "http://www.ncbi.nlm.nih.gov/pubmed/2556801",
                "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                "http://www.ncbi.nlm.nih.gov/pubmed/12909351",
                "http://www.ncbi.nlm.nih.gov/pubmed/731708",
                "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                "http://www.ncbi.nlm.nih.gov/pubmed/16884525"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 848,
                    "offsetInEndSection": 1039,
                    "text": "We estimated the time necessary to evolve, from genomic background, enhancers capable of driving complex gene expression patterns similar to those involved in early development in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Enhancers of RNA polymerase I transcription in higher eukaryotes are repetitive elements within the intergenic spacers of rRNA genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Ribosomal gene promoter domains can function as artificial enhancers of RNA polymerase I transcription, supporting a promoter origin for natural enhancers in Xenopus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 881,
                    "text": "These data demonstrate functional relatedness between the promoter and enhancers, supporting the hypothesis that enhancers could have evolved from duplicated promoter domains that bind essential transcription factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1379,
                    "offsetInEndSection": 1531,
                    "text": "The in silico evolved enhancers had, with a few interesting exceptions, site compositions similar to those seen in real enhancers for the same patterns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 93,
                    "offsetInEndSection": 339,
                    "text": "Although many studies have elucidated how individual enhancers can evolve, most of this work has focused on what are called 'minimal' enhancers, the smallest DNA regions that drive expression that approximates an aspect of native gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 338,
                    "text": "In Xenopus and mouse, enhancers and the gene promoter bind the activator protein, upstream binding factor, and in Xenopus, enhancers also share sequence similarity with an upstream domain of the promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 378,
                    "offsetInEndSection": 488,
                    "text": "Many examples show that enhancers can evolve beyond recognizable sequence similarity while retaining function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 847,
                    "text": "We report on our investigation of enhancer evolution through the use of PEBCRES, a framework for evolutionary simulation of enhancers that employs a mechanistic and well-supported sequence-to-expression model to assign fitness to the evolving enhancer genotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 643,
                    "offsetInEndSection": 892,
                    "text": "Cis-regulatory changes are also a major source of morphological evolution, which might be facilitated by many biochemically functional elements that are selectively neutral and by the buffering function of redundant enhancers and 'shadow' enhancers."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                "http://www.ncbi.nlm.nih.gov/pubmed/3624987",
                "http://www.ncbi.nlm.nih.gov/pubmed/3627450",
                "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                "http://www.ncbi.nlm.nih.gov/pubmed/3980939",
                "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                "http://www.ncbi.nlm.nih.gov/pubmed/3713736",
                "http://www.ncbi.nlm.nih.gov/pubmed/3983046"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3713736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 257,
                    "offsetInEndSection": 430,
                    "text": "This phenomenon is only seen with coexistent carpal tunnel syndrome and median to ulnar nerve communication and suggests carpal tunnel syndrome is present in these patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3627450",
                    "endSection": "abstract",
                    "offsetInBeginSection": 490,
                    "offsetInEndSection": 691,
                    "text": "Recognition of lumbrical sparing supports the electrodiagnosis of carpal tunnel syndrome when the distal latency to thenar muscles or the palm-to-wrist mixed median nerve conduction velocity is normal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "We report a case of carpal tunnel syndrome associated with median nerve motor branch compression by a large superficial palmar branch of the radial artery."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Carpal tunnel syndrome associated with extra tunnel vascular compression of the median nerve motor branch."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A case of the entrapment neuropathy of the palmar cutaneous branch of the median nerve, concomitant with carpal tunnel syndrome is presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 355,
                    "text": "This report demonstrates that the Semmes-Weinstein monofilament test and nerve conduction studies can identify entrapment of the palmar cutaneous branch of the median nerve concomitant with carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Motion of the median nerve was compared on an axial ultrasonographic image in the mid-carpal tunnel in 30 wrists of 15 women with bilateral idiopathic carpal tunnel syndrome and 30 wrists of 15 healthy women."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 186,
                    "text": "Nerve abscess as a cause of acute carpal tunnel syndrome is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3624987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Complications of peripheral nerve injury arising from the surgical treatment of carpal tunnel syndrome are not uncommon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3713736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 256,
                    "text": "In six patients with characteristic symptoms of carpal tunnel syndrome, electrophysiologic studies were normal, except for an initial positive deflection of the thenar muscle action potential with median nerve stimulation at the elbow but not at the wrist."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27296552",
                "http://www.ncbi.nlm.nih.gov/pubmed/22528876",
                "http://www.ncbi.nlm.nih.gov/pubmed/19683237",
                "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                "http://www.ncbi.nlm.nih.gov/pubmed/28036074",
                "http://www.ncbi.nlm.nih.gov/pubmed/25337249",
                "http://www.ncbi.nlm.nih.gov/pubmed/17981747",
                "http://www.ncbi.nlm.nih.gov/pubmed/24650661",
                "http://www.ncbi.nlm.nih.gov/pubmed/21546528"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 264,
                    "text": "Remodeling of the extracellular matrix (ECM), which is induced by lysyl oxidase (LOX), has been demonstrated to accompany tumor progression; however, the association between LOX expression levels and the malignant behavior of prostate cancer (Pca) remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Lysyl oxidase (LOX) is a copper- and lysyl-tyrosyl cofactor containing amine oxidase that has been known to play a critical role in the catalysis of lysine-derived crosslinks in extracellular matrix (ECM) proteins in the dermis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17981747",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Lysyl oxidase (LOX) plays a pivotal role in extracellular matrix (ECM) maturation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24650661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 426,
                    "offsetInEndSection": 525,
                    "text": "Heat shock protein 47 (HSP47) and lysyl oxidase (LOX) are known to be essential for ECM maturation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25337249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "Lysyl oxidase (LOX) has been reported to regulate tumor metastasis and has been found to involve in modification of extracellular matrix (ECM) in the context of tumorigenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19683237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Lysyl oxidase (LOX) is an enzyme critical for the stability of extracellular matrix and also known to have diverse biological functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22528876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 317,
                    "text": "Lysyl oxidase (LOX) family oxidases, LOX and LOXL1-4, oxidize lysine residues in collagens and elastin, resulting in the covalent crosslinking and stabilization of these extracellular matrix (ECM) structural components, thus provide collagen and elastic fibers much of their tensile strength and structural integrity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28036074",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 261,
                    "text": "The lysyl oxidase (LOX) family of oxidases contains a group of extracellular copper-dependent enzymes that catalyze the cross-linking of collagen and elastin by oxidation, thus maintaining the rigidity and structural stability of the extracellular matrix (ECM)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1018,
                    "offsetInEndSection": 1109,
                    "text": "Therefore, LOX expression level in the ECM may function as an independent predictor of Pca."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 782,
                    "offsetInEndSection": 1017,
                    "text": "In addition, although LOX was expressed in cancer and non-cancer tissues, the differential expression pattern observed in the ECM of Pca cells may indicate that LOX is an important molecule that affects the progression of this disease."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25803522",
                "http://www.ncbi.nlm.nih.gov/pubmed/24736271",
                "http://www.ncbi.nlm.nih.gov/pubmed/18184124",
                "http://www.ncbi.nlm.nih.gov/pubmed/24124831",
                "http://www.ncbi.nlm.nih.gov/pubmed/28859824",
                "http://www.ncbi.nlm.nih.gov/pubmed/24260027",
                "http://www.ncbi.nlm.nih.gov/pubmed/8763916",
                "http://www.ncbi.nlm.nih.gov/pubmed/15717387",
                "http://www.ncbi.nlm.nih.gov/pubmed/28381912",
                "http://www.ncbi.nlm.nih.gov/pubmed/18628905"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25803522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 203,
                    "text": "[In the article \"Hepatosplenic Cat Scratch Disease in Immunocompetent Adults: Report of 3 Cases and Review of the Literature\", the author name Asunci\u00f3n L\u00f3pez, MD was left out of the list of author names."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28859824",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 248,
                    "text": "This article has been removed at the request of the authors due to errors in the author list."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 291,
                    "text": "Please check old files, boxes, bookshelves, and other archives for other missing conferences listed here."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25803522",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Hepatosplenic cat scratch disease in immunocompetent adults: report of 3 cases and review of the literature."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 434,
                    "text": "The keys to successful outcome include: 1) early evaluation and listing for transplantation before the patient develops severe complications of cirrhosis; 2) control of comorbid conditions; and 3) a cooperative and dynamic interchange between the transplant center and other physicians involved in the care of the patient."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18184124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 114,
                    "offsetInEndSection": 177,
                    "text": "Article Title: Drug Interactions in Inflammatory Bowel Disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24736271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "Christoph Steininger and colleagues explore how multiple infectious, autoimmune, metabolic, and neoplastic diseases have been associated with changes in the intestinal microbiome, although a cause-effect relationship is often difficult to establish."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18628905",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 612,
                    "text": "(For more background detail on these projects, please see our Featured Organism: Arabidopsis thaliana piece, also in this issue of CFG, or visit the websites listed below)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 185,
                    "text": "The abstracts of four major AIDS conferences that were unavailable online or in libraries around the world have now been found after AIDS Treatment News asked people to look for copies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24124831",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "JAAD Grand Rounds quiz: a 42-year-old woman with stage IIIC melanoma treated with ipilimumab."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                "http://www.ncbi.nlm.nih.gov/pubmed/20440461",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                "http://www.ncbi.nlm.nih.gov/pubmed/8422755",
                "http://www.ncbi.nlm.nih.gov/pubmed/24361078",
                "http://www.ncbi.nlm.nih.gov/pubmed/9462465",
                "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                "http://www.ncbi.nlm.nih.gov/pubmed/6270951"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1337,
                    "offsetInEndSection": 1593,
                    "text": "In support of this model, we show here that mutations M265I or R331H, residues predicted by crystal structure to interact with the carboxylic acid tail of CDCA but not with androsterone, altered CDCA activation but had no effect on androsterone activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 892,
                    "offsetInEndSection": 1128,
                    "text": "Based on these lines of evidence, it is concluded that the large portion of androsterone UDPGT gene is deleted in LA Wistar rats, which results in the absence of androsterone UDPGT mRNA and consequently the corresponding enzyme protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                    "endSection": "abstract",
                    "offsetInBeginSection": 200,
                    "offsetInEndSection": 565,
                    "text": "We have studied the effects of short-term (3 days) fasting and long-term (3 weeks) food restriction to one-third of normal intake (FR33) on hepatic UGT activities for thyroxine (T4), triiodothyronine (T3), bilirubin and androsterone in male and female Wistar rats with either a functional (high activity, HA) or a defective (low activity, LA) androsterone UGT gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 891,
                    "text": "Genomic DNA amplifications with synthetic primers which have nucleotide sequences corresponding to the 5'-region of androsterone UDPGT cDNA, suggested that androsterone UDPGT gene has exon 1 with a length of some 700 bp and that this exon is deleted in LA Wistar rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1507,
                    "offsetInEndSection": 1725,
                    "text": "These results demonstrate different sex-dependent effects of food deprivation on hepatic T4 and T3 glucuronidation that are associated with changes in the expression of bilirubin UGT and androsterone UGT, respectively."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8422755",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Regional assignment of rat androsterone UDP-glucuronosyltransferase gene (UGT2B2) to chromosome 14p21.2-p22."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 537,
                    "offsetInEndSection": 764,
                    "text": "Differences in restriction fragment length observed on Southern blotting of genomic DNA from LA Wistar rats indicate that this inherited deficiency is the result of a deletion in the androsterone UDP-glucuronyltransferase gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "Olfactory sensitivity to two odorants, isoamyl acetate and androsterone, was assessed in 14 obsessive compulsive disorder (OCD) patients, nine major depressive disorder (MDD) patients, and 16 sex- and age-matched healthy controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 770,
                    "offsetInEndSection": 988,
                    "text": "In HEK293 cells, androsterone activated gal4-mouse FXR-LBD and gal4-hFXR-LBD fusion proteins, although in contrast to CDCA, androsterone activation was significantly greater for the mouse FXR-LBD than for the hFXR-LBD."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25561755",
                "http://www.ncbi.nlm.nih.gov/pubmed/25787097",
                "http://www.ncbi.nlm.nih.gov/pubmed/20444377",
                "http://www.ncbi.nlm.nih.gov/pubmed/11599761",
                "http://www.ncbi.nlm.nih.gov/pubmed/21354008",
                "http://www.ncbi.nlm.nih.gov/pubmed/15062212",
                "http://www.ncbi.nlm.nih.gov/pubmed/11045697",
                "http://www.ncbi.nlm.nih.gov/pubmed/6200825",
                "http://www.ncbi.nlm.nih.gov/pubmed/25542678",
                "http://www.ncbi.nlm.nih.gov/pubmed/7774550"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11045697",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Osteochondritis dissecans of the tarsal navicular bone: imaging findings in four patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15062212",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "The navicular bone, located in the midfoot, articulates with the head of the talus, cuboid, and the three cuneiform bones that are involved in the acetabulum pedis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21354008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 277,
                    "text": "Spontaneous osteonecrosis of the navicular in the adult is known as Mueller-Weiss syndrome, which is a rare disease characterized by a collapse of the lateral portion of the tarsal navicular combined with a medial protrusion of the talar head and peri-navicular osteoarthritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6200825",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 251,
                    "text": "Histological and histochemical investigations of the fibrocartilage of facies flexoria from navicular bones of horses with navicular disease have shown alterations similar to those described in the hyaline articular cartilage in osteoarthritic joints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7774550",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1055,
                    "text": "More nerve fibres were present in the dorsal part of CSL bordering the distal interphalangeal joint than was observed palmarly in CSL along the navicular bursa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25561755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 153,
                    "offsetInEndSection": 394,
                    "text": "PATIENTS METHODS AND RESULTS\nA 40-year-old woman with an ununited fracture of the tarsal navicular bone was treated with localized naviculocuneiform arthrodesis (arthrodesis of the navicular, the middle cuneiform, and the lateral cuneiform)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20444377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 349,
                    "text": "Key words: navicular bone of the wrist, pseudoarthrosis of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11599761",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "A case of osteonecrosis of the accessory navicular bone is reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7774550",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 333,
                    "text": "The sensory innervation of the navicular bone (os sesamoideum distale) and its suspensory ligaments [ligamenta sesamoidea collateralia (CSL) and ligamentum sesamoideum distale impar or distal sesamoidean impar (DS-impar) ligament] and the navicular bursa (podotrochlearis) was examined in the neonatal foal using immunocytochemistry."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7774550",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1422,
                    "text": "In terms of relative densities of immunoreactive SP- and CGRP-like peptides, the CSL dorsally and the DS-impar ligament had the highest relative densities of nerve fibres followed by the navicular bone, the palmar aspect of CSL and the DDf tendon bordering the navicular bursa."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25399422",
                "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                "http://www.ncbi.nlm.nih.gov/pubmed/24451198",
                "http://www.ncbi.nlm.nih.gov/pubmed/15708188",
                "http://www.ncbi.nlm.nih.gov/pubmed/22808822",
                "http://www.ncbi.nlm.nih.gov/pubmed/23537911",
                "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                "http://www.ncbi.nlm.nih.gov/pubmed/8644625",
                "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                "http://www.ncbi.nlm.nih.gov/pubmed/17600767"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1089,
                    "offsetInEndSection": 1534,
                    "text": "This suggests additional genetic factors contribute to the dilated cardiomyopathy phenotype.This study represents a meta-analysis of available canine dilated cardiomyopathy genetic datasets with the goal of determining potential multigenic interactions relating the sex chromosome genotype (XX vs. XY) with known dilated cardiomyopathy associated loci on chromosome 5 and the PDK4 gene in the incidence and progression of dilated cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24451198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 84,
                    "offsetInEndSection": 224,
                    "text": "We present the case of a child with dilated cardiomyopathy caused by a 624 kb duplication of 6q22.31, which includes the phospholamban gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8644625",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "Homozygosity for the deletion allele of the angiotensin-converting enzyme gene (DD) has been associated with a variety of cardiovascular diseases, including ischemic and idiopathic dilated cardiomyopathy, in Caucasians."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 555,
                    "offsetInEndSection": 753,
                    "text": "Although multiple human loci have been implicated in the pathogenesis of dilated cardiomyopathy, the identified variants are typically associated with rare monogenic forms of dilated cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 928,
                    "text": "Among the 145 differentially expressed lncRNAs identified in ICM hearts, we found a set of 35 lncRNAs that display strong positive expression correlation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25399422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "Long non-coding RNAs (lncRNAs) have emerged as critical regulators of genes at epigenetic, transcriptional and post-transcriptional levels, yet what genes are regulated by a specific lncRNA remains to be characterized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25399422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 874,
                    "offsetInEndSection": 1021,
                    "text": "Both search types are performed either by browsing a provided catalog of lncRNA names or by inserting lncRNA/target gene IDs/names in a search box."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1672,
                    "offsetInEndSection": 1800,
                    "text": "Our results further indicate that lncRNAs may represent novel regulators of heart function and cardiac disorders, including ICM."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1133,
                    "offsetInEndSection": 1322,
                    "text": "We overexpressed or knocked down selected lncRNAs in cardiac fibroblasts and our results suggest that lncRNAs are important regulators of fibrosis and the expression of ECM synthesis genes."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8783939",
                "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                "http://www.ncbi.nlm.nih.gov/pubmed/10674376",
                "http://www.ncbi.nlm.nih.gov/pubmed/28030792",
                "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                "http://www.ncbi.nlm.nih.gov/pubmed/9665397",
                "http://www.ncbi.nlm.nih.gov/pubmed/11933208",
                "http://www.ncbi.nlm.nih.gov/pubmed/16704453",
                "http://www.ncbi.nlm.nih.gov/pubmed/25208914"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25208914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1436,
                    "offsetInEndSection": 1770,
                    "text": "CONCLUSIONS\nWe hypothesize that differences in KRTAP gene repertoire and gene expression, together with distinct rates of gene conversion/recombination, pseudogenization and positive selection, are likely responsible for micro and macro-phenotypic hair diversification among mammals in response to adaptations to ecological pressures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9665397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 301,
                    "text": "The identification of an association between variants in the human melanocortin 1 receptor (MC1R) gene and red hair and fair skin, as well as the relation between variants of this gene and coat color in animals, suggests that the MC1R is an integral control point in the normal pigmentation phenotype."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 127,
                    "text": "Expression and functional analysis of a novel MYB gene, MdMYB110a_JP, responsible for red flesh, not skin color in apple fruit."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Sequence polymorphism in the human melanocortin 1 receptor gene as an indicator of the red hair phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 205,
                    "text": "We describe a minisequencing protocol for screening DNA samples for the presence of 12 mutations in the human melanocortin 1 receptor gene (MC1R), eight of which are associated with the red hair phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 987,
                    "text": "However, comparison of the MSHR genotypes in dizygotic twin pairs discordant for red hair colour indicates that the MSHR gene cannot be solely responsible for the red hair phenotype, since five of 13 pairs tested had both haplotypes identical by state (with three of the five having both identical by descent)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25208914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1270,
                    "offsetInEndSection": 1433,
                    "text": "Gene expression variation probably also influences hair diversification patterns, for example human have an identical KRTAP repertoire as apes, but much less hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1331,
                    "offsetInEndSection": 1520,
                    "text": "From the results, it was strongly suggested that the red-fleshed phenotype of 'JPP35' fruit was caused by up-regulation of the genes of anthocyanin pathway induced by the MdMYB110a_JP gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28030792",
                    "endSection": "abstract",
                    "offsetInBeginSection": 888,
                    "offsetInEndSection": 1049,
                    "text": "Gene expression in normal skin from RHC cutaneous cells showed dysregulation in 8 out of 23 hub genes (CLN3, ATG10, WIPI2, SNX2, GABARAPL2, YWHA, PCNA and GBAS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "We have succeeded in isolating an MdMYB110a_JP gene responsible for a red-fleshed trait from a fruit of apple cultivar 'JPP35' ('Jonathan'\u00a0\u00d7\u00a0'Pink Pearl')."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/178910",
                "http://www.ncbi.nlm.nih.gov/pubmed/6290339",
                "http://www.ncbi.nlm.nih.gov/pubmed/210371",
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/2988201",
                "http://www.ncbi.nlm.nih.gov/pubmed/8370544",
                "http://www.ncbi.nlm.nih.gov/pubmed/1363938",
                "http://www.ncbi.nlm.nih.gov/pubmed/480473",
                "http://www.ncbi.nlm.nih.gov/pubmed/6090389",
                "http://www.ncbi.nlm.nih.gov/pubmed/25272021"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8370544",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "A new restriction endonuclease, TspEI, from the genus Thermus that generates cohesive termini compatible with those of EcoRI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25272021",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 281,
                    "text": "A simple and facile approach was developed for monitoring EcoRI endonuclease activity and inhibition, in which a hairpin-like DNA containing restriction cutting site for EcoRI endonuclease acts as the sensing element and Hoechst dyes as the signal indicator in a label-free format."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/210371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 163,
                    "offsetInEndSection": 389,
                    "text": "Using EcoRI and Hind III endonuclease restriction sites as reference, the two Pst I sites were mapped at 0.050; 0.265 and the Bam I site was mapped at 0.170 of the genome length, clockwise, from the single EcoRI cleavage site."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6290339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Human cytomegalovirus DNA: BamHI, EcoRI and PstI restriction endonuclease cleavage maps."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6290339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 172,
                    "text": "The cloned HindIII fragments of human cytomegalovirus (HCMV) strain AD169 DNA were mapped with respect to the BamHI, EcoRI and PstI restriction endonuclease cleavage sites."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Phenotypically cryptic EcoRI endonuclease activity specified by the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/178910",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "A restriction endonuclease obtained from Haemophilus gallinarum  (hgaI) cleaves polyoma DNA at four specific sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 379,
                    "text": "Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/178910",
                    "endSection": "abstract",
                    "offsetInBeginSection": 116,
                    "offsetInEndSection": 335,
                    "text": "Using the EcoRI, HindIII, and HpaII endonuclease restriction sites as reference, the four HgaI cleavage sites were mapped at 0.02, 0.14, 0.27, and 0.48 fractional lengths, clockwise, from the single EcoRI cleavage site."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11160967",
                "http://www.ncbi.nlm.nih.gov/pubmed/24756600",
                "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                "http://www.ncbi.nlm.nih.gov/pubmed/3305608",
                "http://www.ncbi.nlm.nih.gov/pubmed/17539247",
                "http://www.ncbi.nlm.nih.gov/pubmed/12685889",
                "http://www.ncbi.nlm.nih.gov/pubmed/21330745",
                "http://www.ncbi.nlm.nih.gov/pubmed/11584993",
                "http://www.ncbi.nlm.nih.gov/pubmed/21905781",
                "http://www.ncbi.nlm.nih.gov/pubmed/27187754"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27187754",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "Cryptococcal meningitis is a leading infectious disease worldwide as a result of the high burden of HIV and AIDS, although its cumulative incidence is very low in children compared with that in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1223,
                    "text": "The incidence rates of CNS opportunistic infections (cryptococcal meningitis, toxoplasmosis, progressive multifocal leukoencephalopathy) and primary CNS lymphoma have decreased since the introduction of HAART."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 448,
                    "text": "Multiple studies now suggest that the incidence rates of HIV-associated neurological disease and central nervous system (CNS) opportunistic infections also are decreasing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12685889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 334,
                    "text": "The incidence of extrapulmonary forms of tuberculosis and cryptococcosis has increased in areas with a high prevalence of human immunodeficiency virus (HIV) infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Highly active antiretroviral therapy (HAART) is effective in suppressing systemic human immunodeficiency virus (HIV) viral load and has decreased mortality rates and the incidence of systemic opportunistic infections in patients with acquired immunodeficiency syndrome (AIDS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12685889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 636,
                    "text": "Atypical presentations of both tuberculosis and cryptococcosis should be considered in areas with a high incidence of these diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 698,
                    "offsetInEndSection": 860,
                    "text": "The incidence of HIV-associated distal sensory polyneuropathy has decreased, although the incidence of antiretroviral drug-induced toxic neuropathy has increased."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11160967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 415,
                    "text": "The incidence rates for HIV dementia, cryptococcal meningitis, and lymphoma decreased following the introduction of highly active antiretroviral therapy (HAART)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21330745",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "The incidence of cryptococcal infection is high in developing countries such as India."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11160967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 253,
                    "text": "This study examined the temporal trends in the incidence rates of HIV dementia, cryptococcal meningitis, toxoplasmosis, progressive multifocal leukoencephalopathy, and CNS lymphoma from January 1990 to December 1998 in the Multicenter AIDS Cohort Study."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                "http://www.ncbi.nlm.nih.gov/pubmed/26454018",
                "http://www.ncbi.nlm.nih.gov/pubmed/26564948",
                "http://www.ncbi.nlm.nih.gov/pubmed/23673643",
                "http://www.ncbi.nlm.nih.gov/pubmed/23227185",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                "http://www.ncbi.nlm.nih.gov/pubmed/17591274",
                "http://www.ncbi.nlm.nih.gov/pubmed/25788450",
                "http://www.ncbi.nlm.nih.gov/pubmed/20979669",
                "http://www.ncbi.nlm.nih.gov/pubmed/23348729"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "The genetic adaptation of Tibetans to high altitude hypoxia likely involves a group of genes in the hypoxic pathway, as suggested by earlier studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25788450",
                    "endSection": "abstract",
                    "offsetInBeginSection": 550,
                    "offsetInEndSection": 921,
                    "text": "Further analyses revealed that several candidate genes in the calcium-signaling pathway are possibly involved in adaptation to the hypoxia experienced by these chickens, as these genes appear to have experienced directional selection in the two Tibetan chicken populations, suggesting a potential genetic mechanism underlying high altitude adaptation in Tibetan chickens."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 901,
                    "offsetInEndSection": 1060,
                    "text": "Collectively, we propose that EP300 harbors adaptive variants in Tibetans, which might contribute to high-altitude adaptation through regulating NO production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20979669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "Genome-wide scans demonstrate that genetic variants associated with high-altitude adaptation in Tibetans and Andeans arose independently as a result of convergent adaptation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26454018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 702,
                    "offsetInEndSection": 1172,
                    "text": "An analysis of 2,269 orthologous genes among cave fish (Astyanax mexicanus), zebrafish (Danio rerio), large-scale loach (Paramisgurnus dabryanus), and Triplophysa fishes revealed that each of the terminal branches of the Triplophysa fishes had a significantly higher ratio of nonsynonymous to synonymous substitutions than that of the branches of the fishes from low altitudes, which provided consistent evidence for genome-wide rapid evolution in the Triplophysa genus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23348729",
                    "endSection": "abstract",
                    "offsetInBeginSection": 999,
                    "offsetInEndSection": 1225,
                    "text": "METHODS\nTo measure for the effects of EGLN1 and EPAS1 altitude genotypes on hemoglobin concentration among Andean highlanders, we performed a multiple linear regression analysis of 10 candidate SNPs in or near these two genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23673643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 351,
                    "offsetInEndSection": 559,
                    "text": "Compared with other plain-dwelling mammals, the genome of the Tibetan antelope shows signals of adaptive evolution and gene-family expansion in genes associated with energy metabolism and oxygen transmission."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23348729",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 667,
                    "text": "One gene previously known to be important in cellular oxygen sensing, egl nine homolog 1 (EGLN1), shows evidence of positive selection in both Tibetans and Andeans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 383,
                    "text": "Here we report on a hypoxia gene ( GCH1, GTP-cyclohydrolase I), involved in maintaining nitric oxide synthetase (NOS) function and normal blood pressure, that harbors many potentially adaptive variants in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23673643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 560,
                    "offsetInEndSection": 715,
                    "text": "Both the highland American pika, and the Tibetan antelope have signals of positive selection for genes involved in DNA repair and the production of ATPase."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23538704",
                "http://www.ncbi.nlm.nih.gov/pubmed/20374958",
                "http://www.ncbi.nlm.nih.gov/pubmed/28448947",
                "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                "http://www.ncbi.nlm.nih.gov/pubmed/26167402",
                "http://www.ncbi.nlm.nih.gov/pubmed/21641555",
                "http://www.ncbi.nlm.nih.gov/pubmed/6383576",
                "http://www.ncbi.nlm.nih.gov/pubmed/28128199",
                "http://www.ncbi.nlm.nih.gov/pubmed/9180264",
                "http://www.ncbi.nlm.nih.gov/pubmed/25428857"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                    "endSection": "abstract",
                    "offsetInBeginSection": 762,
                    "offsetInEndSection": 972,
                    "text": "These data indicate that, unlike liver, skeletal muscle, and whole carcass, BAT protein synthesis is not reduced in protein-restricted rats, and this may be related to activation of thermogenesis in the tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26167402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "Brown adipocytes help to maintain body temperature by the expression of a unique set of genes that facilitate cellular metabolic events including uncoupling protein 1-dependent thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28448947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 238,
                    "text": "Brown adipose tissue (BAT) is a specialized tissue critical for non-shivering thermogenesis producing heat through mitochondrial uncoupling; whereas white adipose tissue (WAT) is responsible of energy storage in the form of triglycerides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9180264",
                    "endSection": "abstract",
                    "offsetInBeginSection": 98,
                    "offsetInEndSection": 273,
                    "text": "The uncoupling protein-1 (UCP1) is the main effector of nonshivering thermogenesis in BAT and the recently described ubiquitous UCP2 [1] has been implicated in energy balance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21641555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "While fatty acids (FAs) released by white adipose tissue (WAT) provide energy for other organs, lipolysis is also critical in brown adipose tissue (BAT), generating FAs for oxidation and UCP-1 activation for thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28128199",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "The adipokine adipocyte fatty acid-binding protein (A-FABP) has been implicated in obesity-related cardio-metabolic complications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25428857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 337,
                    "offsetInEndSection": 572,
                    "text": "The sympathetic neural outflow determining brown adipose tissue (BAT) thermogenesis is regulated by neural networks in the CNS which increase BAT sympathetic nerve activity in response to cutaneous and deep body thermoreceptor signals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 364,
                    "text": "The fact that BAT protein content, unlike that of other tissues, is unnaffected by protein deficiency prompted us to measure tissue protein synthesis in vivo in animals maintained on normal- (18.8%) and low- (7.6%) protein (LP) diets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28128199",
                    "endSection": "abstract",
                    "offsetInBeginSection": 241,
                    "offsetInEndSection": 389,
                    "text": "We find that A-FABP levels are increased in both white (WAT) and brown (BAT) adipose tissues and the bloodstream in response to thermogenic stimuli."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Protein synthesis in liver, skeletal muscle, and brown adipose tissue of rats fed a protein-deficient diet."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                "http://www.ncbi.nlm.nih.gov/pubmed/11996216",
                "http://www.ncbi.nlm.nih.gov/pubmed/24123070",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/16626609",
                "http://www.ncbi.nlm.nih.gov/pubmed/28208678",
                "http://www.ncbi.nlm.nih.gov/pubmed/19965127",
                "http://www.ncbi.nlm.nih.gov/pubmed/28387731",
                "http://www.ncbi.nlm.nih.gov/pubmed/23889826"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1166,
                    "offsetInEndSection": 1278,
                    "text": "An identical set of plasma samples were analyzed utilizing the Bio-Plex Pro\u2122 human cytokine 27-plex immunoassay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 348,
                    "text": "METHODS\nA double antibody sandwich ELISA was developed for detection of SFTSV based on SFTSV nucleocapsid (N) protein specific poly- and monoclonal antibodies, procedures were optimized and evaluated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24123070",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 59,
                    "text": "Multiplex ligase-based genotyping methods combined with CE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "OBJECTIVE\nTo develop an assay for titration of severe fever with thrombocytopenia syndrome virus (SFTSV) based on double antibody sandwich ELISA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24123070",
                    "endSection": "abstract",
                    "offsetInBeginSection": 260,
                    "offsetInEndSection": 402,
                    "text": "As an alternative to the error-prone conventional methods, multiplex ligase-based genotyping methods combined with CE have a strong potential."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 349,
                    "offsetInEndSection": 460,
                    "text": "This ELISA based titration assay was compared with fluorescence assasy and plaque assay based titration method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 660,
                    "offsetInEndSection": 907,
                    "text": "CONCLUSION\nThe novel ELISA based titration method with high sensitivity and specificity is easy to manage and perform, and can overcome the subjectivity associated with result determination of the fluorescence assay and plaque assay based methods."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11803517",
                "http://www.ncbi.nlm.nih.gov/pubmed/25747527",
                "http://www.ncbi.nlm.nih.gov/pubmed/2023912",
                "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                "http://www.ncbi.nlm.nih.gov/pubmed/10359483",
                "http://www.ncbi.nlm.nih.gov/pubmed/17692293",
                "http://www.ncbi.nlm.nih.gov/pubmed/20464528",
                "http://www.ncbi.nlm.nih.gov/pubmed/21295226",
                "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                "http://www.ncbi.nlm.nih.gov/pubmed/19302089"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Monoamine oxidase A (MAOA), a mitochondrial outer membrane enzyme, degrades biogenic amines including norepinephrine, dopamine and serotonin, which have been implicated in the expression of personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21295226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "OBJECTIVE\nPreclinical and human family studies clearly link monoamine oxidase A (MAOA) to aggression and antisocial personality (ASP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20464528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 996,
                    "text": "This finding suggests that T102C in 5-TH(2A) and Val158Met in COMT play roles in some human personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20464528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 533,
                    "offsetInEndSection": 884,
                    "text": "The results showed the T102C in 5-TH(2A) was associated with X3 (emotional and quiet alertness) and B (reasoning) (F = 4.71 and 6.23; p = 0.009 and 0.002), Val158Met in COMT with E (dominance) (F = 7.01; p = 0.0009), while the variations in DBH, DRD(2), DRD(3), MAOA, GRM(1), GRIN2B, and 5-TH(6) were not associated with any of the personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19302089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "BACKGROUND\nAntisocial alcoholism is related to dopamine and serotonin which are catalyzed by monoamine oxidase A (MAOA) and acetaldehyde dehydrogenase 2 (ALDH2)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17692293",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "BACKGROUND\nMonoamine oxidase A (MAOA) is involved in the pathogenesis of mood disorders and Alzheimer's disease (AD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359483",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 309,
                    "text": "We analyzed a novel functional 30-bp repeat polymorphism in the promoter region of the X-chromosomal monoamine oxidase A gene (MAOA) to test whether length variation of the repeat polymorphism contributes to variation in the individual vulnerability to antisocial behavior and liability to alcohol dependence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                    "endSection": "abstract",
                    "offsetInBeginSection": 180,
                    "offsetInEndSection": 351,
                    "text": "Here, we investigated the influence of allelic variation of MAOA activity on aggression-related personality traits and disease risk in patients with personality disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "Genetic variants of the monoamine oxidase A (MAOA) have been associated with aggression-, anxiety-, and addiction-related behavior in several nonclinical and clinical populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19302089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 357,
                    "text": "The objective of this study is to determine whether the interaction between the MAOA and the ALDH2 genes is associated with subjects with antisocial personality disorder (ASPD) having alcoholism."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                "http://www.ncbi.nlm.nih.gov/pubmed/21253530",
                "http://www.ncbi.nlm.nih.gov/pubmed/21277938",
                "http://www.ncbi.nlm.nih.gov/pubmed/22715468",
                "http://www.ncbi.nlm.nih.gov/pubmed/16307490",
                "http://www.ncbi.nlm.nih.gov/pubmed/19855427",
                "http://www.ncbi.nlm.nih.gov/pubmed/18336298",
                "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                "http://www.ncbi.nlm.nih.gov/pubmed/21266250",
                "http://www.ncbi.nlm.nih.gov/pubmed/22621256"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22621256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 286,
                    "text": "HDAC is a family of enzymes involved in deacetylation of lysine residues on histone and non-histone proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 591,
                    "offsetInEndSection": 856,
                    "text": "While histones still represent a primary target for the physiological function of HDACs, the antitumor effect of HDAC inhibitors might also be attributed to transcription-independent mechanisms by modulating the acetylation status of a series of nonhistone targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 803,
                    "text": "This review provides a comprehensive examination of the transcriptional and post-translational mechanisms by which HDACs alter the expression and function of cancer-associated proteins and examines the general impact of HDAC activity in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 274,
                    "offsetInEndSection": 597,
                    "text": "HDACs and histone acetyltransferases can, by reversible acetylation, modify the structure and function of histones and proteins in transcription factor complexes, which are involved in the regulation of gene expression, as well as many non-histone proteins that are involved in regulating cell proliferation and cell death."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19855427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 264,
                    "text": "Classical zinc-dependent histone deacetylases (HDACs) catalyse the removal of acetyl groups from histone tails and also from many non-histone proteins, including the transcription factor FOXP3, a key regulator of the development and function of regulatory T cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 286,
                    "offsetInEndSection": 590,
                    "text": "Although they have been shown to regulate the transcription of a defined set of genes through chromatin remodeling, increasing evidence suggests that modifications of the epigenetic histone code may not be the primary mechanism for HDAC inhibitor-mediated growth inhibition and apoptosis in cancer cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21253530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "HDAC activity is required for efficient core promoter function at the mouse mammary tumor virus promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21277938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1212,
                    "offsetInEndSection": 1384,
                    "text": "Thus, endogenous HDAC inhibitors represent a promising class of \"antitumor agents\" thanks to which oncogenic addiction pathways may be selectively therapeutically targeted."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18336298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 235,
                    "text": "Histone deacetylases (HDACs) catalyze the deacetylation of the acetylated lysine residues of histones and non-histone proteins, and are involved in various fundamental life phenomena, such as gene expression and cell cycle progression."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1522894",
                "http://www.ncbi.nlm.nih.gov/pubmed/24510259",
                "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/23608054",
                "http://www.ncbi.nlm.nih.gov/pubmed/8811095",
                "http://www.ncbi.nlm.nih.gov/pubmed/7678553",
                "http://www.ncbi.nlm.nih.gov/pubmed/9276688",
                "http://www.ncbi.nlm.nih.gov/pubmed/10673027",
                "http://www.ncbi.nlm.nih.gov/pubmed/7509558"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 616,
                    "offsetInEndSection": 766,
                    "text": "The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9276688",
                    "endSection": "abstract",
                    "offsetInBeginSection": 420,
                    "offsetInEndSection": 582,
                    "text": "Precise RNA cleavage site mapping in this divergent Old World virus, LRV2-1, confirms that cleavage is occurring within a region of homology to the LRV1 isolates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10673027",
                    "endSection": "abstract",
                    "offsetInBeginSection": 362,
                    "offsetInEndSection": 671,
                    "text": "Mapping of topoisomerase I-mediated irreversible cleavage sites on homopolymeric DNA substrates containing mismatches showed trapping of the enzyme in several positions in close vicinity of the DNA imperfection, with a strong preference for the 5' junction between the duplex DNA and the base-pairing anomaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23608054",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "The mapping of DNA footprints and affinity cleavage sites for small DNA ligands is affected by the choice of sequencing chemistry and end label, and the potential for indexing errors can be significant when mapping small ligand-DNA interactions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10673027",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Mapping of eukaryotic DNA topoisomerase I catalyzed cleavage without concomitant religation in the vicinity of DNA structural anomalies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Assessing intermolecular RNA:RNA interactions within a ribonucleoprotein complex using heavy metal cleavage mapping."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24510259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Mapping the precise position of endonucleolytic cleavage sites is a fundamental experimental technique used to describe the function of a homing endonuclease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "Heavy metal cleavage mapping analysis of both assembling and fully mature ribonucleoprotein (RNP) complexes are informative techniques for assessing the intermolecular base pairing between small non-coding RNAs and their interacting target RNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7509558",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 206,
                    "text": "We have shown that Integration Host Factor of E. coli can successfully be used in the IHF-mediated Achilles' Heel Cleavage (IHF-AC) technique (Kur et al., 1992b), for generating rare natural cleavage sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10673027",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1086,
                    "offsetInEndSection": 1331,
                    "text": "Taken together these findings suggest that covalent trapping of topoisomerase I proceeds at positions adjacent to mismatches, nicks and single-stranded branches, where the cleavage reaction is allowed and the ensuing ligation reaction prevented."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3460332",
                "http://www.ncbi.nlm.nih.gov/pubmed/25837870",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                "http://www.ncbi.nlm.nih.gov/pubmed/10395804",
                "http://www.ncbi.nlm.nih.gov/pubmed/7929013",
                "http://www.ncbi.nlm.nih.gov/pubmed/3023690",
                "http://www.ncbi.nlm.nih.gov/pubmed/8596958",
                "http://www.ncbi.nlm.nih.gov/pubmed/7590302",
                "http://www.ncbi.nlm.nih.gov/pubmed/8441634",
                "http://www.ncbi.nlm.nih.gov/pubmed/2037291"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "DNA Polymerase \u03b8: A Unique Multifunctional End-Joining Machine."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8596958",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "An RNA polymerase II elongation factor encoded by the human ELL gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8596958",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 376,
                    "text": "Here, ELL was shown to encode a previously uncharacterized elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by polymerase at multiple sites along the DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7929013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 303,
                    "text": "We report the sequence of the gene encoding the DNA polymerase of Methanococcus voltae and describe evidence that it lacks analogous intervening sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2037291",
                    "endSection": "abstract",
                    "offsetInBeginSection": 289,
                    "offsetInEndSection": 377,
                    "text": "The DNA polymerase alpha gene (Pola) was mapped to the mouse X chromosome in region C-D."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7590302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 210,
                    "text": "The polA gene (encoding DNA polymerase I) from Mycobacterium tuberculosis was cloned using an internal gene segment probe generated by PCR amplification of genomic DNA [Mizrahi et al., Gene 136 (1993) 287-290]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3460332",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "The gene encoding the large subunit of human RNA polymerase II is located on the short arm of chromosome 17."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10395804",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Cloning and chromosomal mapping of the human DNA polymerase theta (POLQ), the eighth human DNA polymerase."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2037291",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 205,
                    "text": "Physical mapping of the genes for three components of the mouse DNA replication complex: polymerase alpha to the X chromosome, primase p49 subunit to chromosome 10, and primase p58 subunit to chromosome 1."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21194037",
                "http://www.ncbi.nlm.nih.gov/pubmed/12737315",
                "http://www.ncbi.nlm.nih.gov/pubmed/28325281",
                "http://www.ncbi.nlm.nih.gov/pubmed/12719373",
                "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                "http://www.ncbi.nlm.nih.gov/pubmed/18371406",
                "http://www.ncbi.nlm.nih.gov/pubmed/22511986",
                "http://www.ncbi.nlm.nih.gov/pubmed/17579573",
                "http://www.ncbi.nlm.nih.gov/pubmed/11468272",
                "http://www.ncbi.nlm.nih.gov/pubmed/10704448"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11468272",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28325281",
                    "endSection": "abstract",
                    "offsetInBeginSection": 308,
                    "offsetInEndSection": 494,
                    "text": "Alternatively, antisense therapy can be used to induce destructive exon skipping of myostatin pre-mRNA, knocking down myostatin expression to enhance muscle strength and reduce fibrosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11468272",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 771,
                    "text": "Considering that exon 45 is the single most frequently deleted exon in DMD, whereas exon (45+46) deletions cause only a mild form of BMD, we set up an antisense-based system to induce exon 46 skipping from the transcript in cultured myotubes of both mouse and human origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 764,
                    "offsetInEndSection": 936,
                    "text": "In DMD patient cells, bifunctional U7 snRNAs harboring silencer motifs induce complete skipping of exon 51, and thus restore dystrophin expression to near wild-type levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18371406",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Duchenne muscular dystrophy (DMD) is a hereditary disease caused by mutations that disrupt the dystrophin mRNA reading frame."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17579573",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 314,
                    "text": "Duchenne muscular dystrophy is characterized by an absence of functional protein, whereas Becker muscular dystrophy, commonly caused by in-frame deletions, shows synthesis of partially functional protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disorder caused by mutations in the dystrophin gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28325281",
                    "endSection": "abstract",
                    "offsetInBeginSection": 495,
                    "offsetInEndSection": 801,
                    "text": "We have reported previously that intramuscular or intraperitoneal antisense administration inducing dual exon skipping of dystrophin and myostatin pre-mRNAs was beneficial in mdx mice, a mouse model of DMD, although therapeutic effects were muscle type restricted, possibly due to the delivery routes used."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 600,
                    "offsetInEndSection": 763,
                    "text": "In this study, we demonstrate that enhanced exon skipping can be induced by a U7 snRNA carrying binding sites for the heterogeneous ribonucleoprotein A1 (hnRNPA1)."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24764460",
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/28323040",
                "http://www.ncbi.nlm.nih.gov/pubmed/22722835",
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                "http://www.ncbi.nlm.nih.gov/pubmed/29086764",
                "http://www.ncbi.nlm.nih.gov/pubmed/19574298",
                "http://www.ncbi.nlm.nih.gov/pubmed/26722227",
                "http://www.ncbi.nlm.nih.gov/pubmed/21964070"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 484,
                    "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 578,
                    "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 747,
                    "text": "ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1105,
                    "offsetInEndSection": 1307,
                    "text": "We further show that the testis-specific circRNA, sex-determining region Y (Sry), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21964070",
                    "endSection": "abstract",
                    "offsetInBeginSection": 630,
                    "offsetInEndSection": 848,
                    "text": "This study provides the first evidence for non-coding antisense transcripts as functional miRNA targets, and a novel regulatory mechanism involving a positive correlation between mRNA and antisense circular RNA levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28323040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 251,
                    "offsetInEndSection": 513,
                    "text": "In addition to developing artificial miRNA sponges, scientists have sought endogenous RNA transcripts and found that long non-coding RNAs, competing endogenous RNAs, pseudogenes, circular RNAs, and coding RNAs could act as miRNA sponges under precise conditions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 331,
                    "offsetInEndSection": 394,
                    "text": "Also, ciRS-7 acts as a natural competing endogenous RNA, a.k.a."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 200,
                    "offsetInEndSection": 330,
                    "text": "A recently identified circRNA, ciRS-7, can regulate the activities of miRNAs, mRNAs, and RBP to exert specific biological effects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19574298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 114,
                    "offsetInEndSection": 264,
                    "text": "Here, we show that the RBP HuR reduced c-Myc expression by associating with the c-Myc 3' untranslated region (UTR) next to a miRNA let-7-binding site."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22722835",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1157,
                    "offsetInEndSection": 1341,
                    "text": "Argonaute also binds let-7 primary transcripts in human cells, demonstrating that the miRNA pathway targets non-coding RNAs in addition to protein-coding messenger RNAs across species."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27699049",
                "http://www.ncbi.nlm.nih.gov/pubmed/27595004",
                "http://www.ncbi.nlm.nih.gov/pubmed/27493758",
                "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                "http://www.ncbi.nlm.nih.gov/pubmed/19553672",
                "http://www.ncbi.nlm.nih.gov/pubmed/20941585",
                "http://www.ncbi.nlm.nih.gov/pubmed/23251548",
                "http://www.ncbi.nlm.nih.gov/pubmed/24036685",
                "http://www.ncbi.nlm.nih.gov/pubmed/18338233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27532606"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 845,
                    "text": "As results, 132 bacterial genera and some unidentified operational taxonomic units within 29 phyla in the gut bacteria were detected, with Spirochaetes (11-55%), Firmicutes (7-18%), Bacteroidetes (7-31%), and Proteobacteria (8-14%) as the main phyla, and Treponema, TG5, Dysgonomonas, Tannerella, za29, Lactococcus, Pseudomonas, and SJA-88 as the common genera in all the four termites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 416,
                    "text": "Bacterial clone libraries of the gut microbiota of nurtured and starved Cylindroiulus fulviceps specimens displayed the predominance of the phyla Bacteroidetes (55 and 37 %, respectively) and Proteobacteria (40 and 35 %, respectively) and a high similarity to bacteria previously detected in the intestinal tract of termites and beetles, which are known to harbor symbiotic bacteria essential for digestive activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18338233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 117,
                    "offsetInEndSection": 276,
                    "text": "Novel culture-independent approaches have revealed that the majority of the human gut microbiota consists of members of the phyla Bacteroidetes and Firmicutes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24036685",
                    "endSection": "abstract",
                    "offsetInBeginSection": 580,
                    "offsetInEndSection": 735,
                    "text": "The communities from several rural regions display similarities within each region and are dominated by the bacterial taxa associated with the healthy gut."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 846,
                    "offsetInEndSection": 1323,
                    "text": "The diversity of gut bacterial communities in the higher termite guts was significantly greater than that in the lower termites; while the gut microbiota in M. shangchengensis (wood-feeding higher termite) was more similar to those of the wood-feeding lower termites rather than that of O. formosanus (fungus-feeding higher termite), and phylum Spirochaetes and nitrogen-fixing bacteria were super-dominant in the wood-feeding termites, despite of their phylogenetic relations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23251548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 977,
                    "offsetInEndSection": 1112,
                    "text": "The putative core stomach microbiome comprised 5 OTUs in 3 phyla, while the putative core gut microbiome contained 44 OTUs in 12 phyla."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27595004",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "'Lachnoclostridium massiliosenegalense', a new bacterial species isolated from the human gut microbiota."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27699049",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "\"Lachnoclostridium touaregense,\" a new bacterial species isolated from the human gut microbiota."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493758",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "\"Lachnoclostridium bouchesdurhonense,\" a new bacterial species isolated from human gut microbiota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23251548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 976,
                    "text": "While many members of the stomach and gut microbiomes appeared to be transients or opportunists, a putative core microbiome was identified based on phylotypes that occurred in all stomach or gut samples only."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18831144",
                "http://www.ncbi.nlm.nih.gov/pubmed/21798462",
                "http://www.ncbi.nlm.nih.gov/pubmed/21324845",
                "http://www.ncbi.nlm.nih.gov/pubmed/3490922",
                "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                "http://www.ncbi.nlm.nih.gov/pubmed/8043476",
                "http://www.ncbi.nlm.nih.gov/pubmed/9702244",
                "http://www.ncbi.nlm.nih.gov/pubmed/25242163",
                "http://www.ncbi.nlm.nih.gov/pubmed/26086636"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Yellow fever is an arthropod-borne disease with symptoms ranging from mild fever to acute hepatonephritis, hemorrhages and shock often fatal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 423,
                    "text": "In order to estimate the risk of an epidemic of urban yellow fever in a dengue-infested area we calculated the threshold in the basic reproduction number, R0, of dengue, above which any single sylvatic yellow fever-infected individual will trigger an urban yellow fever epidemic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 329,
                    "offsetInEndSection": 734,
                    "text": "WHO convened a working group of international experts to review factors important for the transmission of yellow fever virus and country-specific yellow fever information, to establish criteria for additions to or removal from the list of countries with risk for yellow fever virus transmission, to update yellow fever risk maps, and to revise the recommendations for vaccination for international travel."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18831144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 639,
                    "text": "We explore the research responses to a variety of disease outbreaks in Colombia in the context of the Rockefeller campaigns against yellow fever, from the time of Roberto Franco's initial description of \"yellow fever of the forests\" in 1907 until the consolidation of the concept of \"jungle yellow fever\" by Fred Soper in 1938."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 254,
                    "text": "The pathophysiology of severe yellow fever in humans and in monkeys susceptible to the virus is largely unknown."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21324845",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 800,
                    "offsetInEndSection": 965,
                    "text": "The theory proposed is illustrated by the case of S\u00e3o Paulo State in southern Brazil, where dengue is endemic and the risk of urban yellow fever is already imminent."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Yellow fever and dengue are viral infections that in urban centres are transmitted by the same arthropod vector, a mosquito of the genus Aedes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 467,
                    "offsetInEndSection": 609,
                    "text": "These findings are attributed to the probable hyperactivity and an all time exposure to yellow fever virus in circulation in the studied area."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9702244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 467,
                    "offsetInEndSection": 609,
                    "text": "These findings are attributed to the probable hyperactivity and an all time exposure to yellow fever virus in circulation in the studied area."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                "http://www.ncbi.nlm.nih.gov/pubmed/1085370",
                "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                "http://www.ncbi.nlm.nih.gov/pubmed/22076482",
                "http://www.ncbi.nlm.nih.gov/pubmed/19515095",
                "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                "http://www.ncbi.nlm.nih.gov/pubmed/7760986",
                "http://www.ncbi.nlm.nih.gov/pubmed/7558460",
                "http://www.ncbi.nlm.nih.gov/pubmed/28345562"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 376,
                    "text": "Here, we show that dogs exhibit a behavioural response similar to that of red-green blind human subjects when tested with a modified version of a test commonly used for the diagnosis of human deuteranopia (i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                    "endSection": "abstract",
                    "offsetInBeginSection": 792,
                    "offsetInEndSection": 983,
                    "text": "These preliminary results suggest that the new test is effective for screening congenital red-green blindness and monitoring colour vision defects in acquired diseases such as optic neuritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 377,
                    "offsetInEndSection": 398,
                    "text": "the Ishihara's test)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "From our results we can be sure that the colour test disk is at least as reliable for mass testing for colour blindness as the Ishihara isochromatic colour plates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                    "endSection": "abstract",
                    "offsetInBeginSection": 203,
                    "offsetInEndSection": 330,
                    "text": "The test, using an error score, examines both the red-green and blue-yellow axes, with four levels of difficulty for each axis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22076482",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "The assessment of colour perception, naming and knowledge: a new test device with a case study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22076482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 361,
                    "offsetInEndSection": 593,
                    "text": "The norms, obtained from 96 healthy Italian participants, allow normality/pathology judgements on the basis of one-sided tolerance limits, after adjusting the score of each test for the demographic variables of the proband subjects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 272,
                    "text": "In practice the test disk has the advantage of constancy of testing conditions and easy and quick procedure."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 42,
                    "text": "A new colour vision test for clinical use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 273,
                    "offsetInEndSection": 411,
                    "text": "If it is necessary to differentiate between protopia and deuteropia the colour test disk is significantly better Ishihara's colour plates."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11407860",
                "http://www.ncbi.nlm.nih.gov/pubmed/18798490",
                "http://www.ncbi.nlm.nih.gov/pubmed/11927395",
                "http://www.ncbi.nlm.nih.gov/pubmed/25828948",
                "http://www.ncbi.nlm.nih.gov/pubmed/7909420",
                "http://www.ncbi.nlm.nih.gov/pubmed/2547375",
                "http://www.ncbi.nlm.nih.gov/pubmed/7748187",
                "http://www.ncbi.nlm.nih.gov/pubmed/10355528",
                "http://www.ncbi.nlm.nih.gov/pubmed/12578586",
                "http://www.ncbi.nlm.nih.gov/pubmed/3790748"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11927395",
                    "endSection": "abstract",
                    "offsetInBeginSection": 102,
                    "offsetInEndSection": 305,
                    "text": "Using the MCF-7 human breast adenocarcinoma cell line, it has been demonstrated that autocrine GH-stimulated mammary carcinoma cell proliferation decreased the apoptosis rate and enhanced cell spreading."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25828948",
                    "endSection": "abstract",
                    "offsetInBeginSection": 145,
                    "offsetInEndSection": 326,
                    "text": "MCF-7 is the most studied human breast cancer cell line in the world, and results from this cell line have had a fundamental impact upon breast cancer research and patient outcomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11407860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 236,
                    "offsetInEndSection": 518,
                    "text": "Since BRCA1 is known to play a role in the maintenance of chromosomal integrity, the increase in chromosomal aberrations in MCF-7 clones suggests that downregulation of BRCA1 expression could be one of the possible mechanisms for increased chromosomal instability in this cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18798490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "OBJECTIVE\nTo investigate whether there are cancer stem cells in the MCF-7 human breast cancer cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18798490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 678,
                    "text": "CONCLUSION\nBreast cancer stem cell exists in MCF-7 and it mainly locates the subpopulation of CD44+ CD24- cells, CD44+ CD24+ cell possibly is breast cancer progenitor cell."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2547375",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Tumor necrosis factor (TNF)-resistant variant of human mammary cancer MCF-7 cell line was isolated by stepwise selection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10355528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 376,
                    "offsetInEndSection": 569,
                    "text": "The major cell surface alterations in MCF-7/6 cells compared with the parental MCF-7 cell line were a markedly increased CD15 (LewisX) and CD44 antigen cell surface expression on MCF-7/6 cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7909420",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25828948",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "It is 45 years since a pleural effusion from a patient with metastatic breast cancer led to the generation of the MCF-7 breast cancer cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7748187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "We have demonstrated previously decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan (MelR MCF-7)."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11102759",
                "http://www.ncbi.nlm.nih.gov/pubmed/11054714",
                "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                "http://www.ncbi.nlm.nih.gov/pubmed/12366811",
                "http://www.ncbi.nlm.nih.gov/pubmed/10734230",
                "http://www.ncbi.nlm.nih.gov/pubmed/19008226",
                "http://www.ncbi.nlm.nih.gov/pubmed/8125750",
                "http://www.ncbi.nlm.nih.gov/pubmed/11348051",
                "http://www.ncbi.nlm.nih.gov/pubmed/19020750",
                "http://www.ncbi.nlm.nih.gov/pubmed/23840601"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "Amino acid sequence from tryptic peptides of three different bovine corneal keratan sulfate proteoglycan (KSPG) core proteins (designated 37A, 37B, and 25) showed similarities to the sequence of a chicken KSPG core protein lumican."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19020750",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Lumican is a member of a small leucine-rich proteoglycan family and is highly expressed in several types of cancer cells and/or stromal tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11054714",
                    "endSection": "abstract",
                    "offsetInBeginSection": 321,
                    "offsetInEndSection": 502,
                    "text": "Western blot study showed that lumican protein is highly abundant relative to decorin, while biglycan and fibromodulin are only detected occasionally in breast tissues (n=15 cases)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11102759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 528,
                    "offsetInEndSection": 666,
                    "text": "Decorin is highly expressed in sclera and sternum, whereas lumican is expressed in these tissues, as well as in liver, at very low levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8125750",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1049,
                    "offsetInEndSection": 1364,
                    "text": "The rate of decorin precursor protein synthesis remained relatively low and constant throughout development, but lumican precursor protein synthesis increased dramatically between days 7 and 9 of embryonic development, to a value 80-fold higher than that of decorin, and then decreased exponentially through day 18."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                    "endSection": "title",
                    "offsetInBeginSection": 100,
                    "offsetInEndSection": 173,
                    "text": "Protein 37B represents bovine lumican and proteins 37A and 25 are unique."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11054714",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1006,
                    "offsetInEndSection": 1224,
                    "text": "Further evidence of altered lumican expression in breast cancer was manifested by discordance between lumican mRNA and protein localization in some regions of tumours but not in adjacent morphologically normal tissues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 840,
                    "offsetInEndSection": 1099,
                    "text": "About two-thirds of the lumican protein consists of a series of 10 amino acid leucine-rich repeats that occur in regions of calculated high beta-hydrophobic moment, suggesting that the leucine-rich repeats contribute to beta-sheet formation in these proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840601",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Lumican is a dermatan sulfate proteoglycan highly expressed in connective tissue and has the ability to regulate collagen fibril assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11348051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 615,
                    "text": "Lumican protein existed in the forms of core protein and proteoglycan in the control rat heart."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12167569",
                "http://www.ncbi.nlm.nih.gov/pubmed/23852652",
                "http://www.ncbi.nlm.nih.gov/pubmed/24412072",
                "http://www.ncbi.nlm.nih.gov/pubmed/8633005",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/11257517",
                "http://www.ncbi.nlm.nih.gov/pubmed/22687401",
                "http://www.ncbi.nlm.nih.gov/pubmed/23846873",
                "http://www.ncbi.nlm.nih.gov/pubmed/21402137",
                "http://www.ncbi.nlm.nih.gov/pubmed/11432536"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 158,
                    "text": "The effect of rifampicin on cytochrome P450 isoforms in the CYP1A and CYP3A subfamilies has been studied in 72-h cultured precision-cut human liver slices."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24412072",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "The HIV protease inhibitor (PI) ritonavir (RTV) has been widely used as a pharmacoenhancer for other PIs, which are substrates of cytochrome P450 3A (CYP3A)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432536",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 649,
                    "text": "The relative potency of the rifamycins as CYP3A inducers is rifampin > rifapentine > rifabutin; rifabutin is also a CYP3A substrate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257517",
                    "endSection": "abstract",
                    "offsetInBeginSection": 652,
                    "offsetInEndSection": 908,
                    "text": "Treatment with phenobarbitone caused CYP2B, CYP2C-2 and CYP3A21 levels to increase, rifampicin caused increases in CYP2B and CYP2C-1 and a decrease in CYP3A21 levels, whereas dioxin caused CYP1A1 and CYP1A2 levels to increase and CYP2E1 levels to decrease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432536",
                    "endSection": "abstract",
                    "offsetInBeginSection": 358,
                    "offsetInEndSection": 516,
                    "text": "The rifamycins are well-known inducers of enzyme systems involved in the metabolism of many drugs, most notably those metabolised by cytochrome P450 (CYP) 3A."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257517",
                    "endSection": "abstract",
                    "offsetInBeginSection": 949,
                    "offsetInEndSection": 1100,
                    "text": "P450 enzyme activities were assessed using 8 different substrates and increases were found after treatment with phenobarbitone, rifampicin, and dioxin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23852652",
                    "endSection": "abstract",
                    "offsetInBeginSection": 460,
                    "offsetInEndSection": 699,
                    "text": "Two Phase 1 clinical trials were conducted in healthy postmenopausal women; crossover designs examined the effects of pretreatment with the CYP modulators rifampicin, ketoconazole, fluconazole and omeprazole on ospemifene pharmacokinetics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 630,
                    "offsetInEndSection": 743,
                    "text": "These results demonstrate that rifampicin induces CYP3A isoforms, but not CYP1A2, in cultured human liver slices."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8633005",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 582,
                    "text": "The magnitude of CYP3A induction by rifampicin was compared in the human parental colon carcinoma cell line LS 180/WT (wild type) and in two derivative clones overexpressing the human multidrug resistance gene MDR1 (also designated PGY1) because of either drug selection (LS 180/ADR) or transfection with MDRI cDNA (LS 180/MDR)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/17726612",
                "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                "http://www.ncbi.nlm.nih.gov/pubmed/23273016",
                "http://www.ncbi.nlm.nih.gov/pubmed/11673470",
                "http://www.ncbi.nlm.nih.gov/pubmed/16721377",
                "http://www.ncbi.nlm.nih.gov/pubmed/8009367",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332641"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 578,
                    "offsetInEndSection": 786,
                    "text": "Experimental haploidisation of such diploids result in two types of products, those with a normal 7 chromosome karyotype and those with an abnormal 6 chromosome karyotype which contains the fusion chromosome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Chromosome-Specific Centromere Sequences Provide an Estimate of the Ancestral Chromosome 2 Fusion Event in Hominin Genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 577,
                    "text": "Thus the chromosome number of the diploids is reduced from the normal 2n = 14 to 2n = 13 with the formation of an abnormally large acrocentric fusion chromosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 632,
                    "offsetInEndSection": 961,
                    "text": "We investigate the most recent product of a chromosome fusion event fixed in the human lineage, human chromosome 2, whose stability was acquired by the suppression of one centromere, resulting in a unique difference in chromosome number between humans (46 chromosomes) and our most closely related ape relatives (48 chromosomes)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1040,
                    "offsetInEndSection": 1230,
                    "text": "Cytological examination of the karyotypes of haploid strains bearing the fusion chromosome suggest that chromosome 2 may correspond to linkage group II and chromosome 3 to linkage group VII."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 415,
                    "offsetInEndSection": 644,
                    "text": "The recombinant chromosome that harbors the beta/delta fusion gene in elephants is structurally similar to the \"anti-Lepore\" duplication mutant of humans (the reciprocal exchange product of the hemoglobin Lepore deletion mutant)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1260,
                    "offsetInEndSection": 1612,
                    "text": "The reduced fitness of the human Hb Lepore deletion mutant helps to explain why independently derived beta/delta fusion genes (which occur on an anti-Lepore chromosome) have been fixed in a number of mammalian lineages, whereas the reciprocal delta/beta fusion gene (which occurs on a Lepore chromosome) has yet to be documented in any nonhuman mammal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 415,
                    "text": "These fusion chromosomes appear to be the products of the tandem translocation of most, if not all, of one acrocentric chromosome to the telomere of a second acrocentric."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22974215",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                "http://www.ncbi.nlm.nih.gov/pubmed/23409978",
                "http://www.ncbi.nlm.nih.gov/pubmed/17940847",
                "http://www.ncbi.nlm.nih.gov/pubmed/23988446",
                "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                "http://www.ncbi.nlm.nih.gov/pubmed/15922867",
                "http://www.ncbi.nlm.nih.gov/pubmed/18508627",
                "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                "http://www.ncbi.nlm.nih.gov/pubmed/25893293"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17940847",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 244,
                    "text": "Among different species, the amino acid sequence of EpCAM is highly homologous, indicating that EpCAM is an evolutionary conserved protein."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is best known as a tumor-associated protein highly expressed in carcinomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22974215",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is a single-transmembrane protein, which is involved in numerous cellular processes including cell adhesion, proliferation, maintenance of stemness of embryonic cells and progenitors, migration and invasion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 912,
                    "text": "To test this hypothesis and to evaluate whether lack of EPCAM expression can already be detected in Lynch syndrome-associated adenomas, we analyzed four carcinomas and two adenomas from EPCAM germline deletion carriers for EPCAM protein expression and allelic deletion status of the EPCAM gene region by multiplex ligation-dependent probe amplification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1381,
                    "offsetInEndSection": 1519,
                    "text": "CONCLUSION\nThese results indicate that loss of EPCAM protein expression is frequent in tumors from patients with EPCAM germline deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23409978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 374,
                    "offsetInEndSection": 550,
                    "text": "To shed light on how proteolytic cleavage is involved in EpCAM signalling, we characterized the protein biochemically using antibodies binding to three different EpCAM domains."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15922867",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18508627",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "The tumor antigen EpCAM: tetraspanins and the tight junction protein claudin-7, new partners, new functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 399,
                    "text": "Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel mutational mechanism causing Lynch syndrome by epigenetic inactivation of the respective MSH2 allele."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24401533",
                "http://www.ncbi.nlm.nih.gov/pubmed/25854486",
                "http://www.ncbi.nlm.nih.gov/pubmed/22595815",
                "http://www.ncbi.nlm.nih.gov/pubmed/22259168",
                "http://www.ncbi.nlm.nih.gov/pubmed/25895845",
                "http://www.ncbi.nlm.nih.gov/pubmed/23382458",
                "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                "http://www.ncbi.nlm.nih.gov/pubmed/24554904",
                "http://www.ncbi.nlm.nih.gov/pubmed/23466963",
                "http://www.ncbi.nlm.nih.gov/pubmed/29138609"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29138609",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 420,
                    "text": "Apixaban belongs to this group of drugs, and is a factor Xa inhibitor that has emerged as a popular pharmacological agent worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 814,
                    "text": "The drugs were dabigatran etexilate mesylate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "BACKGROUND AND OBJECTIVES\nApixaban is a direct oral anticoagulant (DOAC) targeting factor Xa and thus quenching thrombin generation and clot formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29138609",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 287,
                    "text": "Initially, vitamin K antagonists were used as stroke prophylaxis; but more recently, a group of drugs known as novel oral anticoagulants have been developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23466963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Novel oral anticoagulants (OACs), including dabigatran etexilate, rivaroxaban, and apixaban, are available alternative anticoagulant therapy to vitamin K antagonists."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24554904",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 38,
                    "text": "The new factor Xa inhibitor: Apixaban."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23466963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 469,
                    "offsetInEndSection": 712,
                    "text": "Dabigatran, rivaroxaban, and apixaban have all been shown to be noninferior to warfarin treatment for stroke prevention in respective phase 3 clinical trials; dabigatran and apixaban were shown to be superior to warfarin as preventive therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25854486",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "Four new oral anticoagulants (NOAC), apixaban, rivaroxaban, edoxaban, and dabigatran, are now available in the USA; however, only apixaban and rivaroxaban are FDA approved for the prevention of venous thromboembolism following orthopedic surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23466963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 879,
                    "offsetInEndSection": 985,
                    "text": "Among these agents, rivaroxaban is the only FDA-approved drug for the treatment of venous thromboembolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22259168",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 76,
                    "text": "Vitamin K antagonists are currently the most frequently used anticoagulants."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27975249",
                "http://www.ncbi.nlm.nih.gov/pubmed/6421824",
                "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                "http://www.ncbi.nlm.nih.gov/pubmed/24788226",
                "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                "http://www.ncbi.nlm.nih.gov/pubmed/26502977",
                "http://www.ncbi.nlm.nih.gov/pubmed/28106992",
                "http://www.ncbi.nlm.nih.gov/pubmed/25358680",
                "http://www.ncbi.nlm.nih.gov/pubmed/19036972",
                "http://www.ncbi.nlm.nih.gov/pubmed/21705366"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 504,
                    "offsetInEndSection": 698,
                    "text": "Recently, it has become possible to assess the regional distribution and severity of tau burden in vivo with the development of novel radiotracers for positron emission tomography (PET) imaging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26502977",
                    "endSection": "abstract",
                    "offsetInBeginSection": 588,
                    "offsetInEndSection": 839,
                    "text": "In particular, we assessed intracellular tau and extracellular tau, soluble tau, insoluble tau and phosphorylated tau at certain sites utilizing a combination of in vivo microdialysis, biochemical analysis and specific ELISAs recognizing each species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 1053,
                    "text": "In this article, we provide a comprehensive discussion of tau pathophysiology, its quantification with novel PET radiotracers, as well as a systematic review of tau PET imaging in normal aging and various dementia conditions: mild cognitive impairment, Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, and Lewy body dementia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 963,
                    "text": "The recent development of selective in-vivo tau PET imaging ligands including [(18)F]THK523, [(18)F]THK5117, [(18)F]THK5105 and [(18)F]THK5351, [(18)F]AV1451(T807) and [(11)C]PBB3 has provided information about the role of tau in the early phases of neurodegenerative diseases, and provided support for diagnosis, prognosis, and imaging biomarkers to track disease progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 124,
                    "offsetInEndSection": 543,
                    "text": "The introduction of these tracers, namely \u03b2-amyloid (A\u03b2) and later tau, are providing the tools to change the landscape and refine our understanding of A\u03b2 and tau deposition in the brain, allowing to investigate the causes, refine diagnosis and improve treatment of major neurodegenerative conditions such as Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE) and frontotemporal lobar degeneration (FTLD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 278,
                    "offsetInEndSection": 433,
                    "text": "In AD, it has been shown that the density of hyperphosphorylated tau tangles correlates closely with neuronal dysfunction and cell death, unlike \u03b2-amyloid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21705366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 624,
                    "text": "Here we studied how important is Tau phosphorylation for axonal transport and neurohormone release in vivo, using the Drosophila model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24788226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 310,
                    "offsetInEndSection": 588,
                    "text": "In the present study, we used Drosophila as a model to evaluate the toxicity of a set of truncated tau fragments in vivo and found that the flies harboring C-terminal-truncated tau exhibited less toxicity due to the unstable characteristic of C-terminal-truncated tau fragments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1117,
                    "offsetInEndSection": 1455,
                    "text": "In this review, we discuss the role of aggregated tau in tauopathies, the challenges posed in developing selective tau ligands as biomarkers, the state of development in tau tracers, and the new clinical information that has been uncovered, as well as the opportunities for improving diagnosis and designing clinical trials in the future."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21705366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 190,
                    "text": "The microtubule-associated protein Tau is found in large amount in axons of neurons and is involved in human neurodegenerative diseases called tauopathies, which include Alzheimer's disease."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2438584",
                "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                "http://www.ncbi.nlm.nih.gov/pubmed/9274974",
                "http://www.ncbi.nlm.nih.gov/pubmed/14704478",
                "http://www.ncbi.nlm.nih.gov/pubmed/8826485",
                "http://www.ncbi.nlm.nih.gov/pubmed/11785912",
                "http://www.ncbi.nlm.nih.gov/pubmed/16603156",
                "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                "http://www.ncbi.nlm.nih.gov/pubmed/5103482",
                "http://www.ncbi.nlm.nih.gov/pubmed/3095571"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 318,
                    "text": "The formalin test, which is based on these observations, is now widely used as a model of pain produced by tissue injury, but the neural mechanisms of pain and analgesia in this test have not been identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1427,
                    "offsetInEndSection": 1673,
                    "text": "CONCLUSION\nThese data suggest that this automated movement detection system for formalin test is a simple, validated measure with good pharmacological sensitivity suitable for discovering novel analgesics or investigating central pain mechanisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 785,
                    "offsetInEndSection": 969,
                    "text": "These results suggest that the response to formalin is organized in the brain stem but the antinociceptive effect of morphine in this test is mediated by the diencephalon or forebrain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "AIM\nTo investigate the validity and sensitivity of an automatic movement detection system developed by our laboratory for the formalin test in rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16603156",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Although formalin-induced activity in primary afferent fibers and spinal dorsal horn is well described, the forebrain neural basis underlying each phase of behavior in formalin test has not yet been clarified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9274974",
                    "endSection": "abstract",
                    "offsetInBeginSection": 705,
                    "offsetInEndSection": 913,
                    "text": "These observations suggest that cyclooxygenase-2 may not be associated with spinal prostanoid synthesis acutely or with facilitated nociception which occurs within the limited time frame of the formalin test."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Validation of a simple automated movement detection system for formalin test in rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16603156",
                    "endSection": "abstract",
                    "offsetInBeginSection": 406,
                    "offsetInEndSection": 808,
                    "text": "Formalin-induced neuronal activities were simultaneously recorded from primary somatosensory cortex (SI), anterior cingulate cortex (ACC) and medial dorsal (MD) and ventral posterior (VP) thalamus during different phases (i.e., first phase, interphase, second phase and third recovery phase starting from 70 min after injection) of formalin test, using a multi-channel, single-unit recording technique."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2438584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 528,
                    "offsetInEndSection": 682,
                    "text": "It is suggested that zimelidine produces a central antinociceptive effect, but elicits a peripheral hyperalgesia, which predominates in the formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2438584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 324,
                    "text": "The selective inhibitor of the reuptake of 5-hydroxytryptamine (5-HT), zimelidine, was administered intraperitoneally to mice (10 mg/kg) and nociceptive sensitivity was evaluated using the formalin test (20 microliters of 1% formalin, injected subcutaneously) and the assay for substance P (5 ng administered intrathecally)."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25983799",
                "http://www.ncbi.nlm.nih.gov/pubmed/12761012",
                "http://www.ncbi.nlm.nih.gov/pubmed/21397387",
                "http://www.ncbi.nlm.nih.gov/pubmed/26713152",
                "http://www.ncbi.nlm.nih.gov/pubmed/7434194",
                "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                "http://www.ncbi.nlm.nih.gov/pubmed/1738436",
                "http://www.ncbi.nlm.nih.gov/pubmed/16150293",
                "http://www.ncbi.nlm.nih.gov/pubmed/8456713",
                "http://www.ncbi.nlm.nih.gov/pubmed/8886740"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25983799",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Anterior cervical discectomy and fusion(ACDF) is a surgical treatment for cervical radiculopathy and myelopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 914,
                    "offsetInEndSection": 1070,
                    "text": "A 22-yr-old man with a spontaneous spinal epidural hematoma who was receiving warfarin treatment for a mechanical aortic valve is presented in this article."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Spontaneous spinal epidural hematoma is an uncommon cause of spinal cord compression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25983799",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 279,
                    "text": "Though this is a common surgery, spinal epidural hematomas occur rarely and an immediate treatment decision and surgical decompression are required in this situation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 511,
                    "text": "Spontaneous spinal epidural hematoma should be suspected in any patient receiving anticoagulant agents who complains of local or referred spinal pain associated with limb weakness, sensory deficits, or urinary retention."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16150293",
                    "endSection": "abstract",
                    "offsetInBeginSection": 52,
                    "offsetInEndSection": 177,
                    "text": "Progressive neurologic deficits that are associated with epidural hematomas can develop rapidly and require prompt treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Spinal epidural hematoma associated with oral anticoagulation therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 78,
                    "offsetInEndSection": 218,
                    "text": "This study reports a case of thoracic spinal epidural hematoma following spinal manipulative therapy in the absence of predisposing factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8886740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Epidural hematoma is a rare cause of spinal cord compression, which usually provokes severe neurological deficits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12761012",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Transient paraplegia revealed by intraoperative neurophysiological monitoring: was it caused by the epidural anesthetic or an epidural hematoma?"
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                "http://www.ncbi.nlm.nih.gov/pubmed/10568516",
                "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                "http://www.ncbi.nlm.nih.gov/pubmed/23602499",
                "http://www.ncbi.nlm.nih.gov/pubmed/23560303",
                "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                "http://www.ncbi.nlm.nih.gov/pubmed/16205714",
                "http://www.ncbi.nlm.nih.gov/pubmed/26387956",
                "http://www.ncbi.nlm.nih.gov/pubmed/19692580",
                "http://www.ncbi.nlm.nih.gov/pubmed/29186753"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "The expansion of homopolymeric glutamine (polyQ) or alanine (polyA) repeats in certain proteins owing to genetic mutations induces protein aggregation and toxicity, causing at least 18 human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Eight severe inherited neurodegenerative diseases are caused by expansion of glutamine repeats in the affected proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 329,
                    "text": "In every case, proteins with repeats of fewer than 38 glutamine residues are harmless, but those with repeats of more than 41 glutamine residues form toxic neuronal nuclear aggregates in the affected neurons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "Homopolymeric amino acid repeat sequences in proteins are of particular interest due to the discovery that expanded copy numbers of these repeats are the molecular basis for a growing list of human genetic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 607,
                    "text": "Similarly, proteins that have repeats of fewer than 37 glutamine residues are soluble in vitro, whereas proteins with repeats of more than 40 glutamine residues precipitate as insoluble fibres, apparently because of a structural transition associated with the increased length."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 617,
                    "text": "There is emerging evidence that expansions of amino acids encoded by other reading frames of CAG/CUG repeats, including polyalanine and polyleucine, could contribute to toxicity in the 'polyglutamine' diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10568516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 522,
                    "text": "Unfortunately, current methods for preparing recombinant constructs with large glutamine tracts either alter the coding region adjacent to the repeat or yield highly unstable pure CAG repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26387956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 904,
                    "offsetInEndSection": 1062,
                    "text": "Our findings suggest that specific alterations in protein interactions by large polyQ repeats may account for the unique pathology in juvenile polyQ diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29186753",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 304,
                    "text": "Furthermore, disease-causing expansions of the regions containing tandem amino acid repeats often push repetitive proteins towards formation of irreversible aggregates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29186753",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 840,
                    "text": "The major categories of repeat extensions involved in disease include poly-glutamine and poly-alanine homorepeats, which are often times located in the intrinsically disordered regions, as well as repeats in non-coding regions of genes typically encoding proteins with ordered structures."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2719959",
                "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                "http://www.ncbi.nlm.nih.gov/pubmed/9811562",
                "http://www.ncbi.nlm.nih.gov/pubmed/2256928",
                "http://www.ncbi.nlm.nih.gov/pubmed/23142632",
                "http://www.ncbi.nlm.nih.gov/pubmed/11792821",
                "http://www.ncbi.nlm.nih.gov/pubmed/22265972",
                "http://www.ncbi.nlm.nih.gov/pubmed/10984438",
                "http://www.ncbi.nlm.nih.gov/pubmed/11470279",
                "http://www.ncbi.nlm.nih.gov/pubmed/11173535"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11470279",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 376,
                    "text": "The X-linked form of EDMD is caused by mutations in the emerin gene, whereas autosomal dominant EDMD is caused by mutations in the lamin A/C gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2719959",
                    "endSection": "abstract",
                    "offsetInBeginSection": 172,
                    "offsetInEndSection": 509,
                    "text": "The nucleotide sequence and the deduced amino-acid sequence of the mouse lamin C are compared with the previously published human lamin A/C sequences with respect to (a) the general organisation, (b) homologies, (c) predictions for the essential structural characteristics of lamins and (d) the localization of the most conserved region."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2719959",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Nucleotide sequence of the full-length mouse lamin C cDNA and its deduced amino-acid sequence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 211,
                    "offsetInEndSection": 502,
                    "text": "As has been reported for human lamin A/C cDNAs, a large part of the 5' sequence of our mouse lamin A clone was essentially identical with a previously reported mouse lamin C cDNA sequence, and the deduced C-terminal amino acid sequence shared strong homology with the human lamin A sequence."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Nucleotide sequence of a mouse lamin A cDNA and its deduced amino acid sequence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11173535",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 755,
                    "text": "We also used the yeast two-hybrid system to clarify that this interaction requires the top half of the tail domain (amino acid 384-566) of lamin A. Lamin A and lamin C are alternative splicing products of the lamin A/C gene that is responsible for autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11173535",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 443,
                    "text": "Although the function of this protein is still unknown, we revealed that C-terminus transmembrane domain-truncated emerin (amino acid 1-225) binds to lamin A with higher affinity than lamin C. Screening for the emerin binding protein and immunoprecipitation analysis showed that lamin A binds to emerin specifically."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 78,
                    "text": "We have cloned and determined the nucleotide sequence of a mouse lamin A cDNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23142632",
                    "endSection": "abstract",
                    "offsetInBeginSection": 189,
                    "offsetInEndSection": 422,
                    "text": "Mutations of the lamin A/C gene are associated with several different neuromuscular diseases, and the detailed effect of disease-associated amino acid substitutions on the structure and stability of human lamin dimers is yet unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11173535",
                    "endSection": "abstract",
                    "offsetInBeginSection": 756,
                    "offsetInEndSection": 1150,
                    "text": "These results indicate that the emerin-lamin interaction requires the tail domains of lamin A and lamin C. The data also suggest that the lamin A-specific region (amino acids 567-664) plays some indirect role in the difference in emerin-binding capacity between lamin A and lamin C. This is the first report that refers the difference between lamin A and lamin C in the interaction with emerin."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7464911",
                "http://www.ncbi.nlm.nih.gov/pubmed/12589051",
                "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                "http://www.ncbi.nlm.nih.gov/pubmed/3096714",
                "http://www.ncbi.nlm.nih.gov/pubmed/2912448",
                "http://www.ncbi.nlm.nih.gov/pubmed/17702618",
                "http://www.ncbi.nlm.nih.gov/pubmed/20875424",
                "http://www.ncbi.nlm.nih.gov/pubmed/10461185",
                "http://www.ncbi.nlm.nih.gov/pubmed/9827808",
                "http://www.ncbi.nlm.nih.gov/pubmed/3635476"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 350,
                    "text": "In this article, we discuss the structural properties of clathrin cages and the triskelions which assemble to form them."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 351,
                    "offsetInEndSection": 564,
                    "text": "The function of clathrin depends on the structure of these triskelions and the interactions they make both with each other during assembly and with the adaptor protein network that drives coated vesicle formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 436,
                    "text": "Clathrin functions as a heterohexamer, adopting a three-legged triskelion structure of three clathrin light chains and three heavy chains."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9827808",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Atomic structure of clathrin: a beta propeller terminal domain joins an alpha zigzag linker."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 565,
                    "offsetInEndSection": 750,
                    "text": "The atomic resolution structure of clathrin domains has been revealed by X-ray crystallography while scattering studies have enabled the shape of a triskelion in solution to be deduced."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7464911",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 794,
                    "text": "Here we show that purified clathrin coats dissociate reversibly into triskelions, structures composed of three usually bent, rather flexible legs irradiated from a centre."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9827808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 266,
                    "offsetInEndSection": 381,
                    "text": "The structure comprises the globular \"terminal domain\" and the linker that joins it to the end of a triskelion leg."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 946,
                    "text": "Cryo-electron microscopy maps have shown the secondary structure of entire cages, how individual triskelion legs are arranged to form a cage and enabled some bound adaptor proteins to be located."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1282,
                    "offsetInEndSection": 1451,
                    "text": "It now remains to determine the precise nature of the interactions which occur between clathrin triskelions, light chain and heavy chain and the adaptor protein network."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9827808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Clathrin triskelions form the lattice that organizes recruitment of proteins to coated pits and helps drive vesiculation of the lipid bilayer."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/6157451",
                "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                "http://www.ncbi.nlm.nih.gov/pubmed/7520024",
                "http://www.ncbi.nlm.nih.gov/pubmed/18228513",
                "http://www.ncbi.nlm.nih.gov/pubmed/2462020",
                "http://www.ncbi.nlm.nih.gov/pubmed/27068622",
                "http://www.ncbi.nlm.nih.gov/pubmed/6680688",
                "http://www.ncbi.nlm.nih.gov/pubmed/27173133"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 940,
                    "offsetInEndSection": 1183,
                    "text": "The peripheral-central myelin transitional zone is in close proximity to the axonal pole in the vestibular ganglion cells, while in the cochlear nerve it is near the spiral foramina, at variable distance from the axonal pole of ganglion cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 599,
                    "text": "In order to apply remyelinating strategies to these disorders, it is essential to know whether the myelin damage results from a primary attack on myelin or the oligodendrocyte or both, and whether indeed these lead to myelin breakdown and demyelination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 636,
                    "text": "The major myelin-associated glycoprotein is probably not present in compacted myelin, but immunocytochemical and subfractionation studies indicate that it is confined to the periaxonal and paranodal region of the myelin sheath."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7520024",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Myelin-associated glycoprotein is not detectable in perikaryal myelin of spiral ganglion neurons of adult mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Myelin-associated oligodendrocytic basic protein is a member of the proteins constituting the central nervous system myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 265,
                    "text": "The perikaryal myelin is thin and partially loose, whereas axon and dendrite are enveloped by compacted myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 347,
                    "offsetInEndSection": 532,
                    "text": "It is known that the number of myelin lamellae increases linearly with axonal diameter, and that the rate of radial axonal growth is the factor controlling the rate of myelin formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27173133",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Rapid nerve conduction in the CNS is facilitated by insulation of axons with myelin, a specialized oligodendroglial compartment distant from the cell body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 637,
                    "offsetInEndSection": 761,
                    "text": "In experimental demyelination and multiple sclerosis, the major glycoprotein is the first myelin constituent to be affected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7520024",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 842,
                    "text": "Conversely, N-CAM was detectable at the interface between myelin and neuronal perikarya and in non-compacted regions of perikaryal myelin, whereas it was hardly detectable in axonal myelin."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28183751",
                "http://www.ncbi.nlm.nih.gov/pubmed/27789633",
                "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                "http://www.ncbi.nlm.nih.gov/pubmed/26036697",
                "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                "http://www.ncbi.nlm.nih.gov/pubmed/11895955",
                "http://www.ncbi.nlm.nih.gov/pubmed/21976222",
                "http://www.ncbi.nlm.nih.gov/pubmed/15805518",
                "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                "http://www.ncbi.nlm.nih.gov/pubmed/16556309"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11895955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "Brucella is a facultative intracellular parasite that causes brucellosis in animals and humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15805518",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucellosis is a worldwide disease of humans and livestock that is caused by a number of very closely related classical Brucella species in the alpha-2 subdivision of the Proteobacteria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 91,
                    "offsetInEndSection": 342,
                    "text": "Brucella melitensis, B. abortus and B. suis, which are transmitted between animals both vertically and horizontally, cause abortion and infertility in their primary natural hosts - goats and sheep (B. melitensis), cows (B. abortus) and sows (B. suis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27789633",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Brucella abortus is generally known to cause brucellosis in cattle and buffalo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16556309",
                    "endSection": "abstract",
                    "offsetInBeginSection": 14,
                    "offsetInEndSection": 217,
                    "text": "are facultative intracellular pathogens that have the ability to survive and multiply in professional and non-professional phagocytes, and cause abortion in domestic animals and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "The bacterium that causes canine abortion has polynucleotide sequences similar, in deoxyribonucleic acid (DNA)-DNA homology studies, to those of Brucella suis and, by inference from previous data, those of B. abortus and B. melitensis as well as B. neotomae."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16556309",
                    "endSection": "abstract",
                    "offsetInBeginSection": 671,
                    "offsetInEndSection": 814,
                    "text": "The strains that are pathogenic for humans (B. abortus, B. suis, B. melitensis) carry a smooth LPS involved in the virulence of these bacteria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "The use of whole-cell antigens in agglutination and agglutinin-absorption tests showed that the organism causing abortion in dogs is similar to rough Brucella abortus, B. melitensis, and B. ovis, but different from smooth Brucella cultures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28183751",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Brucellosis, which is among the most widespread global zoonotic diseases, is endemic in the nation of Georgia and causes substantial human morbidity and economic loss."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Brucellosis is a disease that causes severe economic losses for livestock farms worldwide."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                "http://www.ncbi.nlm.nih.gov/pubmed/3111268",
                "http://www.ncbi.nlm.nih.gov/pubmed/8855270",
                "http://www.ncbi.nlm.nih.gov/pubmed/25486780",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                "http://www.ncbi.nlm.nih.gov/pubmed/17027252",
                "http://www.ncbi.nlm.nih.gov/pubmed/402080",
                "http://www.ncbi.nlm.nih.gov/pubmed/26693966"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 289,
                    "offsetInEndSection": 524,
                    "text": "The availability of edible insects in East Asia aided the spread of the unaggressive, highly cooperative Neanderthals, who interbred with H. sapiens in Asia, resulting in a higher admixture of Neanderthal DNA in East Asian populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 648,
                    "text": "If the Neanderthal population was large compared to the Homo sapiens population at the beginning of the contact period, we show that genetic introgression should have been fast and complete meaning that most of the Neanderthal private alleles should be found in the modern human gene pool in case of ancient admixture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 813,
                    "offsetInEndSection": 997,
                    "text": "We show that the power to reject ancient admixture increases as the ratio, at the time of putative admixture, of the population size of Homo sapiens over that of Neanderthal decreases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 998,
                    "offsetInEndSection": 1164,
                    "text": "We find that the power to reject ancient admixture might be particularly low if the population size of Homo sapiens was comparable to the Neanderthal population size."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 565,
                    "text": "When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 901,
                    "offsetInEndSection": 1139,
                    "text": "In the Sub-Saharan region, unaffected by Denisovan or Neanderthal interbreeding, H. sapiens interbred with H. heidelbergensis, because high humidity militated against fire-making and allowed the survival of these non-fire-making hominins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/402080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 338,
                    "offsetInEndSection": 754,
                    "text": "Trends for tooth size over this period indicate that (1) human evolution does not stop with the appearance of \"anatomically modern Homo sapiens,\" (2) changes in tooth size fluctuate with increases in the efficiency and complexity of cultural systems, and (3) the Early Upper Paleolithic sample should be considered transitional between Wurm II European Neanderthals and later Upper Paleolithic and Mesolithic groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1139,
                    "text": "In contrast, we find that recent results implying that the Neanderthal sequences are products of PCR artifacts are not well supported, suffering from inadequate experimental design and a presumably high percentage (>68%) of chimeric sequences due to \"jumping PCR\" events."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "A deterministic model of admixture and genetic introgression: the case of Neanderthal and Cro-Magnon."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2926218",
                "http://www.ncbi.nlm.nih.gov/pubmed/8817754",
                "http://www.ncbi.nlm.nih.gov/pubmed/1769984",
                "http://www.ncbi.nlm.nih.gov/pubmed/20478727",
                "http://www.ncbi.nlm.nih.gov/pubmed/432317",
                "http://www.ncbi.nlm.nih.gov/pubmed/2883783",
                "http://www.ncbi.nlm.nih.gov/pubmed/3559089",
                "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                "http://www.ncbi.nlm.nih.gov/pubmed/5563816"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 422,
                    "offsetInEndSection": 609,
                    "text": "Comorbid conditions associated with Dupuytren's contracture are repetitive trauma to the hands, diabetes, and seizures, but it has never before been associated with neuromuscular disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20478727",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 45,
                    "text": "Dupuytren contracture is not a rare disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 421,
                    "text": "Dupuytren's contracture is a common disease, especially in Northern Europe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3559089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Severe recurrent digital Dupuytren's contracture, with pseudomotor changes and inadequate palmar tissue, is often treated with amputation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Limb-girdle muscular dystrophies (LGMDs) is a heterogeneous group of muscular dystrophies that mostly affect the pelvic and shoulder girdle muscle groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 345,
                    "text": "We report here a case of neuromuscular disease associated with Dupuytren's contracture, which has never been described before as cosegregating with an autosomal dominant type of inheritance."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5563816",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Dupuytren's contracture of the fingers: a simplified approach to the surgical treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8817754",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 567,
                    "text": "The nosological individualization of this soft tissue rheumatism is analyzed based on a review of Dupuytren's lectures and of writings by XIXth century practitioners; the other two conditions included in Dupuytren's diathesis, namely Ledderhose's contracture and Peyronie's disease, are also discussed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2883783",
                    "endSection": "abstract",
                    "offsetInBeginSection": 258,
                    "offsetInEndSection": 373,
                    "text": "A disturbance of collagen metabolism must, therefore, be considered as a possible cause of Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5563816",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 290,
                    "text": "A new surgical approach to the disease that can correct the contractures without the attendant morbidity is urgently needed."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20477788",
                "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                "http://www.ncbi.nlm.nih.gov/pubmed/18366057",
                "http://www.ncbi.nlm.nih.gov/pubmed/22497627",
                "http://www.ncbi.nlm.nih.gov/pubmed/27664794",
                "http://www.ncbi.nlm.nih.gov/pubmed/9571181",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                "http://www.ncbi.nlm.nih.gov/pubmed/20634512",
                "http://www.ncbi.nlm.nih.gov/pubmed/16734695"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18366057",
                    "endSection": "abstract",
                    "offsetInBeginSection": 198,
                    "offsetInEndSection": 419,
                    "text": "We performed a meta-analysis on the association between the 9 most studied MC1R variants (p.V60L, p.D84E, p.V92M, p.R142H, p.R151C, p.I155T, p.R160W, p.R163Q and p.D294H) and melanoma and/or red hair, fair skin phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 634,
                    "offsetInEndSection": 736,
                    "text": "The V60L variant, which is common in the population may act as a partially penetrant recessive allele."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 633,
                    "text": "We have investigated 174 individuals from 11 large kindreds with a preponderance of red hair and an additional 99 unrelated redheads, for MC1R variants and have confirmed that red hair is usually inherited as a recessive characteristic with the R151C, R160W, D294H, R142H, 86insA and 537insC alleles at this locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22497627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A single nucleotide polymorphism (MC1R: c.376A>G) in the MC1R gene was found to be highly correlated with pigment phenotype in the Gyrfalcon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 502,
                    "text": "The R151C, R160W and D294H alleles, designated 'R', are strongly associated with the RHC phenotype and have been proposed to result in loss of function receptors due to impaired G-protein coupling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                    "endSection": "abstract",
                    "offsetInBeginSection": 425,
                    "offsetInEndSection": 627,
                    "text": "In vitro expression studies revealed that variant receptors with reduced cell surface expression, including V60L, D84E, R151C, I155T, R160W and R163Q, showed a corresponding impairment in cAMP coupling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16734695",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 172,
                    "text": "We investigated melanocortin 1 receptor (MC1R) as a candidate locus for the Extended brown phenotype in quail, in which there is a general darkening throughout the plumage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27664794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 837,
                    "offsetInEndSection": 1142,
                    "text": "Compared to the MC1R rufous allele, responsible for reddish coloration, the white allele was not only associated with an expected lower expression of melanogenic-related genes (TYR, TYRP1, OCA2, SLC45A2, KIT, DCT) but also with a lower MC1R expression and a higher expression of ASIP, the MC1R antagonist."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20634512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 719,
                    "text": "Moreover, we propose that the recessive black-winged bronze phenotype (linked to b(1)) might be produced by 2 deleterious mutations of MC1R (c.96G > A and c.887C > T)."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9683501",
                "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                "http://www.ncbi.nlm.nih.gov/pubmed/8421783",
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/29094278",
                "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                "http://www.ncbi.nlm.nih.gov/pubmed/24668569",
                "http://www.ncbi.nlm.nih.gov/pubmed/23567048",
                "http://www.ncbi.nlm.nih.gov/pubmed/14729571",
                "http://www.ncbi.nlm.nih.gov/pubmed/24053231"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "The recent elucidation of protein structures based upon repeating amino acid motifs, including the armadillo motif, the HEAT motif and tetratricopeptide repeats, reveals that they belong to the class of helical repeat proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 438,
                    "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 462,
                    "text": "In order to investigate the origin of the stability of these proteins, we dissect the subdomain architecture of the giant repeat protein PR65/A, which comprises 15 \u03b1-helical HEAT repeats, using a series of truncations and deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1088,
                    "text": "HEAT repeats were also found in the TBP-associated TIP120 protein, a global enhancer of transcription, and in the budding yeast Mot1p protein, which is a member of the SWI2/SNF2 family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1266,
                    "offsetInEndSection": 1498,
                    "text": "HEAT repeats also were found in dis1-TOG family and cofactor D family microtubule-associated proteins, which, owing to their roles in microtubule dynamics, perform functions related to mitotic progression and chromosome segregation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The Noc proteins involved in ribosome synthesis and export contain divergent HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1645,
                    "text": "Hence, our analysis predicts structural features of these proteins and suggests that HEAT repeats may play important roles in chromosome dynamics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 707,
                    "offsetInEndSection": 902,
                    "text": "Clathrin adaptor and COP-I coatomer subunits, which function in vesicle coat assembly and were previously noted to share weak sequence similarity to condensin subunits, also contain HEAT repeats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23567048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 310,
                    "text": "Conversion of HSF from a monomer to a homotrimer or heterotrimer is essential for its binding to heat shock elements (HSEs) comprised of inverted repeats of the pentamer nGAAn."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                "http://www.ncbi.nlm.nih.gov/pubmed/15173609",
                "http://www.ncbi.nlm.nih.gov/pubmed/1715506",
                "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                "http://www.ncbi.nlm.nih.gov/pubmed/23825692",
                "http://www.ncbi.nlm.nih.gov/pubmed/27684355",
                "http://www.ncbi.nlm.nih.gov/pubmed/12952867",
                "http://www.ncbi.nlm.nih.gov/pubmed/27264314",
                "http://www.ncbi.nlm.nih.gov/pubmed/23962426",
                "http://www.ncbi.nlm.nih.gov/pubmed/10720679"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1338,
                    "offsetInEndSection": 1384,
                    "text": "Gid4 is also a metabolically unstable protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27684355",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 791,
                    "text": "Here we describe assays to examine the half-life of misfolded proteins in mammalian cells using a highly aggregation-prone protein, Ataxin-1 with an extended polyglutamine (polyQ) stretch, and a conformationally unstable luciferase mutant as models."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 452,
                    "text": "Here we present a full cycloheximide chase assay in our laboratory using a lung adenocarcinoma cell line, CL1-5, as a model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12952867",
                    "endSection": "abstract",
                    "offsetInBeginSection": 754,
                    "offsetInEndSection": 865,
                    "text": "We excluded a potential transcriptional impairment by performing quantitative RT-PCR on the patient's material."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "Although it is widely appreciated that the use of global translation inhibitors, such as cycloheximide, in protein degradation assays may result in artefacts, these inhibitors continue to be employed, owing to the absence of robust alternatives."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1090,
                    "offsetInEndSection": 1141,
                    "text": "a specific ubiquitin ligase) is itself short-lived."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264314",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 438,
                    "text": "For example, Huntington's disease (HD) is an incurable hereditary neurodegenerative disorder caused by the cytotoxicity of mutant huntingtin protein (mHTT)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 576,
                    "text": "In PRT assays, one measures, during a chase, the ratio of a test protein to a long-lived reference protein, a dihydrofolate reductase (DHFR)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1385,
                    "offsetInEndSection": 1566,
                    "text": "Through analyses of short-lived Mdh2 as a target of short-lived Gid4, we illustrate the advantages of PRT over degradation assays that lack a reference and/or involve cycloheximide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264314",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1591,
                    "offsetInEndSection": 1785,
                    "text": "CONCLUSION\nWe have established the first high-throughput-compatible assay capable of measuring endogenous, tag-free HTT degradation, providing a valuable tool for HD research and drug discovery."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                "http://www.ncbi.nlm.nih.gov/pubmed/26983831",
                "http://www.ncbi.nlm.nih.gov/pubmed/22200143",
                "http://www.ncbi.nlm.nih.gov/pubmed/28203202",
                "http://www.ncbi.nlm.nih.gov/pubmed/28603750",
                "http://www.ncbi.nlm.nih.gov/pubmed/15790784"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 580,
                    "offsetInEndSection": 889,
                    "text": "How exosomes target recipient cells in vivo remains largely unknown, however, exosomes are selectively enriched in some transmembrane proteins that can be genetically engineered to display ligands/homing peptides on their surface, which confers exosome targeting capability to cells bearing cognate receptors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "The RNA exosome is a multisubunit 3' to 5' exoribonuclease complex that participates in degradation and processing of cellular RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "The exosome consists of a core often essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "The exosome consists of a core of ten essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 705,
                    "offsetInEndSection": 855,
                    "text": "Here, we review cofactors and functions of the cytoplasmic exosome and provide unanswered questions on the mechanisms of cytoplasmic exosome function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 708,
                    "offsetInEndSection": 858,
                    "text": "Here, we review cofactors and functions of the cytoplasmic exosome and provide unanswered questions on the mechanisms of cytoplasmic exosome function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 376,
                    "text": "The cytoplasmic exosome has been extensively characterized in the budding yeast Saccharomyces cerevisiae and some characterization of its metazoan counterpart indicates that most functional aspects are conserved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 377,
                    "text": "The cytoplasmic exosome has been extensively characterized in the budding yeast Saccharomyces cerevisiae and some characterization of its metazoan counterpart indicates that most functional aspects are conserved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 816,
                    "text": "Comparative biochemical analysis between purified subunits and reconstituted exosomes using AU-rich, polyadenylated (poly[A]), generic, and structured RNA substrates reveals processive phosphorolytic activities for human Rrp41/Rrp45 and the 9-subunit human exosome, processive hydrolytic activities for yeast Rrp44 and the yeast 10-subunit exosome, distributive hydrolytic activities for Rrp6, and processive and distributive hydrolytic activities for the yeast 11-subunit exosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1116,
                    "offsetInEndSection": 1334,
                    "text": "Here, we briefly review exosome biogenesis, mechanisms of exosome-mediated cell\u2013cell communication, and exosome isolation and purification methods, and specifically focus on the emerging exosome targeting technologies."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                "http://www.ncbi.nlm.nih.gov/pubmed/8390924",
                "http://www.ncbi.nlm.nih.gov/pubmed/26864944",
                "http://www.ncbi.nlm.nih.gov/pubmed/2556801",
                "http://www.ncbi.nlm.nih.gov/pubmed/8356050",
                "http://www.ncbi.nlm.nih.gov/pubmed/3031592",
                "http://www.ncbi.nlm.nih.gov/pubmed/21783031",
                "http://www.ncbi.nlm.nih.gov/pubmed/26106594",
                "http://www.ncbi.nlm.nih.gov/pubmed/23479409"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8356050",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 418,
                    "text": "Nonetheless, the arrangement of functional elements, such as spacer promoters and enhancers, is thought to be highly conserved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 881,
                    "text": "These data demonstrate functional relatedness between the promoter and enhancers, supporting the hypothesis that enhancers could have evolved from duplicated promoter domains that bind essential transcription factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26864944",
                    "endSection": "abstract",
                    "offsetInBeginSection": 519,
                    "offsetInEndSection": 674,
                    "text": "In a search of the DHRS4-AS1 region for nearby enhancers, we identified an enhancer located 13.8 kb downstream of the DHRS4-AS1 transcriptional start site."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 603,
                    "offsetInEndSection": 734,
                    "text": "The results indicated the porcine CD4 promoters and enhancers could effectively direct expression of a foreign gene in human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26106594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 801,
                    "offsetInEndSection": 937,
                    "text": "The content of TES in lincRNA genes is substantially higher than that in protein-coding genes, especially in exons and promoter regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26106594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 642,
                    "offsetInEndSection": 800,
                    "text": "Higher frequencies of ancient TEs in promoters and exons compared to introns implies that many lincRNA genes emerged before the split of primates and rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Enhancers of RNA polymerase I transcription in higher eukaryotes are repetitive elements within the intergenic spacers of rRNA genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26864944",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 718,
                    "offsetInEndSection": 947,
                    "text": "We confirm that the pM and pH promoters are activated independently of each other and, in particular, we show that the activation of pM in fast muscle is not responsible for the downregulation of the downstream pH in this tissue."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Ribosomal gene promoter domains can function as artificial enhancers of RNA polymerase I transcription, supporting a promoter origin for natural enhancers in Xenopus."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16475045",
                "http://www.ncbi.nlm.nih.gov/pubmed/17462889",
                "http://www.ncbi.nlm.nih.gov/pubmed/27575436",
                "http://www.ncbi.nlm.nih.gov/pubmed/27697443",
                "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                "http://www.ncbi.nlm.nih.gov/pubmed/25696904",
                "http://www.ncbi.nlm.nih.gov/pubmed/23160865",
                "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                "http://www.ncbi.nlm.nih.gov/pubmed/17629847"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 739,
                    "offsetInEndSection": 943,
                    "text": "Andexanet alfa (r-Antidote, PRT064445; Portola Pharmaceuticals) is a truncated form of enzymatically inactive factor Xa, which binds and reverses the anticoagulant action of the factor Xa inhibitors (e.g."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1329,
                    "offsetInEndSection": 1569,
                    "text": "In addition, the specific antidote anivamersen (RB007; Regado Biosciences Inc.) is an RNA aptamer in clinical development to reverse the anticoagulant effect of the parenteral factor IXa inhibitor pegnivacogin, which is also in development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 577,
                    "offsetInEndSection": 738,
                    "text": "Idarucizumab (BI 655075; Boehringer Ingelheim) is a fragment of an antibody (Fab), which is a specific antidote to the oral direct thrombin inhibitor dabigatran."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 450,
                    "text": "Major advances have been made in targeting downstream clotting factors in the coagulation cascade, resulting in two major new classes of drugs: direct thrombin inhibitors and factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 310,
                    "text": "These new agents exert their anticoagulant effect via direct inhibition of a single Factor within the coagulation cascade (such as Factor Xa or thrombin)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1207,
                    "text": "Although the mechanism of action differs between the direct Factor Xa and direct thrombin inhibitors, phase III studies of these new agents confirmed that both Factor Xa and thrombin are viable anticoagulation targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23160865",
                    "endSection": "abstract",
                    "offsetInBeginSection": 414,
                    "offsetInEndSection": 597,
                    "text": "However, no antidote exists for DTIs or FXa inhibitors though replacement of coagulation factors using clotting factor concentrates is routinely considered in some clinical scenarios."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                    "endSection": "abstract",
                    "offsetInBeginSection": 488,
                    "offsetInEndSection": 719,
                    "text": "Rivaroxaban competitively inhibits Factor Xa and is more than 10,000-fold more selective for Factor Xa than other related serine proteases, and it does not require cofactors (such as antithrombin) to exert its anticoagulant effect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 982,
                    "offsetInEndSection": 1181,
                    "text": "Aripazine (PER-977, ciraparantag; Perosphere Inc.) is a synthetic small molecule (~500 Da) that reverses oral dabigatran, apixaban, rivaroxaban, as well as subcutaneous fondaparinux and LMWH in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23160865",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1013,
                    "offsetInEndSection": 1254,
                    "text": "Monitoring of coagulation tests should continue for 1 to 2 days after achievement of hemostasis, since the duration of the clotting factor concentrate may be shorter than the oral anticoagulant, especially in patients with organ dysfunction."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1381443",
                "http://www.ncbi.nlm.nih.gov/pubmed/27766310",
                "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                "http://www.ncbi.nlm.nih.gov/pubmed/9804357",
                "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                "http://www.ncbi.nlm.nih.gov/pubmed/4027181",
                "http://www.ncbi.nlm.nih.gov/pubmed/10494094",
                "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                "http://www.ncbi.nlm.nih.gov/pubmed/15347343",
                "http://www.ncbi.nlm.nih.gov/pubmed/9036937"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Epidermolysis bullosa simplex is a group of blistering skin disorders caused by defects in one of the keratin genes, KRT5 and KRT14."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "Mutations in genes encoding the keratin intermediate filaments expressed in basal cells have been identified in some families with epidermolysis bullosa simplex as the proximate cause of the fragility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 169,
                    "text": "We examined keratin K14 and K5 genes mutation in a Japanese Dowling-Meara epidermolysis bullosa simplex patient with severe generalized blistering and erosions at birth."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9036937",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "The KRT5 and KRT14 genes encode the proteins keratin 5 and 14, respectively, which are the primary structural components of the 10-nm intermediate filaments of the mitotic epidermal basal cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "A novel keratin K5 gene mutation in Dowling-Meara epidermolysis bullosa simplex."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1381443",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "Linkage of epidermolysis bullosa simplex to keratin gene loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1381443",
                    "endSection": "abstract",
                    "offsetInBeginSection": 778,
                    "offsetInEndSection": 882,
                    "text": "The Weber-Cockayne form of EBS is genetically heterogeneous with linkage to different keratin gene loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10494094",
                    "endSection": "abstract",
                    "offsetInBeginSection": 861,
                    "offsetInEndSection": 962,
                    "text": "So far, other mutations in the same or in other genes have not been reported in patients with EBS-MP."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9036937",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Primers for exon-specific amplification of the KRT5 gene: identification of novel and recurrent mutations in epidermolysis bullosa simplex patients."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                "http://www.ncbi.nlm.nih.gov/pubmed/8629992",
                "http://www.ncbi.nlm.nih.gov/pubmed/24777963",
                "http://www.ncbi.nlm.nih.gov/pubmed/22562473",
                "http://www.ncbi.nlm.nih.gov/pubmed/10608502",
                "http://www.ncbi.nlm.nih.gov/pubmed/17485116",
                "http://www.ncbi.nlm.nih.gov/pubmed/3570498",
                "http://www.ncbi.nlm.nih.gov/pubmed/3066690",
                "http://www.ncbi.nlm.nih.gov/pubmed/1829107",
                "http://www.ncbi.nlm.nih.gov/pubmed/15984957"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8629992",
                    "endSection": "abstract",
                    "offsetInBeginSection": 769,
                    "offsetInEndSection": 1091,
                    "text": "These data demonstrate that activated lymphocytes have the ability to induce the promoter of the TCA3 gene in mast cells through a mechanism requiring cell-to-cell contact, and suggest the possibility that activated lymphocytes may effect other biologic processes in mast cells as well through such heterotypic activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10608502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 566,
                    "text": "However, mast cells may also influence many other biologic responses, including tissue remodeling and angiogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 418,
                    "offsetInEndSection": 760,
                    "text": "Despite the mast cell's well-deserved reputation as a promoter of inflammation, others and we have used bone marrow-derived cultured mast cell (BMCMC) engrafted mast cell-deficient c-kit-mutant mice (so-called \"mast cell knock-in\" mice) to show that mast cells can also have important antiinflammatory and immunosuppressive functions in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22562473",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "The mast cells are multi-effector cells with wide distribution in the different body parts and traditionally their role has been well-defined in the development of IgE-mediated hypersensitivity reactions including bronchial asthma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17485116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Mast cells are widely distributed throughout the body and express effector functions in allergic reactions, inflammatory diseases, and host defense."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10608502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 185,
                    "offsetInEndSection": 450,
                    "text": "Recent work shows that mast cells can also participate in innate immunity to bacterial infection and that the expression of such mast cell-dependent natural immunity can be significantly enhanced by long-term treatment of mice with the kit ligand, stem cell factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24777963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 79,
                    "offsetInEndSection": 423,
                    "text": "Upon activation by diverse mechanisms, mast cells can secrete a broad array of biologically active products that either are stored in the cytoplasmic granules of the cells (e.g., histamine, heparin, various proteases) or are produced de novo upon cell stimulation (e.g., prostaglandins, leukotrienes, cytokines, chemokines, and growth factors)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 985,
                    "offsetInEndSection": 1289,
                    "text": "Subsequently, it was reported that mast cells can mediate negative immunomodulatory effects following Anopheles mosquito bites, and in peripheral tolerance to skin allografts; however, the mechanism(s) by which mast cells mediate immunosuppressive functions in these two studies remains to be elucidated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 417,
                    "text": "Through the release of biologically active products, mast cells function as important effector and immunoregulatory cells in diverse immunological reactions and other biological responses; for example, mast cells promote inflammation and other tissue changes in immunoglobulin E (IgE)-associated allergic disorders, as well as in certain innate and adaptive immune responses that are thought to be independent of IgE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24777963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1214,
                    "offsetInEndSection": 1400,
                    "text": "We discuss how using in vivo tumor models in combination with models in which mast cell function can be modulated has implicated mast cells in the regulation of host responses to tumors."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12645767",
                "http://www.ncbi.nlm.nih.gov/pubmed/10943924",
                "http://www.ncbi.nlm.nih.gov/pubmed/21904954",
                "http://www.ncbi.nlm.nih.gov/pubmed/26075659",
                "http://www.ncbi.nlm.nih.gov/pubmed/19777267",
                "http://www.ncbi.nlm.nih.gov/pubmed/28308787",
                "http://www.ncbi.nlm.nih.gov/pubmed/7478512",
                "http://www.ncbi.nlm.nih.gov/pubmed/1343229",
                "http://www.ncbi.nlm.nih.gov/pubmed/24113466",
                "http://www.ncbi.nlm.nih.gov/pubmed/6228713"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7478512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Exposure to solar ultraviolet (UV) light is a major cause of skin cancer, the most common human neoplasm."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21904954",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "Ultraviolet (UV) radiation has detrimental effects on marine ecosystems, in particular in the polar regions where stratospheric ozone reduction causes higher levels of solar radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24113466",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Measurement of solar ultraviolet (UV) radiation is an important aspect of dosimetry for the improved knowledge of UV exposure and its associated health related issues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26075659",
                    "endSection": "abstract",
                    "offsetInBeginSection": 428,
                    "offsetInEndSection": 604,
                    "text": "Epidemiological data strongly implicate UV radiation exposure as a major cause of melanoma and other cancers, as UVR promotes mutations in oncogenes and tumor-suppressor genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24113466",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 574,
                    "text": "from the thick laminate side, the film exhibits a sensitivity to solar UV radiation which is both measurable and accurate for UV dosimetry."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12645767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 264,
                    "text": "Four billion years ago, sea-level UV exposure was more than 400 times as intense as today, the dose from solar cosmic rays was five times present levels, and galactic cosmic rays accounted for only about 10% their current contribution to sea-level radiation doses."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26075659",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Solar ultraviolet radiation from cancer induction to cancer prevention: solar ultraviolet radiation and cell biology."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12645767",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Inconstant sun: how solar evolution has affected cosmic and ultraviolet radiation exposure over the history of life on Earth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28308787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1346,
                    "text": "This \"solar UV equivalent\" caused inactivation of 50% of exposed eggs within 12 min, whereas exposition to full overhead sunlight produced the same effect only within 3 hrs.It is concluded that the inactivating effect of solar UV (300-310 nm) is counteracted by repair mechanisms requiring light of longer wavelengths (320-480 nm) which are also emitted by the sun.The type of photoreactivation described is difficult to understand within the established framework of nucleic acid repair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10943924",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 226,
                    "text": "Radiochromic film is tested for its broad-band response to ultraviolet (UV) B (290-320 nm) and A (320 nm400 nm), visible and infrared radiation produced by a solar simulator and examined for dosimetry in ultraviolet radiation."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25982799",
                "http://www.ncbi.nlm.nih.gov/pubmed/10569341",
                "http://www.ncbi.nlm.nih.gov/pubmed/16220412",
                "http://www.ncbi.nlm.nih.gov/pubmed/9727688",
                "http://www.ncbi.nlm.nih.gov/pubmed/21099678",
                "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                "http://www.ncbi.nlm.nih.gov/pubmed/22083030",
                "http://www.ncbi.nlm.nih.gov/pubmed/10535368",
                "http://www.ncbi.nlm.nih.gov/pubmed/12955433",
                "http://www.ncbi.nlm.nih.gov/pubmed/12395678"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10569341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 402,
                    "text": "In patients without left atrial spontaneous echo contrast, 78% had some embolic sources other than left atrial thrombus or spontaneous echo contrast, suggesting that these embolic sources play an important role in patients with nonvalvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 238,
                    "offsetInEndSection": 439,
                    "text": "Among the causes in our country, rheumatic mitral valvular disease topped the list followed by rheumatic multiple valvular disease IHD, HHD; lone atrial fibrillation came in the aetiology sequentially."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9727688",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Role of the atrioventricular node in atrial fibrillation: what have we learned from radiofrequency catheter modification of the atrioventricular junction in patients with refractory atrial fibrillation?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16220412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Paroxysmal atrial fibrillation (AF) is a common arrhythmia that may occur after various triggers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16220412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 587,
                    "text": "Marijuana smoking should be included in the list of possible triggers in young adults presenting with paroxysmal AF, once cardiac disease and other common causes of AF have been excluded."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 420,
                    "offsetInEndSection": 694,
                    "text": "Based on very low complication rates, excellent efficacy and proven outcomes with radiofrequency ablation of the atrioventricular node, this approach with permanent pacing should play a larger role in the treatment of symptomatic patients with permanent atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1262,
                    "text": "Catheter ablation techniques for ventricular tachycardia in the setting of coronary artery disease have a role as supplemental therapy to the implantable cardioverter defibrillator in patients with recurrent pharmacologically refractory ventricular arrhythmias requiring frequent device interventions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21099678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 365,
                    "offsetInEndSection": 515,
                    "text": "Sleep-disordered breathing contributes to cardiac chamber enlargement, which may be responsible for increasing atrial fibrillation in this population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 419,
                    "text": "Multiple case series and clinical trials have helped to define the evolving role of these techniques for ablation of the atrioventricular node, atrial fibrillation, and ischemic ventricular tachycardia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 695,
                    "offsetInEndSection": 960,
                    "text": "While linear ablation of atrial fibrillation has limited clinical utility for the treatment of this common arrhythmia, the results of multiple case series of focal atrial fibrillation ablation indicate the potential for an expanding role of this curative technique."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9188637",
                "http://www.ncbi.nlm.nih.gov/pubmed/11278953",
                "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                "http://www.ncbi.nlm.nih.gov/pubmed/10101797",
                "http://www.ncbi.nlm.nih.gov/pubmed/23412358",
                "http://www.ncbi.nlm.nih.gov/pubmed/7761466",
                "http://www.ncbi.nlm.nih.gov/pubmed/10348347",
                "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                "http://www.ncbi.nlm.nih.gov/pubmed/8557038",
                "http://www.ncbi.nlm.nih.gov/pubmed/15846087"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "The tumor suppressor protein p53 is a critical stress response transcription factor that induces the expression of genes leading to cell cycle arrest, apoptosis, and tumor suppression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 1000,
                    "text": "Concurrently, HBx enhanced p53 DNA occupancy to other response elements either alone by displacing specific transcription factors such as CEBPB and NFkB1, or in complex with distinct interacting co-factors Sp1, JUN and E2F1."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Global re-wiring of p53 transcription regulation by the hepatitis B virus X protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15846087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 505,
                    "text": "In this study we tested whether p53, p63, and p73 have different mechanisms of activating transcription and if such a difference could explain how each factor stimulates the transcription of distinct sets of genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15846087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 140,
                    "offsetInEndSection": 290,
                    "text": "The p53 protein is homologous to p63 and p73, proteins that regulate transcription via the same promoter sequences but which activate different genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9188637",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Simian virus 40 T antigen can regulate p53-mediated transcription independent of binding p53."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 676,
                    "text": "Genetic or RNA interference (RNAi)-mediated knockdown of IPMK resulted in decreased activation of p53, decreased recruitment of p53 and p300 to target gene promoters, abrogated transcription of p53 target genes, and enhanced cell viability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "BACKGROUND\nThe tumour suppressor p53 is a central player in transcription regulation and cell fate determination."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15846087",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8422752",
                "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                "http://www.ncbi.nlm.nih.gov/pubmed/8083219",
                "http://www.ncbi.nlm.nih.gov/pubmed/23791361",
                "http://www.ncbi.nlm.nih.gov/pubmed/26364852",
                "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                "http://www.ncbi.nlm.nih.gov/pubmed/9573825",
                "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                "http://www.ncbi.nlm.nih.gov/pubmed/22898924",
                "http://www.ncbi.nlm.nih.gov/pubmed/28282874"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Cystatin C (cysC) is an endogenous cysteine peptidase (proteinase) inhibitor that has been intensively investigated as a biomarker of kidney function for many years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 402,
                    "offsetInEndSection": 528,
                    "text": "Since 1985 cystatin C has been studied mainly in serum/plasma as an alternative biomarker to serum creatinine to estimate GFR."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28282874",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "[Urinary cystatin C as a biomarker of renal tubular injury]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8083219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Human cystatin D is a novel member of the cystatin superfamily of cysteine proteinase inhibitors present in saliva and tears."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28282874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1162,
                    "offsetInEndSection": 1307,
                    "text": "Therefore, serum cystatin C may be a novel biomarker that reflects tumor burden in DLBCL but bears no prognostic significance regarding survival."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                "http://www.ncbi.nlm.nih.gov/pubmed/9097542",
                "http://www.ncbi.nlm.nih.gov/pubmed/21540377",
                "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                "http://www.ncbi.nlm.nih.gov/pubmed/19450402",
                "http://www.ncbi.nlm.nih.gov/pubmed/17552105",
                "http://www.ncbi.nlm.nih.gov/pubmed/8138981",
                "http://www.ncbi.nlm.nih.gov/pubmed/9740286",
                "http://www.ncbi.nlm.nih.gov/pubmed/18843217"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 233,
                    "text": "Leishmania(Leishmania) infantum, causing cutaneous leishmaniasis, has been described in patients living in areas where visceral leishmaniasis is endemic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9097542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Diffuse cutaneous leishmaniasis (DCL) is an unusual form of cutaneous leishmaniasis mainly caused by infection with Leishmania aethiopica in the Old World."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Cutaneous leishmaniasis is caused by different species of the Leishmania genus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17552105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 158,
                    "offsetInEndSection": 361,
                    "text": "We identified Leishmania donovani as the agent of Sri Lanka cutaneous leishmaniasis and showed that these parasites are closely related to those causing visceral leishmaniasis in the Indian subcontinent."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 339,
                    "text": "Identification of 5 isolates from 4 CL patients by enzyme analysis during 2002 showed that they were all Leishmania donovani zymodeme MON-37, the parasite which also causes visceral leishmaniasis in India and East Africa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19450402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Cutaneous leishmaniasis is caused by the intracellular protozoan parasite belonging to the genus leishmania and is characterized by a myriad of clinical lesions including papules, nodules, and ulcers."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18843217",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 266,
                    "text": "A literature survey suggests that strong antigenic stimulation caused by visceral leishmaniasis can induce monoclonal gammopathy in a predisposed subject."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8138981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "In the Mediterranean basin area, visceral leishmaniasis is an endemic disease caused by Leishmania donovani infantum."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
                "http://www.ncbi.nlm.nih.gov/pubmed/15199454",
                "http://www.ncbi.nlm.nih.gov/pubmed/19179293",
                "http://www.ncbi.nlm.nih.gov/pubmed/26990117",
                "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                "http://www.ncbi.nlm.nih.gov/pubmed/22594507",
                "http://www.ncbi.nlm.nih.gov/pubmed/6808349",
                "http://www.ncbi.nlm.nih.gov/pubmed/24281558",
                "http://www.ncbi.nlm.nih.gov/pubmed/1464277",
                "http://www.ncbi.nlm.nih.gov/pubmed/940363"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 403,
                    "offsetInEndSection": 645,
                    "text": "Since the possible interactions between these two classes of drugs have been poorly explored in literature, with a risk to the patients who use them, we reviewed the pharmacology of warfarin and its possible interactions with antidepressants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15199454",
                    "endSection": "abstract",
                    "offsetInBeginSection": 582,
                    "offsetInEndSection": 815,
                    "text": "The pharmacokinetic and pharmacodynamic properties of warfarin as well as its narrow therapeutic index make it particularly susceptible to interactions with other prescription and nonprescription drugs, including dietary supplements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/940363",
                    "endSection": "abstract",
                    "offsetInBeginSection": 128,
                    "offsetInEndSection": 338,
                    "text": "The results indicated that among the different drugs tested phenylbutazone, indomethacin, warfarin and tolbutamide were, in the order listed, the most effective in displacing diftalone from its binding site(s)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26990117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 318,
                    "offsetInEndSection": 606,
                    "text": "We demonstrate here the utility of model-based DDI prediction for a clinically relevant warfarin regimen, using the example of epacadostat (INCB024360), the first-in-class indoleamine 2,3-dioxygenase 1 inhibitor in clinical development as a novel orally active immuno-oncological therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to interact with the oral anticoagulant warfarin and can cause a serious bleeding complication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1021,
                    "offsetInEndSection": 1204,
                    "text": "In conclusion, special caution is required when an NSAID is administered to warfarin users if patients are taking warfarin >40 mg/week and other medications interacting with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24281558",
                    "endSection": "abstract",
                    "offsetInBeginSection": 390,
                    "offsetInEndSection": 444,
                    "text": "Warfarin interacts with several medications and foods."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6808349",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 664,
                    "text": "This is most pronounced in the case of glibenclamide, which strongly inhibits the binding of drugs to the azapropazone site with only minor effects on drugs bound to the warfarin site."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24281558",
                    "endSection": "abstract",
                    "offsetInBeginSection": 629,
                    "offsetInEndSection": 846,
                    "text": "Over the past decade, attempts have been made to develop drugs that are at least as safe and effective as warfarin for the treatment of atrial fibrillation that do not require monitoring nor have as many interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6808349",
                    "endSection": "abstract",
                    "offsetInBeginSection": 665,
                    "offsetInEndSection": 981,
                    "text": "The lone tryptophan residue of human serum albumin, previously shown to be part of the warfarin binding site, is obviously located in the not-overlapping part of the warfarin site, so that its modification affects only the binding of drugs to the warfarin and not to the azapropazone site of this large binding area."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/869834",
                "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                "http://www.ncbi.nlm.nih.gov/pubmed/12144477",
                "http://www.ncbi.nlm.nih.gov/pubmed/17119338",
                "http://www.ncbi.nlm.nih.gov/pubmed/25274322",
                "http://www.ncbi.nlm.nih.gov/pubmed/8368603",
                "http://www.ncbi.nlm.nih.gov/pubmed/1516375",
                "http://www.ncbi.nlm.nih.gov/pubmed/12297573",
                "http://www.ncbi.nlm.nih.gov/pubmed/29207625",
                "http://www.ncbi.nlm.nih.gov/pubmed/26712259"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                    "endSection": "abstract",
                    "offsetInBeginSection": 712,
                    "offsetInEndSection": 967,
                    "text": "The topological body map was assessed by means of the \"Frontal body-evocation subtest\" (Daurat-Hmeljiak, Stambak, & Berges, 1978), in which participants have to put tiles (each representing a body part) on a small wooden board on which a head is depicted."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12297573",
                    "endSection": "abstract",
                    "offsetInBeginSection": 934,
                    "offsetInEndSection": 1179,
                    "text": "CONCLUSION\nThese results can be accounted for by the assumption that body part coding of gestures depends on left hemisphere function and that additional right hemisphere contributions are afforded when demands on perceptual discrimination rise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12297573",
                    "endSection": "abstract",
                    "offsetInBeginSection": 337,
                    "offsetInEndSection": 460,
                    "text": "OBJECTIVE\nTo assess body part specificity of disturbances of imitation for meaningless gestures of fingers, hand, and foot."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/869834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 304,
                    "text": "If the body is only loosely padded in the experimental apparatus, then apparent motion of part of the body surface may be experienced sometime after rotation has been terminated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1516375",
                    "endSection": "abstract",
                    "offsetInBeginSection": 93,
                    "offsetInEndSection": 274,
                    "text": "It also has been reported that psoriasis of the face is more prevalent in children than in adults, and when it does occur, at any age, the face is never the only body part involved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26712259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 395,
                    "offsetInEndSection": 497,
                    "text": "Failure to identify and release the acute constriction may result in amputation of affected body part."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 312,
                    "text": "Processing the position and the relations among different body parts is necessary to build up a specific body representation, that is, the visuospatial body map (or topological map of the body)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26712259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 330,
                    "text": "A strand or strands of hair act like a circumferential constriction band and subsequently strangulate the body appendages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/869834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 487,
                    "text": "This somatosensory motion aftereffect of opposite sign is temporarily abolished if one looks at the affected body area, but is again re-experienced when the gaze is shifted elswhere."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "OBJECTIVE\nBody representation is a complex process involving different sources of top-down and bottom-up information."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                "http://www.ncbi.nlm.nih.gov/pubmed/19116360",
                "http://www.ncbi.nlm.nih.gov/pubmed/26679725",
                "http://www.ncbi.nlm.nih.gov/pubmed/22814459",
                "http://www.ncbi.nlm.nih.gov/pubmed/9239499",
                "http://www.ncbi.nlm.nih.gov/pubmed/26064878"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 692,
                    "text": "BORSA cannot be classified as either truly methicillin-resistant or truly methicillin-susceptible strains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1), but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) - a more common problem than expected?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 455,
                    "text": "BORSA strains show low, borderline resistance to penicillinase-resistant penicillins (PRPs), with oxacillin MICs typically equal to 1-8\u2009\u00b5g\u2009ml-1, and in contrast to methicillin-resistant S. aureus (MRSA), do not have an altered penicillin-binding protein, PBP2a, encoded by the mecA or mecC gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 921,
                    "offsetInEndSection": 1123,
                    "text": "The epidemiology and clinical presentation of BORSA infections seem to be similar to those for MRSA; these infections are usually more severe than those caused by methicillin-sensitive S. aureus (MSSA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA) in the clinical laboratory."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 576,
                    "text": "Under these conditions, ampicillin/sulbactam appears to be more accurate than amoxicillin/clavulanic acid for differentiating BORSA from MRSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19116360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 162,
                    "text": "Clinical evidence for failure with beta-lactam therapy has been lacking for patients with borderline oxacillin-resistant Staphylococcus aureus (BORSA) infections."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1066,
                    "offsetInEndSection": 1175,
                    "text": "This clearly shows that BORSA may be misidentified as MRSA while heteroresistant MRSA may appear to be BORSA."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22874921",
                "http://www.ncbi.nlm.nih.gov/pubmed/15986890",
                "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                "http://www.ncbi.nlm.nih.gov/pubmed/2905685",
                "http://www.ncbi.nlm.nih.gov/pubmed/15685218",
                "http://www.ncbi.nlm.nih.gov/pubmed/12073014",
                "http://www.ncbi.nlm.nih.gov/pubmed/12524352",
                "http://www.ncbi.nlm.nih.gov/pubmed/3607875",
                "http://www.ncbi.nlm.nih.gov/pubmed/20870045"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15685218",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 561,
                    "text": "The discovery of a mutation in FOXP2 in a family with a speech and language disorder has enabled neuroscientists to trace the neural expression of this gene during embryological development, track the effects of this gene mutation on brain structure and function, and so begin to decipher that part of our neural inheritance that culminates in articulate speech."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "BACKGROUND\nMutations in the human FOXP2 gene cause speech and language impairments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2905685",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Antennapedia (Antp), a homeotic gene of Drosophila required for proper differentiation of the thorax of the fly, is expressed in complex spatial patterns during development."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Multiple microRNAs regulate human FOXP2 gene expression by targeting sequences in its 3' untranslated region."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15986890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 847,
                    "offsetInEndSection": 972,
                    "text": "The other interesting feature is that two polyadenylation signal sequences (AATAAA) exist in 3'UTR of the pig myostatin gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "The moleskin gene product is essential for Caudal-mediated constitutive antifungal Drosomycin gene expression in Drosophila epithelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "The homeobox gene, Caudal, encodes the DNA-binding nuclear transcription factor that plays a crucial role during development and innate immune response."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 712,
                    "text": "Furthermore, Caudal-mediated constitutive expression of antifungal Drosomycin gene was severely affected in the moleskin-RNAi flies, showing a local Drosomycin expression pattern indistinguishable from that of the Caudal-RNAi flies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1168,
                    "offsetInEndSection": 1338,
                    "text": "CONCLUSIONS\nOur results reveal novel regulatory functions of the human FOXP2 3' UTR sequence and regulatory interactions between multiple miRNAs and the human FOXP2 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2905685",
                    "endSection": "abstract",
                    "offsetInBeginSection": 258,
                    "offsetInEndSection": 455,
                    "text": "To characterize cis-acting regulatory elements responsible for the expression pattern, fusions of the Antp promoter 2 cap site and upstream sequences to an Adh-lacZ gene were introduced into flies."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 919,
                    "offsetInEndSection": 1050,
                    "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892",
                    "endSection": "abstract",
                    "offsetInBeginSection": 654,
                    "offsetInEndSection": 926,
                    "text": "The extract, when tested colorimetrically for its inhibitory activities on phosphordiesterase-5 (PDE-5) in vitro towards p-nitrophenyl phenyl phosphate (PNPPP), was observed to induce significant dose-dependent inhibition of PDE-5, with an ID(50) of 0.161\u2009mg/ml (P < .05)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 531,
                    "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "OBJECTIVE\nTo study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1647,
                    "offsetInEndSection": 1826,
                    "text": "Structural comparison of PdeM with its homologs showed that it lacked critical residues required for dimerization, cAMP hydrolysis, and for the high affinity binding of bis(pNPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1225,
                    "offsetInEndSection": 1399,
                    "text": "Overexpression of PdeM in E.coli neither affected catabolite respression nor did the recombinant protein hydrolyzed cAMP in vitro, indicating its inability to hydrolyze cAMP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 532,
                    "offsetInEndSection": 702,
                    "text": "The + MP plant lines, as compared with other transgenic plants, exhibited higher nucleotide-phosphodiesterase activity in the soluble as well as in the membrane fraction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 703,
                    "offsetInEndSection": 961,
                    "text": "Substrate concentration kinetic studies revealed the presence of a nucleotide-phospho-diesterase with a high substrate affinity in the +MP extracts in addition to the enzyme with a relatively low substrate affinity present also in the - MP transgenic plants."
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27418254",
                "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                "http://www.ncbi.nlm.nih.gov/pubmed/26695521",
                "http://www.ncbi.nlm.nih.gov/pubmed/27486138",
                "http://www.ncbi.nlm.nih.gov/pubmed/26695146",
                "http://www.ncbi.nlm.nih.gov/pubmed/26162196",
                "http://www.ncbi.nlm.nih.gov/pubmed/26910273",
                "http://www.ncbi.nlm.nih.gov/pubmed/27061298",
                "http://www.ncbi.nlm.nih.gov/pubmed/19432981"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2503,
                    "offsetInEndSection": 2707,
                    "text": "As an increasing number of epidemiologists employ Mendelian randomization methods in their research, caution is therefore needed in drawing conclusions from these studies if these assumptions are not met."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27061298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 696,
                    "offsetInEndSection": 930,
                    "text": "In a simulation analysis, it is shown to have better finite-sample Type 1 error rates than the inverse-variance weighted method, and is complementary to the recently proposed MR-Egger (Mendelian randomization-Egger) regression method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2146,
                    "offsetInEndSection": 2376,
                    "text": "CONCLUSION\nGiven an inheritance of gene expression from parents, Mendelian randomization studies not only need to assume a random distribution of alleles in the offspring, but also a random distribution of epigenetic changes (e.g."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 984,
                    "text": "We also give a framework for performing and interpreting investigations performed in the style of Mendelian randomization, but where the choice of genetic variants is statistically, rather than biologically motivated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26695146",
                    "endSection": "abstract",
                    "offsetInBeginSection": 257,
                    "offsetInEndSection": 475,
                    "text": "The incorporation of Mendelian randomization (MR) with a meta-analysis has revolutionized traditional practice and is emerging as a viable technique to strengthen causal unconfounded inferences from observational data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27061298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 193,
                    "offsetInEndSection": 460,
                    "text": "However, obtaining reliable results from a Mendelian randomization investigation remains problematic, as the conventional inverse-variance weighted method only gives consistent estimates if all of the genetic variants in the analysis are valid instrumental variables."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 122,
                    "offsetInEndSection": 304,
                    "text": "If genetic variants which are instrumental variables for a risk factor are shown to be additionally associated with a disease outcome, then the risk factor is a cause of the disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1293,
                    "offsetInEndSection": 1723,
                    "text": "Although previous articles have addressed some of the limitations of Mendelian randomization (such as the lack of suitable genetic variants, unreliable associations, population stratification, linkage disequilibrium (LD), pleiotropy, developmental canalization, the need for large sample sizes and some potential problems with binary outcomes), none has directly characterized the impact of epigenetics on Mendelian randomization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 770,
                    "offsetInEndSection": 871,
                    "text": "The authors conclude that Mendelian randomization is a powerful addition to etiologic research tools."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27486138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1093,
                    "text": "An observed association between the genetic instrumental variable and the outcome supports the hypothesis that the exposure in question is causally related to the outcome."
                }
            ]
        }
    ]
}